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ABSTRACT
The Enhanced Recovery After Surgery model of perioperative care targets the
obstacles to recovery following major abdominal surgery: pain, gastrointestinal
dysfunction and immobility. This model of care combines elements that have
individually been shown to attenuate the surgical stress response, reduce
postoperative analgesia requirement or maintain perioperative nutrition. Through
combining these elements it has been possible to improve early postoperative function
and reduce the requirement for hospital stay with an unaltered or even reduced
complication rate.
Within the available ERAS studies subjective postoperative outcomes are employed
and it is difficult to assess the true contribution of many of the individual protocol
elements to postoperative recovery. The reduction in length of stay, in itself, may
represent more efficient use of inpatient care rather than an improved rate of
functional recovery. Further refinement and validation of the ERAS model will be
achieved by establishing randomised controlled trials that test its feasibility and
effectiveness within other surgical specialties, establish objective, reproducible
outcome measures and examine the specific contribution of individual protocol
elements within the ERAS protocol. It is expected that further improvement in
postoperative recovery may specifically rely on reducing gut dysfunction in the early
postoperative period. The establishment of randomised controlled trials and objective
endpoints will facilitate testing individual element that target gastrointestinal
recovery.
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This thesis demonstrates that the application of an ERAS model of care to hepatic
surgery is feasible and results in a reduction in postoperative stay similar to that seen
in colorectal surgery. This suggests that the ERAS programme of care may be
extrapolated to other surgical specialties. The present thesis also demonstrates that
activity meters and stable isotope gastric empting breath tests can be employed in the
early postoperative period to provide objective measures of postoperative recovery.
Most significantly this thesis demonstrates through a randomised controlled trial that
within an ERAS protocol early routine administration of laxatives can improve
postoperative rate of gastrointestinal recovery following hepatic resection.
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SUMMARY OF THESIS
The ERAS programme aims to reduce postoperative organ dysfunction and the
requirement for inpatient hospital stay through a series of perioperative measures that
abate the stress response to surgery. The present thesis describes the concept of the
surgical stress response and the current knowledge base for the ERAS protocol in
colorectal surgery. It then explores the application of such a protocol in liver
resection, potential benefits for higher risk patients, the development of novel
objective outcome measures and the significance of perioperative nutritional
conditioning and postoperative laxation within an ERAS protocol.
Chapter 1 describes the pathophysiological response to surgery and its negative
impact on postoperative recovery. The evidence for individual elements of the ERAS
protocol is explored along the overall benefits of a combining such elements. The
limitations of the existing evidence base are also described. Finally, the potential role
of routine laxation and oral nutritional supplements administered in the early
postoperative period within an overall ERAS programme is discussed along with
potential objective endpoints to better gauge the success of enhanced recovery
programmes.
Many ERAS trials present small, single hospital series. The ERAS study group is an
international collaboration of five European centres each contributing to a prospective
database providing a multi-centre, prospective database of over 1000 patients was
available. This database was examined to determine the overall safety of the ERAS
programme and to assess its potential benefit for higher risk patients specifically the
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elderly, undernourished and those with significant comorbidity. In Chapter 2 of the
present thesis the ERAS programme of care is shown to promote faster postoperative
recovery for 1035 patients undergoing colorectal resection within an ERAS
programme of care. A median hospital stay of 6 days is achieved with a readmission
rate of 8-6 percent and a morbidity rate lower than predicted by P-POSSUM. Against
this background of favourable clinical outcomes, neither poor nutritional status (BMI
below 20 kg/m2), nor advanced age (80 years or more) were independent predictors of
postoperative 30 - day morbidity or mortality. These findings suggest that within an
ERAS programme the surgeon does not need to individualize postoperative morbidity
or mortality risk assessment for elderly or undernourished patients. In contrast,
comorbidity was a consistent independent determinant for all outcomes.
The ERAS model has been developed mainly within colorectal surgery. Although
other areas of surgery have adapted the ERAS approach (orthopaedics, vascular),
upper gastrointestinal and hepatobiliary surgery remains relatively under-researched.
In Chapter 3 a multimodal ERAS programme for patients is demonstrated to be safe
and effective for 61 patients undergoing liver resection. Fifty-six patients in the ERAS
group tolerate fluids within four hours of surgery, median time to commencing oral
diet is one day compared with three in the control group (P < 0 001) and median time
to discharge is six days compared with eight in the control group (P < 0 001). These
outcomes were achieved without any significant increase in readmission rate,
morbidity or mortality.
In order to develop ERAS programmes further, novel outcome measures are required
to assess postoperative gastrointestinal function and overall functional recovery
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objectively. In Chapter 4 32 patients underwent stable isotope breath testing (SIBT)
on postoperative day three following hepatic resection and managed within an ERAS
programme of care. SIBT is demonstrated to be a feasible postoperative test to
examine liquid gastric emptying as a measure of postoperative recovery. A link
between delayed gastric emptying and delayed hospital discharge is suggested.
Early mobilisation is a key component of the ERAS protocol. Activity monitoring can
document patients' mobility in he early postoperative period and act as a measure of
recovery. In Chapter 5 the use of postoperative physical activity monitoring is
evaluated in 50 patients in the early postoperative period following hepatic resection
within an ERAS programme of care. Physical activity monitoring is shown to be a
feasible method of assessing recovery in the early postoperative period. Patients
following an ERAS programme of care demonstrate a prompt increase in activity
level in the early postoperative phase and early step count appears to correlate with
length of hospital stay.
Preoperative conditioning is a significant part of any ERAS programme. One element
of this preparation is to send the patient to theatre in a metabolically fed state.
Traditionally, not only have patients been fasted, they have also been given
mechanical bowel preparation. Whilst MBP has been largely abandoned for colonic
procedures there are occasions when it is still desirable. Currently use of MBP
precludes feeding. In Chapter 6 the use of preoperative carbohydrate and fluid
loading are demonstrated to be feasible for patients also receiving mechanical bowel
preparation. In a prospectively audited group of 147 patients receiving MBP, 83 % of
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patients were able to complete the prescribed ONS, 80 % the prescribed CHO/fluid
loading and 74 % completed both.
A further concept in preoperative preparation is to provide additional metabolic
conditioning agents along with carbohydrate loading. There are, however, questions
related to the gastric emptying profile and therefore safe preoperative administration
of any new preparation. In Chapter 7 the gastric emptying rate of a new beverage
containing glutamine and antioxidants in two concentrations is evaluated and
compared with an existing and widely used clear carbohydrate beverage in a three-
way crossover study of 20 healthy volunteers using MR imaging. MR imaging
confirms complete emptying of the clear carbohydrate solution from the stomach
within 120 minutes and therefore its suitability to be administered up to two hours
prior to anaesthesia as any other clear fluid. The new beverage, however, required 180
minutes to empty from the stomach in both 300 ml and 400 ml concentrations and
therefore cannot be safely administered as a 'clear fluid'.
The evidence for many of the individual elements of the ERAS protocol has been
established within traditional care. There is a need to examine which elements are
significant when employed within an overall ERAS package. In Chapter 8, 74
patients were recruited to a 2 x 2 factorial study evaluating the effect of routine
postoperative laxation, postoperative nutritional supplements and their potential
interaction within an ERAS programme of care. In this study routine postoperative
laxation is shown to expedite gastrointestinal recovery within an ERAS protocol for
patients undergoing liver resection. This resulted in an earlier first passage of stool.
There was not any additional benefit demonstrated when laxation is combined with
15
preoperative carbohydrate loading and postoperative oral nutritional supplements.
Overall, patients following the ERAS protocol recommenced oral fluid intake on the
same day as surgery, had started eating the day after surgery and were fully mobile by
the third postoperative day. They had achieved discharge criteria on the fourth
postoperative day and median length of hospital stay was 6 days. There was no further
improvement in overall rate of recovery beyond that achieved within the ERAS
programme for the groups receiving laxation or nutritional supplements.
This thesis demonstrates the clinical safety and efficacy of ERAS when applied to
both colorectal and hepatobiliary surgery. The first randomised trial of a protocol
element within an ERAS programme is presented along with novel, objective
endpoints to allow further protocol development. It would appear that ERAS
represents an important step forwards for perioperative care. There is both the
potential to develop such a programmes in different surgical models and to further
refine the ERAS protocol for a more effective recovery.
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SECTION A. HYPOTHESIS AND AIMS
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Through targeting the key elements that delay postoperative hospital discharge, pain,
immobility and gut dysfunction, the ERAS programme has been shown to promote
earlier recovery following major colorectal surgery. These benefits are achieved with
a similar or even reduced incidence of postoperative morbidity. The elderly,
undernourished and infirm population are at particular risk following postoperative
complications and therefore would have most to gain from any intervention that can
successfully reduce postoperative morbidity. It is currently unclear if such benefits
can be achieved in these high-risk patients.
To further test and refine the ERAS protocol it should be applied to other surgical
specialties. It is currently unclear if such a model of care will be feasible for all
surgical specialities and if similar improvements in postoperative outcomes can be
achieved. Due to the fact that postoperative outcomes following hepatic resection are
relatively predictable the establishment of an ERAS-liver care pathway is likely to
provide a suitable model in which to further test the individual elements of the ERAS
protocol within randomised controlled trials.
Much of the evidence for individual elements of the ERAS package has been
established within traditional perioperative care. Although the overall ERAS package
has been shown to be of benefit it is not clear which of the elements employed are of
most significance. Within existing ERAS studies the outcomes employed as endpoints
are often subjective or in effect markers of protocol compliance. Few objective
markers exist to allow appropriate comparison between perioperative interventions.
The development of suitable, objective endpoints and structured randomised
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controlled trials within a background of an ERAS care pathway will provide a more
scientific measure of the significance of individual protocol elements.
Future improvements in postoperative recovery rate are likely to be gained by
optimising gastrointestinal function in the early postoperative period and increasing
oral intake. Preoperative carbohydrate drinks are one element employed within ERAS
that has been demonstrated to reduce the negative metabolic effects of surgery. New
preoperative drinks, which combine glutamine and antioxidants with carbohydrate,
may provide further benefits, however, their gastric emptying profile is unknown and
it may not be safe to administer these drinks in the same time frame as existing
carbohydrate only drinks.
The aims of this thesis are to explore the feasibility of an ERAS package of care in
other surgical specialties, examine its benefits in higher risk groups and assess the
safety of a novel preoperative, conditioning drink. Through a randomised controlled
trial this thesis aims to assess the specific contribution of combining routine
postoperative laxation with preoperative nutritional conditioning and postoperative
nutritional supplements to promote earlier recovery of gastrointestinal functional and
therefore overall functional recovery. This is summarised in Figure 1.1.
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Figure 1.1 Overview of thesis aims and objective.
Desire for rapid recovery and low morbidity
rate despite increased number of high risk
patients
1
Unclear ifERAS model can be applied to
hepatic surgery.
Unclear which patient groups benefit from an
ERAS programme of care
Unclear which elements ofERAS protocol
are significant
Requirement for RCTs and objective
outcomes
No clear evidence of the benefit of routine
postoperative laxation and perioperative
nutritional supplements to promote early
return ofGI function and overall recovery
Examine the benefits
of an ERAS protocol























1. The benefits of the ERAS approach to perioperative care are
applicable to all patient groups including those traditionally at
higher risk.
2. The ERAS protocol can be safely applied to patients undergoing
hepatic resection.
3. Hepatic resection can provide a suitable human model for
randomised controlled trials in enhanced recovery.
4. Gastric emptying and activity level can provide objective
postoperative outcomes for future trials of enhanced recovery
protocols.
5. Administration of preoperative, metabolic conditioning drinks in
combination with mechanical bowel preparation is safe and feasible.
6. Preoperative drinks combining carbohydrate with additional
metabolic conditioning elements (glutamine and antioxidants) can
be safely administered to patients two hours prior to surgery
21
7. Enhanced recovery of gastrointestinal function combined with use of
oral nutritional supplements and preoperative carbohydrate and
fluid loading may optimise recovery of postoperative nutritional
status and physical function following hepatic resection.
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To establish if the improved postoperative outcomes demonstrated within an ERAS
pathway could be achieved by all patient groups, including those traditionally at
higher risks (advanced age, undernourished or those with significant comorbidity), a
cohort study of 1035 patients undergoing colorectal resection within an enhanced
recovery after surgery programme was explored. This included data on patient
demographics, perioperative management and postoperative outcomes (including time
to achieve targeted mobility, total length of hospital stay, complications and 30-day
mortality) and was collected prospectively across a number of centres. The outcomes
for specific groups of patients with adverse nutritional risk (body mass index (BMI)
below 20 kg/m2), advanced age (80 years or more) and comorbidity (American
Society ofAnesthesiologists (ASA) grade III—IV) are discussed in Chapter 2.
A pilot study of patients undergoing liver resection within an ERAS care pathway was
performed to examine both its feasibility in such a group and to develop a predictable
model for future randomised controlled trials. A consecutive series of sixty-one
patients, undergoing hepatic resection, followed an ERAS protocol modified for
hepatobiliary surgery. Postoperative outcomes were compared with a consecutive
series of patients undergoing surgery within a traditional care pathway. The feasibility
of the enhanced recovery protocol and a comparison of the endpoints for both groups
are discussed in Chapter 3.
The potential role of gastric emptying and physical activity as objective markers of
postoperative recovery was assessed in patients undergoing hepatic resection within
an ERAS pathway. A stable isotope breath testing technique, suitable for bedside
testing was used to measure liquid gastric emptying on postoperative day three and a
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discrete, patient worn accelerometer device used to record physical activity between
postoperative days 3 - 9 and 30 - 40. The results obtained from both techniques were
compared with other traditional postoperative outcomes in Chapters 4 and 5.
To determine the feasibility of administering preoperative metabolic conditioning
drinks and protein supplements in combination with mechanical bowel preparation
where necessary, a cohort of patients receiving such a combination of preoperative
interventions is presented in Chapter 6.
To guide the safe administration of a novel preoperative metabolic conditioning
regimen containing glutamine and antioxidants, a randomised, crossover study was
performed. This compared the gastric emptying times of two concentrations of the
novel drink with a widely available carbohydrate only preparation using magnetic
resonance imaging. This is presented in Chapter 7
To establish the potential role of routine postoperative laxation to promote early
recovery of gastrointestinal function within an ERAS programme and then assess the
potential interaction of such an improvement with a combination of preoperative
carbohydrate/ fluid loading and postoperative oral nutritional supplementation, a
randomised controlled trial was performed. This two-by-two factorial study is




Chapter 1. Enhanced Recovery After Surgery concept
This chapter briefly outlines the surgical stress response and its metabolic sequelae
following uncomplicated major abdominal surgery, the concept of the Enhanced
Recovery After Surgery programme and its potential role in both colorectal and
hepatic surgery. The limitations of existing datasets, the evidence base for specific
elements of the ERAS protocol and the subjective outcome measures currently
employed in most of the existing trials are also discussed.
The future direction of the ERAS programme and therefore potential improvements in
both rate of postoperative recovery and morbidity are likely to depend on optimising
perioperative gastrointestinal function. This chapter assesses the role of the existing
protocol elements to promote early recovery of gastrointestinal function and discusses
the limitations in the current models used to test such elements. Evidence to support
the use of routine postoperative laxation within an enhance recovery of
gastrointestinal function is examined along with its potential combination with
preoperative carbohydrate/ fluid loading and postoperative oral nutritional
supplementation to improve overall functional recovery.
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1.1 The surgical stress response and metabolic sequelae.
Cuthbertson originally described an orchestrated stress response to trauma,
characterised by a period of catabolism (Cuthbertson, 1930;Cuthbertson, 1931). In the
period following major surgery there is a similar period of hypermetabolism, malaise
and potentially organ dysfunction due to activation of the endocrine, metabolic and
inflammatory systems (Wilmore, 2002).
The endocrine response is activated by afferent neuronal stimulation from the site of
injury/ incision and direct release of cytokines (IL1, IL6, TNFa) from macrophages
and monocytes in the damaged tissues (Egdahl, 1959). There is activation of the
sympathetic nervous system and release of catecholamines; an increased level of
ACTH stimulating the release of glucocorticoids such as Cortisol; and increased
release of growth hormone and vasopressin (Ingle et al, 1947;Cochrane et al,
1981;Starnes et al, 1988;Hill, 2000). There is a decreased production of insulin, a
reduced cellular response to insulin and a transient increase in glucagon (Thorell et al,
1999). Blood glucose level is elevated in proportion to the intensity of surgery and
remains so for over 24 hours (Thorell et al, 1993). The net increase in catabolic
hormones results in a breakdown of carbohydrate, fat and protein (Bessey et al,
1984;Shaw et al, 1987;Bessey et al, 1993). Protein (predominantly skeletal muscle but
including visceral protein) is broken down for the production of energy and acute
phase proteins resulting in muscle wasting and weight loss (Kinney et al,
1983;Schricker et al, 2001). There is lipolysis and mobilisation of
triglycerides (Jorgen et al, 1991). The increased release of vasopressin promotes water
retention through concentration of urine along with the Renin-angiotensin-aldosterone
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system, which promotes the reabsorption of sodium and water from the distal tubules
in the kidney. The increased release of catecholamines produces tachycardia and
hypertension (Desborough, 2000).
Overall there is a mobilisation of substrate to provide energy, which is combined with
a mechanism to retain salt and water to support cardiovascular haemostasis. These
responses have presumably evolved to confer a survival benefit (allowing catabolism
of stored body fuels and maintained blood pressure). Within modern surgical practice,
however, they may be less useful and if prolonged they may have deleterious effects
on the body's nutritional status and physiological reserves (Kehlet, 1997). Left
unabated this surgical stress response, compounded by the effects of traditional
perioperative care (starvation, fluid overload and immobilisation), can result in
functional decline following major abdominal surgery. Patients undergoing
technically uncomplicated procedures therefore require an indefinite period of
hospital stay. Usually the key factors that necessitate this inpatient care are a
requirement for parenteral analgesia, intravenous fluids or immobility.
Although advances in perioperative care have reduced the rate of surgical and
anaesthetic complications, no single intervention has been able to eliminate 'medical'
complications (MI, pulmonary dysfunction, renal failure, infective complications).
There is an ever-increasing number high-risk and elderly patients presenting for
surgery. Traditionally within surgery these groups require special consideration and
individually tailored perioperative management, however, despite this they still have
an increase risk of both postoperative morbidity and mortality (Giner et al,
1996;Polanczyk et al, 2001;Fazio et al, 2004). Modification of the undesirable effects
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of the stress response (organ dysfunction, immobility, catabolism) may be the key to
improving postoperative outcomes.
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1.2 The Enhanced Recovery After Surgery Concept
Enhanced recovery after surgery is a clinical pathway, which combines preoperative
metabolic optimisation, optimal pain relief, perioperative stress reduction with
regional anaesthesia, early enteral nutrition and early mobilisation. It aims to reduce
postoperative functional decline, postoperative morbidity and accelerate postoperative
recovery after major abdominal surgery.
The ERAS protocol challenges both the traditional view of an inevitable perioperative
stress response and the elements of traditional perioperative care which compound
postoperative organ dysfunction (Fig 1.2). Many elements of the programme elements
focus on postoperative pain, gastrointestinal function and mobility. These are the
main elements that delay hospital discharge; therefore addressing these may allow
earlier discharge from hospital.
As patients following such protocols often achieve discharge criteria earlier and
require a shorter duration of hospital stay (in comparison with those following a
traditional pathway) the term 'fast-track surgery' is often used interchangeably with
ERAS. However, the aim of the ERAS protocol is to reduce postoperative functional
decline and morbidity. In achieving these outcomes it is likely that requirement for
postoperative inpatient care will also be reduced (Basse et al, 2000). Hospital stay,
however, may be unrelated to rate of functional recovery especially if other obstacles
to hospital discharge exist (Maessen et al, 2007). It is possible that the organisational
changes associated with 'fast track surgery' i.e. targeted discharge planning and
avoidance of the potentially unnecessary inpatient days towards the end of a hospital
stay are being mimicked by ERAS protocols (Maessen et al, 2008).
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Other markers may better reflect the attenuation of the surgical stress response.
Cardiac demand (HR/ Sp02) is preserved in groups undergoing colorectal surgery
within an ERAS pathway but elevated in patients following a traditional care
pathway. Pulmonary function (FEVi, FVC, PEF) is preserved in the ERAS group but
reduced in traditional care groups (Basse et al, 2002). There is also a greater
preservation of muscle strength in the early and late postoperative period in patients
following an ERAS protocol (Henriksen et al, 2002). This preservation of muscle
strength and organ function translates into a shorter period of convalescence, an
earlier resumption of physical activities (walking up stairs, house work, driving car,
shopping), a reduced fatigue score by postoperative day fourteen and a greater
incidence of recommencement of leisure pursuits (Jakobsen et al, 2006).
The ERAS protocol attempts to maintain the patient in as near to a physiologically
and metabolically normal state (Fearon et al, 2005). The reduction in organ
dysfunction associated with this regimen of care may also translate into reduced
postoperative morbidity for patients undergoing colorectal resection (Wind et al,
2006). In higher risk patient groups undergoing surgery within an ERAS programme
reduced postoperative morbidity will be ofmore benefit than reduced length of stay.
In the past two decades, the application of multimodal Enhanced Recovery After
Surgery care protocols has achieved significant improvements in the outcome of a
variety of surgical procedures. Such protocols are safe, effective, accelerate recovery
and can reduce hospital stay following elective aortic aneurysm repair (Podore et al,
1999), oesophagectomy (Cerfolio et al, 2004) and colorectal resection (Basse et al,
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2000).
These protocols, however, have not been universally adopted despite evidence to
support the role of an ERAS package of care. This may be due to the fact that there
are few randomised controlled trials of ERAS available and many of the existing
outcome markers are subjective. The multidisciplinary nature of the protocol
necessitates the participation of a large group of professionals and achieving the high
rates of compliance required to achieve uniformity of patient care is
difficult (Maessen et al, 2007). The increased readmission rate associated with the
most dramatic results achieved in specialist centres is also undesirable (Basse et al,
2004). As there is variable evidence for the individual protocol elements many centres
have chosen to implement the individual protocol elements with strong evidence
rather than a more complicated care pathway.
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Fig 1.2 Target domains for ERAS
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1.3 The components of the ERAS multimodal care pathway within colorectal
surgery
The enhanced recovery protocol combines individual elements that optimise
perioperative fluid balance, provide dynamic analgesia, enforce early mobilisation
and encourage early oral feeding (See Figure 1.3 - 1.4). Within colorectal surgery, the
introduction of the ERAS protocol has been shown to significantly reduce hospital
stay from two weeks down to five days (Nygren et al, 2005;Wind et al, 2006). This
can be achieved without any increase in postoperative morbidity, mortality or
readmission rate (Gatt et al, 2005). A small number of studies even suggest that a
two-day hospital stay may be feasible after colorectal resection, although this has
been associated with a readmission rate of 11.3 - 20.1 % (Basse et al, 2000;Andersen
et al, 2007).
There is a varying level of evidence to support each of the individual elements of the
ERAS protocol and in many cases evidence is often extrapolated from traditional care
pathways (Fearon et al, 2005). Avoiding routine mechanical bowel
preparation (Guenaga et al, 2005), restricting unnecessary preoperative fasting (Brady
et al, 2003) and providing preoperative oral carbohydrate loading has been shown to
improve perioperative fluid balance. Restriction of postoperative intravenous fluid
and sodium, judicious use of a vasopressor to treat epidural related hypotension and
early return of oral fluid intake is both tolerated and has been demonstrated to further
improve postoperative fluid balance (Basse et al, 2000;Holte et al, 2004). Individually
these elements have been shown to reduce preoperative anxiety (Hausel et al, 2001),
improve postoperative insulin sensitivity (Svanfeldt et al, 2007) and reduce
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complication rate and length of stay (Noblett et al, 2006). The avoidance of long
acting anaesthetic agents and pre-anaesthetic medication (Moiniche et al, 2002)
reduces time to postoperative mobilisation and oral intake. The use of intraoperative
epidural analgesia, achieves both analgesia and sympathetic blockade contributing to
a reduction in the stress response, postoperative insulin resistance (Uchida et al, 1988)
and gut paralysis (Miedema et al, 2003). Epidural analgesia in the postoperative
period also provides dynamic analgesia for both open (Marret et al, 2007) and
laparoscopic surgery (Senagore et al, 2003) without the side effects of sedation. Pain
relief can then be maintained with step-down analgesics such as paracetamol and non¬
steroidal anti-inflammatory drugs.
Early postoperative feeding is promoted (Lewis et al, 2001) in the presence of a multi¬
modal anti-ileus package (Charoenkwan et al, 2007), even in the presence of
colorectal anastomoses, and has been associated with a reduced postoperative
stay (Andersen et al, 2006). The routine administration of postoperative oral
nutritional supplements are of clear benefit in malnourished patients (Beattie et al,
2000) and may benefit patients that are not malnourished (Keele et al, 1997;Smedley
et al, 2004). Their use in combination with preoperative carbohydrate loading and
epidural analgesia has been shown to reduce catabolism and even result in nitrogen
equilibrium (Soop et al, 2004). The ERAS protocol aims to facilitate early oral intake
through minimising postoperative nausea, vomiting and ileus. Exposure to systemic
opiates is minimised and routine intraoperative and postoperative antiemetics
employed (Apfel et al, 2002). Both these measures combined with the previously
mentioned avoidance of fluid overload (Nisanevich et al, 2005), epidural
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analgesia (J0rgensen et al, 2000;Miedema et al, 2003;Marret et al, 2007) and early
mobilisation have been shown to reduce postoperative ileus.
Minimal access surgery has been shown to reduce short-term wound morbidity, time
to gastrointestinal recovery and length of hospital stay within traditional care (Tjandra
et al, 2006). Its benefit is less clear within an ERAS care pathway and it has not been
universally adopted (King et al, 2008). Short, transverse incisions improve rate of
postoperative recovery (O'Dwyer et al, 1992) and may reduce analgesic requirement
and pulmonary compromise (Brown et al, 2005).
Peritoneal drains are avoided as their use does not reduce the incidence or severity of
anastomotic leak (Jesus et al, 2004;Karliczek et al, 2006) and they inhibit
mobilisation. Similarly urinary catheters are removed early, this may be possible
within 24 hours of surgery, even with a thoracic epidural in situ (Basse et al, 2000).
Mobilisation is encouraged and facilitated as protracted bed rest increases insulin
resistance, muscle loss and the risk of medical complications such as
thromboembolism and chest infection. Measures generally accepted within traditional
care such as antibiotic prophylaxis, thromboprophylaxis, avoidance of routine
nasogastric tubes and avoidance of perioperative hypothermia are also employed.
Meta-analysis of the available ERAS trials (each including at least 4 of the core
ERAS elements) demonstrate that patients following such a protocol had a shorter
initial hospital stay, a shorter overall hospital stay (initial stay plus readmission days)
and earlier return of gut function (as marked by reduced time to first passage of flatus
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and stool post surgery) in comparison to those following a traditional care pathway.
There was not any significant difference in readmission rates (Wind et al, 2006).
Although there is variation between the protocol elements employed in published
studies, ERAS pathways reduce both postoperative length of stay and incidence of
postoperative complications. Overall if such a package of care is utilised,
gastrointestinal function recovers earlier, nutritional status is maintained and
postoperative exercise tolerance is improved (Basse et al, 2002). However, despite
these reported benefits, wide spread implementation has often been slow.
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1.4 Development of an Hepatic model of ERAS
Due to advances in liver surgery, long term survival following hepatic resection has
improved dramatically. Within a traditional perioperative care pathway postoperative
recovery following hepatic resection is relatively predictable especially in relation to
perioperative morbidity and mortality. For simple hepatic resection published median
length of hospital stay ranges from 8-14 days (Belghiti et al, 2000;Jarnagin et al,
2002;Dimick et al, 2004). Ten year survival for resection of colorectal metastases
may be as high as 33% and the operative mortality as low as 1% (Memon et al, 2001).
Patients undergoing hepatic surgery are subject to a similar perioperative course as
those undergoing bowel resection, therefore the stress response should be equivalent.
The postoperative recovery will also be subject to the same delays from medium term
sequelae: pain, poor appetite and immobility. Flowever, following liver resection there
will be no gastrointestinal anastomosis or disruption to the gastrointestinal tract. It is
feasible that a modified colorectal ERAS pathway may be applied to liver surgery and
due to the predictable nature of postoperative recovery may have a higher rate of
protocol compliance (Maessen et al, 2007). As many of the existing individual
protocol elements of the ERAS programme are extrapolated from traditional
care (Fearon et al, 2005) this model of ERAS perioperative care for patients
undergoing liver resection would serve as an ideal model in which to evaluate
individual elements of the protocol such as early feeding and gastrointestinal
stimulation and provide evidence that could be extrapolated to other surgical
specialties.
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1.5 Acceptance of the Enhanced Recovery After Surgery concept
Traditionally it has been accepted that major abdominal surgery is followed by a
prolonged period of postoperative recovery. Postoperative length of hospital stay for
patients undergoing colorectal resection has been quoted as 10-12 days (Bokey et al,
1995;Schoetz et al, 1997) with a complication rate of 15-48% (Bokey et al,
1995;Basse et al, 2000). Moreover, certain elements routinely employed in traditional
perioperative care have been shown to have a negative effect postoperative recovery.
Drains and catheters reduce mobility (Jesus et al, 2004;Karliczek et al, 2006) and both
prolonged fasting and sodium rich intravenous fluids (Lobo et al, 2002) delay
gastrointestinal recovery. The ERAS programme was devised to address these
particular issues (Fearon et al, 2005) and its adoption has resulted in an improved rate
of recovery following colorectal surgery. Certain specialist centres achieving a length
of hospital stay as low as 2 - 3 days (Kehlet et al, 1999;Andersen et al, 2007). The
ERAS protocol has been tailored to other areas such as oesophagectomy (Cerfolio et
al, 2004;Jiang et al, 2009), aneurysm repair (Podore et al, 1999;Murphy et al, 2007)
and gynaecological surgery (Moller et al, 2001;Ottesen et al, 2002) with a similar
reduction in length of hospital stay and morbidity. It may therefore be possible to
apply this system of care to most major surgical procedures and its use in hepatic
surgery will be explored within this thesis.
Despite the evidence supporting the implementation of an Enhanced Recovery After
Surgery most of the existing data is subject to the similar limitations. These
limitations may go some way to explain why universal uptake of the ERAS protocol
has been slow.
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The majority of studies examining the role of an ERAS programme compare the
outcomes achieved within an ERAS group with either a retrospective group of
patients following a traditional care pathway, patients undergoing care in another
institution (Hjort Jakobsen et al, 2004) or even care within another country (Nygren et
al, 2005). Moreover, only a small number of trials adequately randomise patients to
ERAS versus a traditional care (Anderson et al, 2003;Gatt et al, 2005).
Blinding is an important part of the methodology in randomised controlled trials,
however, both blinding and randomisation are difficult to perform in ERAS trials.
Attempts that have been made to decrease bias include the introduction of objective
discharge criteria (Gatt et al, 2005). Other elements are more difficult to blind from
the subject and the assessor. For elements such as reduced preoperative fasting,
CHO/fluid loading, epidural use, early postoperative mobilisation, early feeding and
avoidance of drains and catheters it is simply not possible to blind the subject.
Preoperative counselling is a significant part of the ERAS protocol. This is seen to
empower patients and give them ownership of their recovery and inform them about
the benefits of early postoperative mobilisation and diet early. Medical staff are also
part of this perioperative journey. Many of the elements of the ERAS protocol require
both motivated patients and hospital staff and it is clear that improved protocol
compliance may promote further improvements in postoperative outcomes (Maessen
et al, 2007). As the key to further improvements appears to be the intervention of
hospital staff and compliance of patients it would appear that efforts to enforce
blinding might hinder further improvements.
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Elements of the ERAS programme of care may be adopted on an element-to-element
basis depending on available evidence. Perioperative thoracic epidural analgesia has
become almost standard practice, carbohydrate loading is being readily adopted and
there is increased emphasis on early postoperative mobilisation and feeding. The
individual elements employed within ERAS are based on the best available evidence.
Although such a perioperative care strategy may not incorporate all of the elements of
the ERAS programme or indeed may not mobilise or feed patients as it does represent
an evolution towards the ERAS protocol of care.
Within the multimodal ERAS programme of care much of the evidence for the
individual elements is taken in isolation from traditional care pathways, consensus
review or simply accepted standard care (as described in Sections 1.3,1.4). Little
evidence is available concerning the importance of each element when considered
within the context of an enhanced recovery pathway. For this reason there may be
resistance to adopting the entire ERAS programme of care, which may be regarded as
complicated and labour intensive, in favour of adopting individual elements such as
perioperative epidural analgesia and preoperative carbohydrate loading for which
strong supporting evidence exists.
Moreover, specific elements such as minimal access surgery have been associated
with improved short-term postoperative outcomes, shorter hospital stay, reduced
morbidity and postoperative pain when compared with open surgery within traditional
care (Abraham et al, 2004). Minimal access surgery is associated with early
mobilisation and oral diet without the intervention of an ERAS programme (Tjandra
et al, 2006). Within an ERAS programme of care no further improvement has been
identified (MacKay et al, 2007), however, there may be increased patient satisfaction
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with laparoscopy and an earlier return to activities such as driving or hobbies (King et
al, 2008).
Furthermore, the readmission rate of 20 - 25 % reported for the seminal fast-track
programme in Denmark would be unacceptable in many centres (Basse et al, 2000).
Although more recent papers with a less aggressive planned length of stay have been
associated with a much lower readmission rate (Andersen et al, 2007) the perception
of increased readmission with early discharge persists.
ERAS programmes are often considered a strategy for younger and fitter patients,
specifically targeting early discharge. Therefore not all patients may be considered as
eligible for such a programme, creating a two-tier system. Arguably the elderly, those
with comorbidity and the undernourished may have as much if not more to gain in the
form of reduced postoperative morbidity, this is discussed further in this thesis.
Traditionally targeted pre-optimisation of patients with high levels of comorbidity, the
elderly or those with preoperative malnutrition has been employed. Where the clinical
situation allows, further optimisation of the patients physiology on the form of blood
pressure, heart failure and diabetic management, correction of anaemia and
improvement of nutritional status are all associated with improved outcomes. More
recently cardiopulmonary exercise testing is becoming more prevalent (Older et al,
2000;01der et al, 2004). This tailored approach to preoperative care may not be a well
recognised part of most ERAS programmes, however, where appropriate relevant
modifiable risk factors should be addressed in the preoperative period. The success of
many perioperative interventions is evaluated against patient comorbidity and indeed
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many ERAS programmes compare predicted outcome calculated from P-POSSUM
scores or group patients according to American Society of Anesthesiologists grade.
These, however, often overestimate postoperative morbidity or mortality. The ERAS
programme itself me be considered a preoperative strategy, as carbohydrate is one of
its most significant components along with preoperative use of epidural analgesia.
Moreover, many of the postoperative elements of the ERAS protocol could be
considered as outcomes of recovery in themselves
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1.6 Issues with ERAS protocol compliance
Although compliance is not universally reported within ERAS trials, it will be
significant when an ERAS cohort is being compared with a retrospective cohort of
patients. It has been demonstrated that a reduced length of hospital stay may be
explained by a policy targeting early discharge rather than any real improvement in
rate of recovery (Maessen et al, 2008). Within papers that do report protocol
compliance there appears to be a similar pattern of greater compliance with
preoperative and intraoperative elements and not postoperative elements (Gatt et al,
2005;Maessen et al, 2007).
Maessen and colleagues also suggest a relationship between compliance with
postoperative elements of the care protocol and shortened hospital stay (Maessen et
al, 2007). Postoperative variables often overlap as both markers of protocol
compliance and markers of postoperative recovery. It is therefore difficult to draw
conclusions, as multivariate analysis will be confounded. This problem highlights the
difficulties of establishing objective outcomes on which to evaluate the success of
ERAS programmes. It is important that the introduction of an ERAS protocol is
accompanied by appropriate audit to assess the success of the programme, to highlight
areas where further development may be required and to specify the most significant
elements of the protocol (Wind et al, 2006). Within the randomised controlled trial
presented in this thesis, compliance with elements of the ERAS protocol was audited
prospectively.
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1.7 Limitations of existing clinical outcomes
In achieving an improved rate of recovery, it may be possible to reduce the
requirement for inpatient care and facilitate early discharge from hospital. Within the
ERAS protocol, however, the reduced requirement for inpatient care should be a side
effect of the faster functional recovery. Length of hospital stay (LOS) is often quoted
as a measure of the success of enhanced recovery programmes, however, it is also
used as an index of hospital efficiency. Outwith the development and implementation
ofERAS programmes other protocols and guidelines have been introduced to regulate
inefficient use of services. Scheduled discharge planning and increased use of primary
health care facilities are aimed specifically at reducing the length of postoperative
hospital stay, often targeting the lower intensity days towards the end of a hospital
admission when medical discharge may be appropriate. There are inherent flaws in
using length of postoperative hospital stay as an outcome. It is not necessarily an
objective measure of recovery. Moreover, a shorter recovery period may not
automatically result in a shorter length of hospital stay.
Initial evaluation of the length of hospital stay for patients managed within an ERAS
programme revealed that up to 70% of patients were not being discharged on the day
that they achieved all of the discharge criteria (No requirement for intravenous fluids,
tolerance of solid food, good pain control on oral analgesics and mobilisation to
preoperative level) (Maessen et al, 2007). Follow-up studies show that up to 87% of
patients managed within an ERAS programme had discharge delayed beyond the
point in time when they met discharge criteria. A similar delay was identified in 90 %
of patients managed within a traditional care pathway. The median delay to discharge
was 1 day for the ERAS group and 2 days for the traditional care
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group (p<0.01) (Maessen et al, 2008). It is clear that the effect of a shorter recovery
period on length of stay is frustrated by additional days in hospital beyond the patients
achieving discharge criteria. Although in the study by Maessen and co¬
workers (2008) there was not any significant difference between the ERAS group and
the Traditional Care (TC) group with regard to the number of patients who had a
delayed discharge, there was a significant difference in the median number of delayed
days to discharge in each group. It may be that reduction in the median length of
delayed discharge beyond when the patient achieves discharge criteria reflects a
change in the attitudes of the medical and nursing staff rather than a true improvement
in the rate of recovery.
Traditionally, factors such as patient age, severity of disease, pre-existing
comorbidity, postoperative complications and social circumstances along with
availability of beds and hospital discharge policies (Seymour et al, 1982;Epstein et al,
1988;van Doorslaer et al, 1989;Burns et al, 1991;Maessen et al, 2007) have all been
shown to affect length of hospital stay. Postoperative complications specifically have
been shown to have a strong adverse influence on length of stay (Maessen et al,
2007). Familiarity with the ERAS protocol, previous experience with an ERAS
programme and elements associated with restoration of food intake were associated
with early recovery and discharge from hospital. However, it has not been possible to
demonstrate which other protocol elements have an independent influence on
outcome.
Protocols that have targeted a particularly short length of inpatient stay have been
associated with higher readmission rates (15 - 27 % compared with 2 - 16 % within
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traditional care) (Basse et al, 2000). When a three day postoperative stay was planned
rather than two days following elective colonic resection, readmission rate was
reduced from 20.1 - 11.3 % (Andersen et al, 2007). The latter study highlighted that
although the number of readmissions related to surgical complications remained
unchanged, when the length of stay was increased to 3 days there were fewer
readmissions for observation or social reasons.
There is an expected incidence of complications following major colorectal surgery
and there must be appropriate preadmission counselling and a clear pathway for
prompt and safe readmission of the 1 - 3 % of patients who may experience an
anastomotic leak (Fearon et al, 2005). If this pathway is not available then safe
discharge from hospital cannot take place and early discharge from hospital is not an
appropriate target. This is also important for patient satisfaction, as patients
themselves do not always want to be discharged from hospital early (Basse et al,
2005).
It is expected that postoperative complications, such as infection rate, will be
beneficially modulated by a relatively stress free perioperative care pathway which
promotes improved immune function. However, using this as an outcome marker is
difficult as shorter lengths of hospital stay may result in many of the minor infective
complications being diagnosed and treated in the community.
Time to first passage of flatus or passage of stool post surgery is traditionally used to
guide reintroduction of oral diet and has been employed in several papers as a
surrogate marker of return of gastrointestinal function (Basse et al, 2000). However,
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time to passage of stool may not be an appropriate measure of upper gastrointestinal
function. Oral intake or the ability to assimilate nutrients in the early postoperative
phase may be tolerated days prior to the passage of flatus or stool (Catchpole, 1989).
Following major abdominal surgery, feeding in the first 24 hours has been shown to
be safe, even following colorectal anastomosis. Oral intake of food is associated with
a reduced length of stay and lower mortality rate (Andersen et al, 2006). However,
there is an increased risk of bloating, nausea and vomiting with early feeding. One of
the aims of the ERAS programme is to hasten recovery of gastrointestinal function,
thereby promoting assimilation of calories and minimising catabolism in the early
postoperative period.
An appropriate objective marker of postoperative gastrointestinal recovery is of great
interest when examining this key domain of the recovery protocol. Currently there is
no universally applied objective measure of gastrointestinal function in the
postoperative period and often surrogate markers such as time to first passage of
flatus/ stool or calorie intake are used. Discontinuation of intravenous fluids, tolerance
of oral fluids or oral diet, time out of bed and mobilisation have also been used as
markers of recovery, however, many of these outcomes are in themselves protocol
elements and therefore may simply mark compliance. An objective measure of
gastrointestinal recovery may be one of the most robust milestones of overall
functional recovery.
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1.8 The role of nutritional conditioning/support within ERAS
The role of preoperative metabolic conditioning with an orally administered 12.5%
carbohydrate solution has become a significant part of most ERAS
programmes (Svanfeldt et al, 2007). The administration of such a carbohydrate-rich
drink stimulates the release of insulin and mimics the effect of a mixed
meal (McMahon et al, 1989). As a clear fluid, such a carbohydrate rich drink, can be
administered safely up to two hours prior to anaesthetic induction (Nygren et al,
1995) in keeping with modern preoperative fasting guidelines (Soreide et al, 2006).
Fluid and carbohydrate loading prior to surgery assists in the optimal maintenance of
fluid balance (Lobo et al, 2006) and reduces preoperative thirst and anxiety before
elective surgery (Hausel et al, 2001). In the early postoperative period a reduction in
nausea has also been demonstrated following laparoscopic cholecystectomy (Hausel
et al, 2005).
Preoperative carbohydrate loading reduces postoperative insulin resistance (Nygren et
al, 1998) due to an increase in glucose disposal in peripheral tissue and improved
oxidative metabolism in the early postoperative phase (Soop et al, 2001). This effect
persists up to three days post surgery and can result in a measurable reduction in
nitrogen loss (Soop et al, 2004). When used as part of an ERAS programme of care
postoperative enteral feeding can be provided without hyperglycaemia and achieve
nitrogen balance (Soop et al, 2004). Preoperative carbohydrate loading may also
attenuate postoperative loss of muscle mass (Yuill et al, 2005). In colorectal surgery
its use is associated with a reduced duration of postoperative stay (Noblett et al,
2006).
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It is proposed that the addition of other nutrients in combination with carbohydrate
may promote further benefits in postoperative recovery. However, any novel
preparation must have a rapid gastric emptying profile to be administered safely prior
to surgery. This thesis explores the gastric emptying profile of such a novel drink
containing glutamine and antioxidants in combination with carbohydrate to assess its
suitability as a preoperative metabolic conditioning regimen.
In the period following major abdominal surgery weight loss is known to continue up
to eight weeks beyond surgery. Use of nutritional supplements in malnourished
patients, (defined as those with a BMI </= 20 kg/m2, anthropomorphic measurements
</= 15th percentile on admission or initiation of diet postoperatively and/ or weight
loss of 5% or more during the perioperative period), have been shown to reduce the
period of weight loss to 4 weeks and significantly reduce the overall amount of
weight loss along with improving quality of life and morbidity (Beattie et al, 2000).
In unselected patients undergoing moderate to major gastrointestinal surgery
administration of oral nutritional supplements ad libitum within the early
postoperative period results in a significantly increased overall calorie intake. Not
only as a consequence of the energy intake form the supplements but due to more of
the ward diet being consumed (Rana et al, 1992). Those receiving oral nutritional
supplements lose less weight in the postoperative period (Keele et al, 1997) or may
even maintain their preoperative weight (Rana et al, 1992). They also have a smaller
decrease in grip strength and lower incidence of wound infection. Patients receiving
ONS who have lost weight in the perioperative period appear to return to preoperative
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weight earlier, report lower levels of fatigue (Keele et al, 1997) and suffer fewer
major complications (Lawson et al, 2003).
It has been suggested that perioperative oral nutritional supplementation started
before hospital admission for lower gastrointestinal tract surgery diminishes the
degree of weight loss and incidence of minor complications (Smedley et al, 2004)
although some studies disagree that any benefit exists for patients that are otherwise
well nourished (MacFie et al, 2000). Within an elderly population undergoing
orthopaedic surgery the effectiveness of oral supplementation is dependent on
compliance (Bruce et al, 2003) and within the normally nourished or mildly
malnourished patient group benefit may be restricted to patients suffering
postoperative complications or a prolonged hospital stay (Botella-Carretero et al,
2008).
Within traditional perioperative care enterally administered perioperative
immunonutrition has been shown to reduce postoperative infections rate and length of
hospital stay (Braga et al, 1999). Nasojejunal feeding within an ERAS protocol is
associated with minimal postoperative insulin resistance and nitrogen loss (Soop et al,
2004).
The ERAS programme of care promotes the combination of preoperative oral
carbohydrate loading with both early return of diet and oral supplementation.
Although there is clear evidence supporting the benefits of the ERAS programme of
care as a package (Wind et al, 2006) the contribution gained from combining
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preoperative oral carbohydrate loading and postoperative ONS has not been fully
examined.
1.9 The role of laxation/optimised gastrointestinal function within ERAS
Major abdominal surgery is associated with a period of gastrointestinal dysfunction or
postoperative ileus that may persist up to five days beyond surgery (Miedema et al,
2003). This is characterised by bowel distension, absence of bowel sounds and a
delayed passage of flatus and stool. It can delay resumption of oral diet, mobilisation
and discharge from hospital and contribute to postoperative pain and complications.
Traditionally, postoperative ileus has been accepted as an unavoidable consequence of
abdominal surgery, however, the benefit of such a physiological response is unclear.
Although postoperative ileus is particularly related to the degree of intraoperative
bowel handling (Kalff et al, 1998), the persistence of postoperative gastrointestinal
dysfunction and ileus is multifactorial. Not all parts of the gastrointestinal tract are
equally affected. It is believed that the small intestine recovers within the first 24
hours, the stomach within 48 hours and the colon within 72 hours (Catchpole,
1989;Holte et al, 2000). Clinically ileus and its resolution are not well defined.
Within the ERAS programme of care the multifactorial approach to treating
postoperative gastrointestinal dysfunction combines limiting the factors that
contribute to ileus, such as systemic opiates and utilising factors that promote early
recovery of gastrointestinal function such as mid-thoracic epidural analgesia or
balanced intravenous fluid therapy (Luckey et al, 2003). This multimodal approach
within the ERAS programme has been shown to reduce the duration of postoperative
gastrointestinal dysfunction (Wind et al, 2006).
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Laxatives, although commonly used in the postoperative period, are not administered
routinely and only a small number of studies have examined the effectiveness of their
routine administration. Magnesium salts combined with bisacodyl suppositories
administered to a series of twenty patients undergoing gynaecological surgery
promoted a faster gastrointestinal recovery and earlier discharge from
hospital (Fanning et al, 1999;Hansen et al, 2007). Magnesium salts have also been
employed within an ERAS protocol of care for patients undergoing colorectal
surgery, which as a package of care has facilitated shorter time to first passage of
stool and earlier discharge from hospital (Basse et al, 2004;Nygren et al, 2005),
however, the specific impact of postoperative laxation, within these ERAS protocols,
is not clear. Bisacodyl has also been shown in a randomised controlled trial to
promote earlier passage of flatus and stool and tolerance of oral diet following
colorectal resection (Zingg et al, 2008).
Sham feeding has been shown to promote a shorter time to passage of flatus and stool
but not a shorter hospital stay or reduced complications (Parnaby et al, 2009).
However, since reintroduction of diet following colorectal surgery is both tolerated
and safe (Lewis et al, 2001) the role of sham feeding is less clear. Although several
studies have demonstrated early tolerance of food, return to full diet and even earlier
recovery of bowel sounds this did not always equate to a cessation of postoperative
ileus (Reissman et al, 1995;Feo et al, 2004;Charoenkwan et al, 2007). Some studies
have suggested that early diet itself results in an earlier recovery of gastrointestinal
function and discharge from hospital (Stewart et al, 1998). Within a multimodal
programme of interventions, elements such as early mobilisation have been shown to
be associated with early recovery of gastrointestinal function (Henriksen et al, 2002).
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Although other pharmacological agents have been suggested to be effective, evidence
is limited and insufficient to allow recommendation of a particular agent. Alvimopan
(a p-receptor antagonist) may have a beneficial role (Traut et al, 2008) but has not
been widely adopted.
It is clear that minimising the period of postoperative gastrointestinal dysfunction will
allow early ingestion of food and improve rate of recovery. Further improvements in
the effect of the ERAS protocol may rely specifically on improving the rate of
gastrointestinal recovery. Evidence of a specific benefit from routine postoperative
taxation, within an ERAS programme, is limited. This thesis examines the use of
routine postoperative magnesium hydroxide within an ERAS protocol of care
following major abdominal surgery and any potential interaction of such laxation with
preoperative metabolic conditioning and postoperative oral nutritional supplement
administration.
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1.10 Further Development of the ERAS model
Although many of the elements of the ERAS programme have been validated in meta¬
analysis or randomised controlled trials, adoption of these standards is still varied.
This may be due to longstanding surgical traditions regarding elements such as
preoperative fasting and early postoperative feeding. Some of the elements of the
ERAS programme (minimal use of mechanical bowel preparation, drains and
nasogastric tubes along, improved perioperative nutrition and early mobilisation) have
been employed to a varying degree in different surgical units and lead to regional and
international variations in practice (Nygren et al, 2005). Introduction of the ERAS
protocol requires comprehensive education and audit to assess compliance (Fearon et
al, 2005).
The protocol itself is subject to refinement as further evidence becomes available.
Currently many of the elements are based on evidence gained within traditional care.
Therefore although the ERAS package of care overall has been shown to be of
benefit (Wind et al, 2006), the individual contributions of each protocol elements
remains unclear.
The outcomes used to evaluate the success of the ERAS programme will have to
evolve. It is clear that the implementation of the ERAS programme has reduced the
requirement for hospital stay (Wind et al, 2006). However, in future studies, length of
hospital stay may not be sensitive enough to assess the efficacy of further subtle
changes to the programme (Maessen et al, 2007;Maessen et al, 2008). The application
of discharge criteria and achievement of functional recovery have been used as a more
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objective outcome, however, novel markers of postoperative mobility, gastrointestinal
function or assimilation of calories may provide a better measure of recovery.
The reduction in postoperative morbidity is the most desirable outcome of the ERAS
protocol especially in higher risk groups. Currently, careful screening and focussed
care has been shown to be effective in reducing adverse outcomes in high-risk
subgroups of patients, however, it is difficult to screen patients adequately (Murphy et
al, 2006). Debate exists over the most effective method of screening and in many
busy surgical units screening is simply not performed. It is proposed within this thesis
that a stress free and nutritionally aware ERAS programme will provide better
outcomes for all patients, including those traditionally at higher risk, rather than
screening patients and providing focussed care only to those at risk. It is possible that
the improved postoperative outcomes achieved within an ERAS programme will be
applicable to all patients.
It is suggested that improving postoperative compliance with the ERAS protocol may
provide greater improvements but will also be more challenging. Postoperative
routines are more difficult to influence and may require a greater structural change
along with education of the junior medical and nursing staff that frequently rotate
through other wards and specialties.
The original positive results from the Enhanced recovery publications need to be
supported by further robust randomised clinical trials. It may be more useful to
investigate the specific impact of individual elements within the overall ERAS
protocol, this is explored further in the present thesis.
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SECTION C. THE ERAS MODEL OF PERIOPERATIVE
CARE
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Chapter 2. The colorectal model: Results from the ERAS international
collaboration. What outcomes can be achieved and which patient
subgroups benefit?
2.1 Background
This chapter examines postoperative outcomes for patients undergoing colorectal
resection within an ERAS programme of care in four different European centres.
Specifically the outcomes for patients traditionally considered high risk. Patients were
grouped according to preoperative BMI (WEIO categories) as an indicator of
preoperative nutritional status and given the elderly nature of the overall population a
2 • •• •BMI < 20kg / m was considered as indicating risk of undernutrition. Patients were
also grouped according to age and comorbidity with those > 80 years old considered
elderly and patients with an ASA (3-4) considered to have major comorbidity. The
aim of this chapter was to establish if these higher-risk patients can also achieve the
improved postoperative outcomes associated with an ERAS programme of care. This
would remove the requirement for patient screening and tailored perioperative
management of higher-risk patients.
Patients undergoing major abdominal surgery can be at increased risk of delayed
recovery, morbidity and mortality due to a variety of factors including age,
undernutrition and comorbidity. This increased risk may be due to the combined
effects of tissue wasting, impaired immune function, impaired healing and organ
dysfunction (Arora et al, 1982;Giner et al, 1996). The links between advanced age or
poor nutritional status and adverse surgical outcome have long been
recognised (Studley, 1936;Ergina et al, 1993;Hill, 1994). Although it may be argued
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that modern surgery with prophylactic antibiotics, better analgesia, improved suture
materials and high dependency postoperative care might avoid such adverse
outcomes, recent studies involving traditional perioperative care show that a similar
relationship still exists (Polanczyk et al, 2001;Hamel et al, 2005). Indeed, a recent
study showed that in-hospital mortality for colorectal patients over 85 years of age
was nine-times as high as that for those aged 65 and under (Fazio et al, 2004).
Although recent evidence suggests an epidemic of obesity (World Health
Organisation, 2000), a significant proportion of the surgical population remain
undernourished and potentially at increased risk (Beattie et al, 2000). Likewise, it is
evident that the general population is getting older. In the USA life expectancy is
seven years for the average 80-year-old man and nine years for the average 80-year-
old women (Manton et al, 1995). In such elderly patients, increased
morbidity / mortality following surgery is thought to result from a lack of organ
function / reserve to sustain the patient in the event of complications (Ergina et al,
1993). However, it is often difficult to discriminate between the risks attributable
primarily to one factor by itself (e.g. age) versus the compounding effects of other co-
variables (e.g. increased comorbidity with old age).
Enhanced Recovery After Surgery (ERAS) is based on reducing the surgical stress
response and supporting basic body functions by the use of optimised analgesia, early
mobilisation and early return to normal food / diet (Fearon et al, 2005;Kehlet, 2008).
These interventions have been shown to improve postoperative outcomes (Wind et al,
2006;Khoo et al, 2007;Varadhan et al, 2010). The elderly appear to be at particular
risk of mortality once a postoperative complication has developed (Hamel et al,
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2005). It is therefore of interest that systematic analysis of enhanced recovery has
suggested that ERAS may favourably influence postoperative morbidity (Wind et al,
2006;Varadhan et al, 2010) and therefore might be a particularly useful prophylactic
measure for patients at risk (e.g. the elderly).
This chapter presents a study looking at the feasibility, efficacy and safety of an
ERAS protocol for open, elective colorectal surgery. Observed morbidity and
mortality rates have been compared with the predicted rates based on Portsmouth-
Physiological and Operative Severity Score for the enumeration of Mortality and
morbidity (P-POSSUM) scoring (Prytherch et al, 1998). In addition the prognostic
value of BMI, age, ASA grade, malignancy status, gender and operation type were
investigated
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2.2 Patients and methods
Between March 2002 and December 2005 patients aged 18-94 years undergoing
elective open colorectal surgery with formation of an anastomosis (above the
peritoneal reflection) were included. The upper limit of the rectum was defined as
level with the sacral promontory. Patients with rectal cancer were included if the
tumour was in the upper 1/3 of the rectum and allowed anastomosis in the middle 1/3
of the rectum (at or about the level of the peritoneal reflection). Patients requiring
total mesorectal excision were excluded. Most sigmoid and all rectosigmoid and
upper rectal tumours underwent formal anterior resection with high ligation of the
vessels and takedown of the splenic flexure. Patients with benign or malignant
pathology and with an American Society of Anaesthesiology (ASA) grade of 1-4
were included in the study. Four Departments of Surgery in Northern Europe
(University Hospital, Maastricht, The Netherlands; University Hospital Northern
Norway, Tromso, Norway; Karolinska Institute at Ersta Hospital, Stockholm,
Sweden; The Western General Hospital, Edinburgh, UK) participated for a minimum
of 12 months. Ethical approval and informed written consent was obtained from all
patients in centres where de-identification of data did not provide dispensation of this
obligation.
All patients followed an ERAS protocol based on continuous thoracic epidural
anaesthesia / analgesia, early mobilisation and diet and nutritional supplements as
published previously (Fearon et al, 2005) (Table 2.1). Mechanical bowel preparation
was not used routinely but was applied mainly before left-sided or anterior resections
when employed. Compliance was audited prospectively.
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(Egbert et al, 1964;Disbrow et al, 1993;Kiecolt-Glaser et al,
1998;Halaszynski et al, 2004;Forster et al, 2005)
Normal diet until midnight
(Brady et al, 2003)
No preanaesthetic medication
(Smith et al, 2003)
Selective use of mechanical bowel preparation
(Wille-Jorgensen et al, 2003;Slim et al, 2004;Contant et al, 2007;Jung et al,
2007;Guenaga et al, 2009)
Carbohydrate drink 2 hours before surgery
(Hausel et al, 2001;Yuill et al, 2005;Noblett et al, 2006;Svanfeldt et al,
2007)
Mid-thoracic epidural analgesia (local anaesthetic and low-dose opioid)
(Uchida et al, 1988;Liu et al, 1995;j0rgensen et al, 2000;Block et al,
2003;Miedema et al, 2003)
Short acting anaesthetic agent
Minimal incision length/ transverse incision
(O'Dwyer et al, 1992)
No nasogastric drainage
(Cheatham et al, 1995;Nelson et al, 2007)
Intraoperative body warming device
(Kurz et al, 1996;Schmied et al, 1996;Frank et al, 1997;Scott et al,
2006;Wong et al, 2007)
Avoidance if excessive IV fluids (intraoperative and peroperative)
(Lobo et al, 2002;Brandstrup et al, 2003;Tambyraja et al, 2004;Nisanevich
et al, 2005;Rahbari et al, 2009)
No routine drainage of the peritoneal cavity
(Jesus et al, 2004;Karliczek et al, 2006)
Early Resumption of oral diet
(Lewis et al, 2001;Andersen et al, 2006;Charoenkwan et al, 2007;Flan-
Geurts et al, 2007)
ONS ad libatum
(Keele et al, 1997;Beattie et al, 2000;Smedley et al, 2004)
Early mobilisation (Kehlet et al, 2002)
Early discontinuation of IV fluids (Basse et al, 2000)
Continuation of epidural/ opiate sparing analgesia (Marret et al, 2007)
Stop epidural/ stepdown analgesia
Removal of urinary catheter
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Measurements
In all centres data were collected prospectively, on a computerised database as
described previously (Maessen et al, 2007). Data included patient demographics
(including preoperative BMI), surgical procedures and postoperative outcomes
(including time to achieve targeted mobility, total length of hospital stay,
complications and 30 day mortality). Follow-up for morbidity and mortality was
verified either during the primary admission, by telephone contact at 30 days or at the
subsequent outpatient clinic visits.
Time to achieve targeted mobilisation was defined as the number of days after surgery
until the patient was out of bed >6 hours / day and at the same level of independence
for activities of daily living as prior to surgery. Total length of stay was defined as the
number of nights spent in hospital after surgery, including nights after readmission
within 30 days after surgery. To define the influence of complications on
postoperative recovery and hospital stay, all adverse events in the postoperative
period were recorded prospectively as described previously (Nygren et al, 2005). A
patient's postoperative course was considered complicated if any complication by
accepted standard definitions occurred (Lang et al, 2001;Basse et al, 2004).
Patients were grouped according to preoperative BMI (World Health Organisation
categories) (World Health Organisation, 2000), as an indicator of preoperative
nutritional status. Given the elderly nature of the overall population a BMI below 20
kg/m2 was considered to indicate a risk of undernutrition. Patients were also grouped




Predicted [expected (E)] morbidity and mortality were based on P-POSSUM
scoring (Prytherch et al, 1998) with the observed (O) morbidity and mortality
recorded up to 30 days post surgery. Results were expressed as 0:E ratios. Missing
values (less than 5 percent of all variables) for P-POSSUM were assumed to be
normal.
Statistical analysis
SPSS (version 16 for Mac; SPSS Inc. Chicago, Illinois, USA) was utilised to analyse
the data. Data were collected prospectively to assess the efficacy of an Enhanced
Recovery After Surgery programme and included all patients undergoing elective
colorectal resection with an ASA grade 1-4. No specific sample size calculation was
undertaken.
The dataset was analysed using time to achieve mobilisation, total length of hospital
stay, complication rates and 30d mortality as the main outcome variables. Factors
possibly influencing these variables included: gender, age (less than 80 years or 80 or
more years), type of surgery (colonic, rectal), presence of malignancy, BMI (less than
20 or at least 20 kg/m2) and comorbidity (ASA 1-2, 3-4). Univariate analysis was
initially undertaken to assess any relationship between all the elements described
above and the defined outcome variables. Comparisons were made using Chi-squared
test or Fisher's exact test where appropriate for all categorical variables and Mann-
Whitney U test for continuous variables. Multivariate analysis, using binary logistic
regression for categorical variables and linear regression of log transformed
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continuous variables, was then performed for all variables with a significant or near
significant difference (p < 0.15) demonstrated in univariate analysis. In multivariate
analysis non-significant factors were excluded sequentially and the model rerun.
P < 0.05 were considered statistically significant.
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2.3 Results
A total of one thousand and thirty five patients followed the ERAS protocol.
Compliance with preoperative and intraoperative elements of the protocol was high
(87.5 % patients received preoperative counselling and instruction, 63.4 % patients
completed carbohydrate loading and 87.6 % patients received epidural
analgesia / anaesthesia). Protocol compliance in the postoperative phase was lower
(IV fluids discontinued on the day after surgery in 44.3 %, 39.2 % were out of bed on
the day of surgery and 61.4 % resumed full diet on the day after surgery). Overall
demographics and outcomes are shown in Table 2.1. The male to female ratio was
1:1.1 and 68.6 % were treated for malignant disease. There were 724 colonic and 311
rectal resections. Some 7.9 % of patients had a BMI below 20 kg / m2, 18.7 % were
aged 80 years or more and 20.6 % had an ASA grade of 3-4.
The overall median time to achieve targeted mobilisation was 3 days and total length
of hospital stay was 6 days. The overall readmission rate was 8.6 %, reoperation rate
7.4 % and anastomotic leak rate 5.1 %. The morbidity rate for the whole group was
significantly lower than that predicted by P-POSSUM [observed: expected (0:E) 0.68
(p < 0.001], and 30-day mortality was not significantly different from the predicted
value [0:E 0.68 (p = 0.212)]. Patients undergoing rectal resection had a longer
hospital stay, a higher overall complication rate and were readmitted more frequently
than those having colonic surgery. In contrast, observed: expected morbidity and
mortality tended to be higher in the colonic resection group.
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Table 2.1 Overall Demographics and Outcomes: 1035 patients from 4
centres. Patients underwent elective colorectal resection and were
cared for within the context of an ERAS pathway.
All Colonic Rectal Pf
(n=1035) (n=724) (n=311)
M:F 498:537 340:384 1:1 0.257J
Age (years)* 59 (69,78) 71(59,79) 65 (57,75) <0.001 §
ASA
1 177(17.1) 107(14.8) 70 (22.5)
2 645 (62.3) 464(64.1) 181 (58.2)
3 203 (19.6) 144(19.9) 59(19.0)
4 10(1.0) 9(1.2) 1 (0.3) <0.0011
Malignant disease 710(69.4) 501(70.1) 209 (67.9) 0.481 J
Neoadjuvant therapy 15(1.4) 5(0.7) 10(3.2) 0.0041
Time to mobilise (days)* 3 (2,5) 3 (2,5) 3 (2,5) 0.191 §
Total length of stay
(days)* 6 (4,8) 6 (4,8) 7(5,10) <0.001 §
Readmissions 86 (8.6) 57 (8.2) 29 (9.6) 0.444J
Anastomotic leaks 53 (5.1) 37(5.1) 16(5.1) 0.982J
Reoperations 77 (8) 56(8) 21 (6.9) 0.563 J
Morbidity
(Complications)(3Od) 294 (28.4) 185 (25.6) 109 (35.0) <0.0011
Mortality (30d) 17(1.6) 14(1.9) 3 (0.96) 0.423 J
Expected morbidity 430 (41.5) 259(35.7) 171 (55.0) <0.001 J
Expected mortality 25 (2.4) 14(1.8) 11.0 (3.3) 0.156J
0:E morbidity 0.69 0.71 0.64
0:E mortality 0.69 1.00 0.27
Values in parentheses are percentages unless indicated otherwise; *values are median
(interquartile range). ASA, American Society of Anesthesioloists; 0:E, observed to
expected, f colonic versus rectal; J chi squared test; § Mann-Whitney U test;
1 Fisher's exact test.
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The complications are summarised in Table 2.2. The most frequent complications
were infective, including wound and urinary tract infections. Patients most commonly
developed only a single complication. A higher proportion of patients developed one
or more complications after receiving mechanical bowel preparation (184 (30 9 %) of
596 versus 106 (24-9 %) of 425 patients having no mechanical bowel preparation;
P = 0 041). There were no differences in anastomotic leak rates or 30-day mortality
between those who did or did not receive mechanical bowel preparation.
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Table 2.2 Postoperative complications in 1035 patients from 4 centres
who underwent elective colorectal resection and were cared for
within the context of an ERAS pathway.
Type of Complication Number of patients
Cardiopulmonary Respiratory failure 23 (2.2)
Pulmonary oedema 4 (0.4)
Pulmonary embolism 6 (0.8)
Cardiac failure 22 (2.1)
Acute MI 3 (0.3)
Stroke 2 (0.2)
DVT 1 (0.1)
Acute Renal Failure 6 (0.6)
Surgical Wound Dehiscence 28 (2.7)
Postoperative Bleeding 29 (2.8)
Anastomotic leak 53 (5.1)
Infective Wound infection 128 (12.4)
Pneumonia 24 (2.3)
Chest infection 15 (1.4)
Sepsis 18 (1.7)
UTI 67 (6.5)
Values in parentheses are percentages. A total of 741 patients had no complication;
213, 45, 23, eight and five patients had one, two, three, four and five complications
respectively.
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The results of univariate analysis of the relationship between outcomes and potential
outcome predictors are shown in Tables 2.3 - 2.5. BMI category was not related to
any of the outcome variables. Age had an influence on time to achieve
mobilisation (P < 0 001) and total hospital stay (P < 0 001). There was a significant
relationship between ASA grade and mobilisation (P < 0 001), total hospital
stay (P < 0 001) and postoperative morbidity rate (P = 0 003). Sex influenced
postoperative morbidity rate (P = 0 011). Operation type affected total hospital
stay (P < 0 001) and postoperative morbidity rate (P = 0 002). The presence of
malignancy did not relate to any of the outcomes.
In multivariate analysis independent predictors of delayed mobilisation were age
80 years or more (P = 0 025) and ASA grade 3 - 4 (P < 0 001). Prolonged total length
of hospital stay was predicted by age 80 years or more (P = 0 002), ASA grade 3-
4 (P< 0-001), male sex (P = 0 037) and rectal surgery (P < 0 001). Postoperative
morbidity was predicted by ASA grade 3^4 (P = 0 004), male sex (P = 0 023) and
rectal surgery (P = 0 002). Mortality was not related to any of the factors.
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Table 2.3 Univariate analysis of postoperative outcomes according to
age, gender, comorbidity, type of surgery and presence of malignancy
for 1035 patients from 4 centres who underwent elective colorectal
resection and were cared for within the context of an ERAS pathway.
No of Time to Total 30-day 30-day





<20 82 3 (2,4) 6 (4,8) 27 (33) 1(1)
>20 953 3 (2,5) 6 (4,8) 267 (28.0) 16(1.7)
P 0.791 J 0.820$ 0.344§ 1.0001
Age (years)
<80 839 3 (2,5) 6 (4,8) 229 (27.3) 11(1.3)
>80 194 4 (2,6) 7(5,11) 64 (33.0) 6(3.1)
P <0.001 J <0.001$ 0.113 § 0.109H
ASA grade
1-2 822 3 (2,5) 6 (4,8) 216(26.3) 11(1.3)
3-4 213 4 (3,6) 7(5,12.5) 78 (36.6) 6 (2.8)
P <0.001 J <0.001$ 0.003§ 0.133H
Sex
M 498 3 (2,5) 6 (4,9) 160 (25.6) 11 (2.2)
F 537 3 (2,5) 6 (4,8) 109 (35.0) 6(1.1)
P 0.986$ 0.123$ 0.002§ 0.1681)
Type of
surgery
Colonic 724 3 (2,5) 6 (4,8) 185 (25.6) 14(1.9)
Rectal 311 3 (2,5) 7(5,10) 109 (35.0) 3(1.0)
P 0.1911 <0.001$ 0.002§ 0.255§
Types of lesion
Malignant 313 3 (2,4) 6 4,8) 88 (28.1) 2 (0.6)
Benign 710 3 (2,5) 6 (4,9) 203 (28.6) 13 (1.8)
P 0.0671 0.161$ 0.876§ 0.254H
*Values are median (interquartile range); fvalues in parentheses are percentages.
ASA, American society of Anesthesiologists. $Mann-Whitney U test; §Chi squared
test; Fisher's exact test.
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Table 2.4 Multivariate analysis of postoperative recovery outcomes
according to BMI group, age group, ASA group, gender, operation
type, and malignancy status for 1035 patients from 4 centres who
underwent elective colorectal resection and were cared for within the
context of an ERAS pathway.
Outcomes




(>80 yrs) 1.18 (1.04-1.34) p=0.012 1.16 (1.05-1.28) p=0.002
ASA Group
(Grade 3/4) 1.34 (1.19-1.6) pO.001 1.3 (1.19-1.43) pO.001
Gender (F) - 0.93 (0.86-1) p=0.037
Operation type
(Rectal) - 1.2 (1.11-1.29) pO.001
Malignancy
Values are: Parameter estimates (95% CI) significance; Values that were not
significant in univariate analysis were not included
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Table 2.5 Multivariate analysis of postoperative 30 day morbidity and
mortality according to BMI group, age group, ASA group, gender,
operation type, and malignancy status for 1035 patients from 4
centres who underwent elective colorectal resection and were cared
for within the context of an ERAS pathway.
Outcomes




(>80 yrs) 1.31 (0.91-1.87) p=0.143 p=0.186(NS)
ASA Group
(Grade 3/4) 1.61 (1.17-2.22) p=0.004 p=0.285 (NS)
Gender
(F) 0.73 (0.55-0.96) p=0.023
Operation type
(Rectal) 1.58 (1.18-2.1 l)p=0.002
malignancy
Values are: Odds Ratio (95% CI) significance; Values that were not significant in
univariate analysis were not included
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2.4 Discussion
Within the study presented in this chapter, the overall morbidity rate was 28.4 % and
mortality rate was 1.6 %. Morbidity was significantly lower than that predicted by the
P-POSSUM system whereas mortality rate was similar to the predicted value.
Morbidity and mortality in this cohort were lower than those published for the same
units prior to the introduction of an ERAS protocol (morbidity 35 %, mortality
2 %) (Nygren et al, 2005) and for other European units (morbidity 35 - 38.3 %,
mortality up to 3.4 %) following traditional care pathways (Braga et al, 2002;Alves et
al, 2005). The findings presented in this chapter attest to the safety and potential
benefits of the ERAS approach to perioperative care. Median length of hospital stay
was 6 days, which is below that published for similar series using traditional care in
combination with either open (Nygren et al, 2005) or laparoscopic
techniques (Guillou et al, 2005;Veldkamp et al, 2005). The readmission rate of 8.6 %
was higher than that associated with traditional perioperative care (Nygren et al,
2005), but was considerably lower than the rate of 20 - 25 % reported for the seminal
fast-track programme in Denmark (Basse et al, 2000).
There was good compliance with the preoperative and intraoperative elements of the
protocol, however adherence to the protocol fell in the postoperative phase, which is
in keeping with previous publications (Maessen et al, 2007). Postoperative variables
are both markers of protocol compliance and markers of recovery. Patients achieving
the postoperative goals of the protocol are likely to be those making good progress
and potentially an accelerated postoperative recovery.
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Against the background of such favourable clinical outcomes obtained with the ERAS
protocol, the present study demonstrates that neither BMI below 20 kg / m nor age
80 years or more were independent predictors of postoperative 30-day morbidity or
mortality. The results presented in this chapter suggest that within the context of an
enhanced recovery programme the surgeon does not need to individualise
postoperative morbidity or mortality risk assessment for elderly or undernourished
patients. In contrast, comorbidity is a consistent independent determinant for a range
of outcomes.
The mortality rate for those aged 80 years or above was 3.1 %. The outcome from
elective colorectal surgery in such elderly patients is variable with reported rates from
single institutions as low as 1.1 % (Ong et al, 2008) and from national studies as high
as 11.3 % (Heriot et al, 2006). When colorectal patients have been managed using
traditional perioperative care, age has been demonstrated repeatedly to be a significant
independent predictor of increased mortality after colorectal surgery, even when
elderly patients have been selected as 'fit for surgery' (Alley, 2000;Tekkis et al,
2003). Advanced age has also been related to increased postoperative
morbidity (Polanczyk et al, 2001) and postoperative pulmonary and renal
complications in the elderly have been shown to be independent predictors of
decreased long-term survival (Manku et al, 2003). However, if older patients make it
through the immediate postoperative period, 5-year survival in those aged 80 years or
more is similar to that of the younger group (Smith et al, 2002). This has led to
suggestions that an effort to improve perioperative care delivery to elderly surgical
patients must include measures to minimise in-hospital postoperative complications,
particularly these involving the pulmonary and renal systems (Manku et al, 2003).
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The results of the study presented in this chapter suggest that when patients are
managed according to an enhanced recovery programme age is no longer an
independent risk factor for mortality. This is in keeping with recent meta¬
analysis (Wind et al, 2006) and suggests that the principles of relatively stress-free
surgery and minimisation of organ dysfunction translate into reduced morbidity and
the apparent attenuation of the increased surgery risk in the elderly.
Elderly patients are a heterogeneous group and the use of age to predict surgical
outcome may be confounded by differences in cancer stage (Alley, 2000), tumour site
and most significantly level of comorbidity. However, age is not always associated
with increased comorbidity and excellent outcomes for the elderly undergoing major
surgery have been documented (Ong et al, 2008). In the series presented in this
chapter, age was not significantly related to outcomes other than time to achieve
targeted mobilisation and total length of hospital stay on multivariate analysis. The
increase in total length of hospital stay itself might be attributed to delayed discharge
related to difficulties in arranging social care post discharge (Maessen et al,
2007;Maessen et al, 2008).
In the UK, current guidelines suggest that all patients admitted for major abdominal
surgery should undergo nutritional screening (National Institute for Health and
Clinical Excellence, 2006). The basis for this recommendation lies with the
observation that malnourished patients are at increased risk of postoperative
morbidity and mortality and that nutritional support might attenuate such risk.
However, routine preoperative nutritional screening has been difficult to achieve and
one UK study highlighted that it only took place in 33 % of cases (Murphy et al,
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2006). This chapter demonstrates that when patients are managed with an enhanced
recovery protocol, a low BMI is not an independent risk factor for adverse outcome
and therefore nutritional screening may not be required. The metabolic and nutritional
elements of the ERAS protocol designed to minimise catabolism (Soop et al, 2004)
may be the basis for such an effect. There are clear limitations to the use of BMI to
screen nutritional status. Some patients weigh less than is usual for their height but are
otherwise fit and healthy and (in the case of athletes often healthier) and a normal
BMI does not exclude the presence of malnutrition. Despite these limitations, BMI is
regarded generally as a robust 'field' method especially within a population the size
of the present study. BMI is used as part of the nutritional assessment guidelines of
The European Society for Clinical Nutrition and Metabolism (ESPEN) (Weimann et
al, 2006) and in the Malnutrition Universal Screening Tool (MUST) published by The
British Society for Parenteral and Enteral Nutrition (BAPEN, 2003).
Comorbidity is a significant factor in predicting the postoperative outcomes achieved
in open surgery (with traditional perioperative care) as evidenced by its use in the
POSSUM scoring system (Prytherch et al, 1998), the ASA risk stratification system
and most recently in the simplified risk stratification system (Bowles et al, 2008). The
present chapter confirms such findings for open surgery combined with enhanced
recovery. It has been suggested that ERAS programmes might benefit those with
significant cardiorespiratory or renal comorbidity (Kehlet et al, 2002) and this benefit
might be most evident in vulnerable sub-groups such as the elderly. The present study
demonstrates lower rates of morbidity with use of an ERAS protocol even though
20.6 % of patients had significant comorbidity (ASA 3 or more). Thus, although
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comorbidity is still a highly relevant predictor of outcome, it may be modulated
beneficially by the ERAS approach.
Rectal surgery and male sex were identified as independent predictors of total length
of hospital stay and postoperative morbidity. These associations could be explained
by the known increased risk in rectal surgery itself and the greater difficulties of
dissection in the male pelvis (Salerno et al, 2006). The present data set was initiated at
a time when there was uncertainty about the value of mechanical bowel preparation.
Patients who received mechanical bowel preparation had a significantly greater
complication rate than those who did not, consistent with the current literature (Slim
et al, 2004). The ERAS protocol now recommends the use of mechanical bowel
preparation only in specific circumstances (such as low anterior resection with a
covering ileostomy on table colonoscopy or small, difficult to palpate tumours).
Within this chapter it is demonstrated that the ERAS protocol represents an overall
strategy to condition all patients and to improve all aspects of perioperative care and
outcomes rather than the provision of specialised care for a difficult-to-define group
of patients. The challenge remains how to optimise further the ERAS protocol. This
chapter suggests that a focus on improvement of organ function may be one route
forwards. Preoperative metabolic conditioning is explored later in this thesis.
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Chapter 3. The hepatic resection model: Results from a Phase II study
3.1 Background
The preceding chapter presented the postoperative outcomes achieved within an
ERAS programme of care for patients undergoing colorectal surgery and
demonstrated that the benefits achieved were also applicable to elderly and
undernourished patients. ERAS care protocols have also been applied successfully to
open aortic aneurysm repair and oesophageal surgery (Podore et al, 1999;Cerfolio et
al, 2004). This chapter examines the application of an Enhanced Recovery After
Surgery programme of care for patients undergoing liver resection.
Within traditional perioperative care following liver surgery, median hospital stay
ranges from 8 to 14 days (Pessaux et al, 2007). The incidence of postoperative
morbidity is also relatively predictable, with haemorrhagic complications occurring
predominantly during surgery or in the early postoperative phase, and biliary
complications, intra-abdominal abscess or liver failure in the later postoperative
phase (Belghiti et al, 2000;Burt et al, 2002). As postoperative outcomes following
liver resection are relatively predictable it is ideally suited for the application of an
ERAS protocol. The predictable outcomes in this type of surgery also make it a
suitable model in which to base randomised controlled trials through which the
individual elements of the ERAS programme can be assessed.
This chapter evaluates the feasibility, safety and effectiveness of an ERAS protocol
for patients undergoing curative hepatic resection in two European liver units. In this
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consecutive case series/control study the postoperative outcomes achieved within the
ERAS programme were compared with those achieved within traditional care in the
same two units.
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3.2 Patients and methods
This study was conducted in two surgical units that perform high-volume liver
surgery. It was a prospective case series comparing outcomes with those in a
historical control group in the same two units.
The ERAS patient group comprised of a consecutive series of 61 patients admitted to
either the liver unit in Maastricht University Medical Center, The Netherlands,
between 15 February 2005 and 31 August 2006, or the liver unit of the Royal
Infirmary in Edinburgh, UK, where patient recruitment started on 1 February 2006.
The control group consisted of a consecutive series of 100 patients who underwent
liver resection in one of the two units between 1 July 2003 and 31 December 2004 (50
consecutive patients from each unit), when a traditional care pathway was employed.
Patient and outcome data were derived from a prospectively collected database of all
liver resections performed since 1 January 2000 in both units. In both groups, patients
undergoing elective liver resection for primary or secondary tumours were considered
eligible for the study if they had normal underlying liver function. Patients were
excluded if they required biliary reconstruction or had emergency surgery. In both
units, the same group of liver surgeons performed the liver resections in the ERAS
group as well as in the control group. In Maastricht more fellows with
hepatopancreatobiliary training operated in the ERAS group. Bilateral subcostal
transverse abdominal incisions were used. The transection plane was determined by
intraoperative ultrasonography. To avoid excessive blood loss central venous pressure
was reduced to below 5 mmflg during transection using the Cavitron Ultrasonic
Surgical Aspirator (CUSA®; Valleylab, Boulder, Colorado, USA) and argon beam
coagulation. The portal pedicles supplying and veins draining the sectors to be
resected were divided and ligated with a running polypropylene suture. After removal
of the liver specimen, the raw surface of the liver remnant was subjected to argon
beam coagulation and sealed with TachoSil® (Nycomed, Zurich, Switzerland). In
accordance with the protocol, no abdominal drains were placed in the ERAS group
and the abdomen was closed with a standard running suture.
Before the introduction of the ERAS programme neither of the institutions had a
written, agreed perioperative care pathway. There were no specific measures to avoid
prolonged preoperative and postoperative fasting, nasogastric decompression,
excessive use of intravenous fluids and systemic opioids, prophylactic abdominal
drains and postoperative immobilisation. This conventional postoperative care
programme emphasized prolonged rest for both the patient and the gastrointestinal
tract.
The multimodal ERAS protocol, originally designed for elective colonic surgery, was
modified to cover all aspects of elective liver resection (Fearon et al, 2005). Details of
the ERAS liver protocol are given in Table 3.1.
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Table 3.1 Care plan for patients undergoing liver resection within the
Enhanced Recovery After Surgery programme of care
Time period Protocol element
Day before surgery Normal oral nutrition until midnight
No preanaesthetic medication
Day of surgery Carbohydrate drink 2 hours before surgery
Mid-thoracic epidural analgesia (local anaesthetic and low-
dose opioid)
Short acting IV anaesthetic agent
No nasogastric drainage (if used then removed immediately
after surgery)
Warm IV fluids
Intraoperative body warming device
Avoidance if excessive IV fluids
No routine drainage of the peritoneal cavity
Patient sent to recovery ward/HDU
Restart oral intake ofwater/nutrition ad libatum
Postoperative day 1 Patient mobilises
Discontinuation of IV fluids if patient drinks at least 1.5 litres
of fluid
Normal diet
Continuation of epidural analgesia (local anaesthetic and low-
dose opioid)
lg paracetamol QDS
1 g magnesium hydroxide BD




1 g magnesium hydroxide BD
Normal diet
Postoperative day 3 Stop epidural, Removal of urinary catheter
Commence NSAIDs
Continue mobilisation and normal diet
Review discharge criteria
Postoperative day 4 Review discharge criteria and discharge when achieved
The above table is based on Table 2.1 presented earlier in the present thesis
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In both groups, data were obtained prospectively during the hospital stay and for 30
days after surgery. Data recorded for each patient included morbidity, defined as
complications related to the liver surgery, mortality, readmissions, postoperative
hospital stay, use of preoperative chemotherapy, duration of surgical procedure, blood
loss, anaesthetic agents used and extent of liver resection. Extent of liver resection
was defined according to Brisbane 2000 terminology (International Hepato-Pacreato-
Biiary Association, 2000). Following implementation of the ERAS protocol data on
epidural use, removal of the nasogastric tube if used, and time to resumption of oral
intake and mobilisation were also recorded.
The primary endpoint of this study was total length of hospital stay, which was
defined as the number of nights spent in hospital, including nights after readmission
within 30 days of surgery. To facilitate objective assessment of clinical outcome
predefined discharge criteria were used in the ERAS group (Table 3.2). Patients
received preadmission counselling and were informed about the protocol prior to
admission to hospital. Elements such as the importance of early mobilisation and
early oral intake were explained. Patients were discharged only if they met the
discharge criteria. Patients were given a mobile telephone number of the surgical team
or myself to allow direct communication and safe deployment of the protocol.
Patients in the control group were discharged without formal discharge criteria.
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Table 3.2 Objective criteria to indicate eligibility for hospital
discharge for patients managed within an ERAS programme of
perioperative care.
Pain control with only oral analgesia
Tolerance of solid food
No requirement for IV fluids
Independently mobile or back at preoperative level
Blood tests returning towards normal ranges
All of the above and willing to go home
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The following secondary endpoints were evaluated: resumption of oral intake, defined
as oral intake of water or normal food without discontinuation for at least 24h,
readmissions to hospital, total morbidity, death and length of primary hospital
stay (defined as the number of nights spent in hospital after surgery excluding
readmissions). Complications were registered during the primary admission or at
subsequent outpatient clinic visits up to 30 days following surgery.
Statistical analysis
Continuous data are expressed as median (range). Hospital stay, time to resumption of
oral intake and postoperative duration of epidural analgesia were analysed using the
Mann-Whitney U test. Readmission, complication and mortality rates were analysed
using chi-squared test or Fisher's exact test. P < 0-050 was considered to be
statistically significant. Data were analysed using SPSS® version 13.0 for Windows®
(SPSS, Chicago, Illinois, USA).
89
3.3 Results
Patient characteristics were similar in the ERAS and control groups (Table 3.3).
Extent of liver resection is shown in Table 3.4. A higher proportion of patients in the
ERAS group underwent repeat resections (11 % versus 5 % in control
group; p = 0-214) and resections after intensive chemotherapy (62 versus
33 %; p < 0-001).
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Table 3.3 Demographics and underlying pathology of 61 patients
managed within an ERAS care programme compared with 100
patients managed within traditional care.
ERAS Control
(n=61) (n=100)
Age (years)* 62 (24-82) 60(20-81)
Sex ratio (M:F) 35:26 51:49
ASA grade
1 11(18) 14(14.0)
2 42 (69) 64 (64.0)
3 8 (13) 22 (22.0)
Liver pathology
Colorectal metastases 51 (84) 72 (72)
Other metastases 2 (3) 4 (4)
Hepatocellular carcinoma or 4 (7) 9 (9)
cholangiocarcinoma
Benign lesion 4(7) 14(14)
T4 invasive tumours in liver 0 (0) 1 (1)
Values in parentheses are percentages unless indicated otherwise; *values are
median (range). ERAS, Enhanced Recovery After Surgery; ASA, American Society
ofAnesthesiologists.
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Table 3.4 Extent of liver resection: 61 patients managed within an
ERAS care programme and 100 patients managed within traditional
care
ERAS Control
(n = 61) (n - 100)
Hemihepatectomy 20 (33) 38 (38)
Hemihepatectomy+ > 1 metastasectomies 6(10) 16(16)
Extended hemihepatectomy 7(11) 3(3)
Multiple segmentectomy (> 2 segments) 17 (28) 18 (18)
Central resection/ trisectionectomy 1 (2) 4 (4)
Matastasectomy or monosegmentectomy 10(16) 21(21)
Repeat hepatectomy 7 (11) 5 (5)
Values in parentheses are percentages.
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The median (range) duration of surgery was 220 (60 - 420) minutes in the ERAS
group and 270 (106 - 510) minutes in the control group (P < 0 001) and blood loss
during surgery was 750 (0 - 5000) and 800 (0 - 6000) ml respectively (P = 0 758).
Abdominal drains were used significantly less often in the ERAS group (2 versus
66 %; P < 0 001).
In Edinburgh, the use of a nasogastric decompression tube in patients having partial
liver resection had already been discontinued before 1 July 2003. In Maastricht,
nasogastric decompression tubes were still used in most control patients. A
nasogastric tube was inserted at induction in 37 of 47 patients in the ERAS
group (Maastricht), significantly less frequently than in the control group (96%) (P =
0 013). In the ERAS group, the nasogastric tube was removed at the end of surgery or
in the recovery ward within 4 h of surgery.
Oral intake was resumed within 4 h of surgery in 56 patients (92 %) in the ERAS
group. Two patients required reinsertion of a nasogastric tube. The median (range)
time to successful resumption of normal diet was 1 (0-3) day in the ERAS group,
compared with 3 (0 - 14) days in control group (P < 0 001). Three patients in the
ERAS group (5 %) became constipated after postoperative day 3, despite initial
tolerance of normal food, but this resolved within 5 days. In the ERAS group, 58
patients (95 %) followed the anaesthetic protocol of mid-thoracic epidural analgesia
commencing before surgery (0 1 per cent bupivacaine + 2 pg/ml fentanyl) with
maintenance isoflurane or sevoflurane inhalation anaesthesia, or intravenous propofol,
as described previously (Fearon et al, 2005). After surgery continuous epidural
analgesia comprising 01% bupivacaine and 2 pg/ml fentanyl was administered for at
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least 3 days at a rate of4 - 10 ml/h and combined with oral, non-opioid analgesia.
This was different from the control group. Although 89 patients (89 %) received
epidural analgesia combined with isoflurane or sevoflurane inhalation anaesthesia. In
the postoperative period epidural analgesia consisting of 0 -1 per cent bupivacaine and
2 pg/ml fentanyl was administered without a specific time schedule at a daily fixed
dose of 4 - 10 ml/h, combined with intramuscular opioids and oral analgesia.
Postoperative epidural analgesia was continued for a median (range) of 3 (1-5) days
in the ERAS group and 2 (0 - 6) days in the control group (P < 0 001). Epidural
analgesia was discontinued earlier in the control group, and intramuscular or
intravenous opioids were used more frequently.
Outcome data are summarized in Table 3.5. There were no deaths in the ERAS group
but one patient died within 30 days in the control group. A further control patient died
after 62 days. Overall morbidity rates (percentage of patients with at least one
complication) were 41 % and 31 % in the ERAS and control groups
respectively (P = 0197) (Table 3.6). All complications in the ERAS group were
managed by non-surgical means. Readmission rates in ERAS and control groups were
similar (13 % versus 10 % respectively; P = 0-610). Fifty-two (85 %) of 61 patients in
the ERAS group were completely mobile on the third day after operation and 29 (48
%) were discharged from hospital within 5 days. Median (range) total postoperative
hospital stay, including readmissions, was 6 0 (3 - 82) days in the ERAS group and
8 0 (4 - 68) days in the control group (P < 0 001) (Fig. 3.1).
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Table 3.5 Postoperative outcome data: 61 patients undergoing
hepatic resection managed within an ERAS programme of care and
100 patients undergoing hepatic resection within traditional
perioperative care
ERAS Control P
Maastricht only (n=47) (n=50)
NGT 37 (79) 48 (96) 0.013 J
Removal of nasogastric tube on day of surgery 34 of 37 (92) Oof48 (0) <0.001
Maastricht and Edinburgh (n=61) (n= 100)
Epidural analgesia 58 (95) 89 (89) 0.184J
Abdominal drain 1(2) 66 (66) < 0.001J
Complications 24 (41) 31 (31) 0.197 J
Death 0(0) 2(2) 0.526
Readmission 8(13) 10(10) 0.543$
Total Hospital stay (including readmissions) 6 (3-82) 8(4-68) <0.001
9days)*
Primary hospital stay (days)* 6 (3-82) 8(4-55) <0.001
Values in parentheses are percentages unless indicated otherwise; * values are median
(range). "[Nasogastric tubes (NGTs) were used in Maastricht only; they were used in
neither group in Edinburgh. ERAS, Enhanced Recovery After Surgery. P values by
Fisher's exact test, except J Chi squared test.
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Table 3.6 Postoperative complications: 61 patients undergoing
hepatic resection managed within an ERAS programme of care and







No of patients with complications 25(41) 31 (31) 0.197f
Bile leak 4(7) 4(4) 0.479
Liver failure 3(5) 1(1) 0.153
Sepsis 0(0) 1(1) 1.00
Abdominal collections 5(8) 7(7) 0.779f
Delayed GI function (>7 day) 3(5) 1(1) 0.153
Pneumonia 3(5) 2(2) 0.368
Pleural effusion 2(3) 2(2) 0.634
Pulmonary embolism 0(0) 1(1) 0.433
Myocardial infarction 2(3) 3(3) 0.921
Wound infection 9(15) 5(5) 0.033f
Other Minor 3(5) 16(16) 0.018t
Values in parentheses are percentages. ERAS, Enhanced Recovery After Surgery; GE
gastrointestinal. *Fisher's exact test, except tChi squared test.
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Fig 3.1 Total length of hospital stay, including any period following
readmission to hospital: 61 patients undergoing hepatic resection
managed within an ERAS programme of care and 100 patients
undergoing hepatic resection within traditional perioperative care
Fig. 1 Horizontal lines within boxes, boxes and error bars represent median,
interquartile range and total range respectively. *P < 0-001 (Mann-Whitney U test)
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3.4 Discussions
The case / control series presented within this chapter demonstrates that application of
an evidence-based multimodal enhanced recovery programme after liver resection can
accelerate postoperative recovery and result in a significantly shorter hospital stay.
Patients managed within this protocol were able to drink fluids within 4 h of liver
resection and return to normal diet on the day following surgery. Most patients were
mobile after 3 days and almost half were discharged within 5 days of surgery. Median
total hospital stay (including readmissions) was reduced from 8 to 6 days. This is
considerably shorter than the 8-14 days reported by other European
centres (Jarnagin et al, 2002;Dimick et al, 2004;Capussotti et al, 2006). Application of
the ERAS protocol did not have any detrimental effect on postoperative morbidity
rate.
Based on previous experience of enhanced recovery implementation studies within
these units, and attempts to randomise between fast-track and traditional care in a
multicentre abdominal surgery trial (Maessen et al, 2007), a randomised clinical trial
comparing fast-track and traditional care was considered impractical. ERAS protocols
had been implemented over the previous years in both units in view of the growing
evidence base for such programmes a traditional perioperative care protocol was felt
to represent suboptimal care. Therefore it was felt more appropriate to compare the
prospective ERAS group with a historical control group.
The study presented in this chapter demonstrates that adverse outcomes (rate of
hospital readmission, postoperative complications and death) following liver resection
were similar for both the ERAS and control groups. The complication rate in the
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ERAS group was in keeping with recently published rates of 23 - 52 % (Jarnagin et
al, 2002;Petrowsky et al, 2006;Schroeder et al, 2006;Benzoni et al, 2007;Figueras et
al, 2007). Although the morbidity rate was higher in the ERAS group, the study was
not sufficiently powered to determine statistical differences in the incidence of
postoperative complications. Moreover, complications directly related to liver
surgery, such as bleeding, bile leakage or temporary liver failure, are unlikely to be
influenced by postoperative care. Avoidance of abdominal drains in this study might
arguably have influenced the complication rate, however, the incidence of bile leak
and intra-abdominal collection was similar in the two groups. Prophylactic drains are
employed in many centres to detect early complications such as postoperative
haemorrhage or bile leakage, however, there is no evidence that abdominal drainage
after liver resection aids diagnosis of such an event, reduces their incidence or
provides sufficient drainage for these complications if they arise (Fong et al,
1996;Petrowsky et al, 2004). Some studies have suggested that drains may be
detrimental to clinical outcome by providing a route for ascending infections and
noted higher rates of infected collections when drainage was used (Fong et al,
1996;Burt et al, 2002;Liu et al, 2004). The main disadvantage of drains within an
enhanced recovery setting is that they represent a significant impediment to achieving
early mobilisation.
Despite the existing evidence base for the ERAS programme it has not been
universally accepted (Kehlet et al, 2006). The use of carbohydrate drinks before
surgery reduces thirst, hunger and anxiety, and is safe up to 2 h before abdominal
surgery (Nygren et al, 1995;Brady et al, 2003). However, a preoperative fasting
policy of 'nil by mouth from midnight' is still common in many surgical units.
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Nasogastric decompression tubes were still commonly used during surgery in both
groups in Maastricht owing to tradition in the anaesthesia department. In the ERAS
group they were removed immediately after surgery, which was a major change in
clinical routine. Nasogastric decompression is still used commonly following
abdominal surgery (Kehlet et al, 2006), despite evidence that it is unnecessary and can
result in more pulmonary complications (Cheatham et al, 1995;Nelson et al, 2007).
Further support for avoidance of nasogastric tubes specifically in liver surgery has
been published recently (Pessaux et al, 2007).
Early postoperative enteral nutrition compared with 'nil by mouth' improves clinical
outcome (Lewis et al, 2001;Andersen et al, 2006). Early resumption of normal diet in
combination with other elements of the enhanced recovery programme such as a
restrictive perioperative intravenous fluid regimen (Lobo et al, 2002) is designed to
reduce the occurrence of delayed gastrointestinal function after surgery and to
promote overall recovery. In the study presented in this chapter, oral intake of water
was tolerated within 4 h after surgery and recommencement of oral diet on the day
after surgery in the ERAS group. Delayed return of gastrointestinal function, which
was observed in a few patients, was recorded as a postoperative complication.
It is important that surgical patients are treated in an environment that encourages
mobilisation in the early postoperative period (Kehlet et al, 2002), and provided with
both adequate pain control and support from the nursing staff. Mobilisation on the day
of surgery was possible in Edinburgh, but proved difficult in Maastricht as this setup
did not exist.
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In conclusion, this chapter presents a prospective case series of patients undergoing
curative resection of primary or secondary liver tumours with otherwise normal
hepatic function within a multimodal enhanced recovery programme. The programme
of care was found to be both feasible and effective. Patients were able to drink within
4 h of surgery, eat on the following day and were mobile by the third day after
surgery. This early recovery and was accompanied by a reduction in median length of
hospital stay from 8 to 6 days. Half of the patients were discharged within 5 days and
with increased familiarity with the protocol further reductions in length of stay may
be possible. The study demonstrates that ERAS principles developed for the









Current postoperative outcomes utilised as endpoints in the existing ERAS studies are
often both markers of compliance and markers of recovery (Maessen et al, 2007). It
has also been demonstrated that variables outwith the control of a perioperative care
programme will influence length of hospital stay (Maessen et al, 2008). This section
of the thesis explores novel markers of recovery that may provide a more objective
measure of postoperative recovery rate. These outcomes may be of use in future
ERAS trials.
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Chapter 4. Development of the 13C isotope gastric emptying breath test
as a marker ofoverall recovery
4.1 Background
Within traditional perioperative care transient, postoperative gastrointestinal
dysfunction is accepted as an obligatory consequence of major abdominal surgery. In
some cases this dysfunction may persist as ileus beyond the early period. It is unclear
why the gastrointestinal tract follows this pattern, as postoperative gastrointestinal
dysfunction does not appear to provide any protective benefit. The severity of
postoperative gastrointestinal dysfunction is usually related to the degree of trauma or
handling of the bowel (Kalff et al, 1998). Immobility and administration of systemic
opiates in the postoperative period exacerbate this gastrointestinal dysfunction (Holte
et al, 2002;Ludwig et al, 2008) and measures such as mid-thoracic epidural (Miedema
et al, 2003) and avoidance of excessive intravenous sodium and water (Lobo et al,
2002) facilitate its recovery.
Appropriate assessment of postoperative gastrointestinal function is difficult.
Surrogate endpoints such as passage of flatus or stool are used as markers of gut
recovery, however, first passage of stool following surgery only addresses excretory
bowel function. The stomach recovers some activity within 24 hours and the small
intestine demonstrates contractile activity within hours of surgery (Catchpole,
1989;Miedema et al, 2003). First passage of stool is not an early marker of recovery
as patients may already be mobile, tolerating diet and ready for discharge (Andersen
et al, 2006). Within existing ERAS trials these surrogate measures of gastrointestinal
function are used along with endpoints that are themselves protocol elements,
therefore achievement of these outcomes overlaps with protocol compliance (Maessen
et al, 2007). Gastric emptying may, therefore, be a more objective measure of
recovery in the early postoperative phase.
Early postoperative feeding is associated with both reduced mortality and hospital
stay, however, it can result in bloating and vomiting (Andersen et al, 2006). To
effectively facilitate early diet a multimodal regimen is required to minimise nausea,
vomiting and ileus (Kehlet et al, 2001 ;Delaney et al, 2006). Although the ERAS
package of care has been shown to promote early tolerance of oral diet (Holte et al,
2000;Basse et al, 2002) currently it is unclear which specific elements of the protocol
are most significant. Measurement of postoperative gastric emptying may be an
effective, reproducible and objective endpoint through which these individual
elements could be assessed and may also be a useful predictor of postoperative nausea
and vomiting, the ability to start oral diet or anticipated hospital stay (Wallden et al,
2006).
There are a number of methods available to assess gastric emptying, each with its own
advantages and disadvantages. Each technique requires a different level of specialist
equipment and expertise. Results vary depending on the methodology
employed (Bratten et al, 2006). Although scintigraphy is often considered the gold
standard assessment of gastric emptying allowing accurate, non-invasive assessment
of solid and liquid phase gastric emptying (Lobo et al, 2002), it requires the
administration of a radioisotope, use of specialised equipment and is not suitable in
many groups of patients. The 13C labelled stable isotope breath test (S1BT) would
appear to be an attractive alternative as this test is easy to perform, does not involve
any radiation exposure and can be used repeatedly in the same subject. This test is
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relatively inexpensive and is applicable to field testing because the collected breath
samples are stable and can be sent to a central laboratory for analysis (Schoeller,
2005). Although S1BT is an indirect measure of gastric emptying, (measuring the rate
at which 13CC>2 is exhaled in breath, rather than the rate at which 13C-Na Acetate is
emptied from the stomach) this is taken into consideration in the self-correcting
model described by Bluck and Coward (Bluck et al, 2006). When this model is
applied to the raw data from SIBT the results are directly comparable with direct
measurement methods such as scintigraphy
This chapter explores the use of SIBT to assess gastric emptying rate as a marker of
postoperative recovery and a potential objective outcome measure for use in future
ERAS studies. The data was obtained as part of a larger randomised controlled trial
presented in Chapter 8. The feasibility of the technique as a bedside test in the
postoperative period was assessed and patient acceptability documented. In addition
comparison was made with a) traditional indices of return of gastrointestinal function
b) outcome measures of overall recovery
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4.2 Patients and methods
All patients undergoing breath testing were programmed to undergo hepatic resection
for benign or malignant conditions at the Liver Unit at Edinburgh Royal Infirmary
Edinburgh, UK, between July 2006 and June 2008. All were aged between 18-80
years of age, had a BMI of between 18 and 30 Kg/m2 and had no pre-existing
limitations to mobility or underlying cirrhotic liver disease. Informed, written consent
was obtained from all patients recruited.
Patients followed a standardised perioperative and anaesthetic regimen based on a
previously published ERAS protocol (Fearon et al, 2005). On the third postoperative
day following an overnight fast, patients underwent assessment of gastric emptying
rate of a 200 ml liquid test meal, which contained 36.8 g of carbohydrate, 12 g of
protein and 11.6 g of fat (Nutricia Fortisip® nutritional supplement (Appendix A)
through a non-invasive stable isotope (sodium l3C-acetate) breath test (Braden et al,
1995). After an overnight fast two basal breath samples were collected. For each
breath test sample the subject was asked to exhale through a drinking straw into a 12
ml screw topped glass Exetainer tube. The patients then ingested 50 ml of the oral sip
13feed (Fortisip, Nutricia®) containing 75 mg of sodium C-acetate (Cambridge
isotopes, USA), the remainder of the 200 ml of drink was ingested promptly as the
patient's comfort level allowed.
A further 19 breath samples were taken, in a similar fashion to the first two. These
occurred every 5 minutes for the first 30 minutes, every 10 minutes until 60 minutes
and then every 15 minutes until 3.5 hours after the initial tracer was ingested (See Fig
4.1). During the test period activity was restricted (Slater et al, 2006) and subjects
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remained in a sitting position (Moore et al, 1988). The breath samples in the
exetainers tubes were analysed within 5 days. Previous studies have shown that
samples remain unchanged for over 60 days post collection (Schoeller, 2005).
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Fig 4.1. Diagram of gastric emptying, stable isotope breath testing
protocol.
Breath samples collected
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Analysis of 13C02 enrichment in exhaled breath
The 13C02 enrichment of breath samples (13C:I2C ratio) was measured by automated
continuous-flow Isotope Ratio Mass Spectrometry (Preston et al, 1988) and the unit
1 13PDRh" or percentage dose recovered per hour calculated as the product of C
enrichment and volume flow rate of C02 (VCO2) in exhaled breath. VCO2 was
estimated from resting VC02, which was predicted from body surface area and
applying a physical activity level of 1.3 (Slater et al, 2006). Cumulative output
(cPDR) was then derived by differentiating the PDR 1 data.
The raw data for percentage of dose recovered per hour along with the Seigel curve
fit (Siegel et al, 1988) was according to the following equation:
B(t)+mk(3(l-exp(-kt)) p"1exp(-kt)
An example graph of this data is presented in Fig 4.2. B(t) is the breath test output,
m is the area under the curve, k is a rate constant and (3 a constant which describes the
decay. T1/2 of breath appearance is calculated according to the equation:
T! /2=(-1 /k)*Ln( 1 -1 /217") -
The self-correcting model takes the form:
G(t)=G(P(l-exp(-kt)) |,"'-(P-l)(l-exp(-kt))11.
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Where G is the gastric output. GE Ty2 is derived by interpolation. The self-correcting
model assumes that the bicarbonate kinetics can be described using a single body pool
and accounts for the delay in appearance of 13CC>2 in breath (Bluck et al, 2006) (Fig
4.3). The test drink remaining in the stomach (retention) is the inverse of the self-
correcting cumulative output line (Fig 4.4).
The data reduction presented in this chapter was facilitated using Microsoft Excel®
and a semi-automated spreadsheet template (designed by Prof T Preston) (Bluck et al,
2006). The raw IRMS data is entered into the template spreadsheet where prepared
formulae calculate and predict PDRh-1 using estimates of the parameters m, k & b
from the Seigel fit. The sum of squares of the difference between measured and
predicted values is calculated. The SOLVER function is used for non-linear curve
fitting by minimising the sum of squares through iteratively adjusting the three
parameters of the Seigel fit. As the self-correcting model uses the same three
parameters, its output is produced and graphed automatically. GE Tl/2 is calculated
using the GOAL SEEK function to facilitate estimation of the time when half the area
under the curve has appeared (m/2).
The 'self corrected' T1/2 was used to assess the rate of gastric emptying. Gastric
emptying rate was considered delayed when the T1/2 was above the 90th percentile.
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Fig 4.2 Example output from breath test data with percentage dose
recovered per hour and Seigel curve fit.
Time (h)
♦ Raw Data ~'Seigel Fit
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Fig 4.3 Example output from breath test data with Cumulative dose
recovered and Seigel curve fit.
Cumulative PDR
0.0 1.0 2.0 3.0 4.0 5.0 6.0
Time (h)
♦ Raw Data Seigel Fit
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Fig 4.4 Example output of breath test data and application of self-
correcting model and fluid retention line
Cumulative PDR
0.0 1.0 2.0 3.0 4.0 5.0 6.0
Time (h)




Of fifty-six patients who were eligible to participate in the gastric emptying protocol
32 underwent stable isotope breath testing. All, participating patients tolerated the
protocol with only one subject complaining of nausea and vomiting shortly after
completing the test. For the group overall the male to female ratio was 19:13, median
(IQR) age was 62 (52,68) years and median (IQR) BMI 27 (25,30). All patients were
ASA grades I-III, twenty-seven patients (84.4 %) were treated for malignant disease
and there were 21 major and 11 minor resections.
Oral fluid intake was resumed on the day of surgery in 94 % of patients.
Reintroduction of diet was achieved on day one in 47 % of patients and by day two in
96 % of patients. Time to first passage of stool and length of hospital stay were
5 (5,6) and 5 (5,7.75) [median (IQR)] days respectively. Overall postoperative gastric
emptying (T1/2) was 0.74 (0.46,1.41) hours [median (IQR)]. A small number of
subjects (n=5) had significantly delayed gastric emptying (T(i/2) > 1.677 hours (90th
percentile). In comparison with the rest of the patients undergoing measurement of
gastric emptying rate (n=27), the group with a significantly delayed gastric emptying
time also had a significantly prolonged length of hospital stay (10 (7,11) v 6 (5,7)
days [median (IQR)]: p=0.019)(see Fig 4.5). There were no significant differences
between these two groups for other postoperative outcomes (Table 4.1).
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Table 4.1 Comparison of outcomes for patients with significantly
delayed GE (>90th percentile) and patients with normal GE (<90th
percentile) on postoperative day three
> 90th percentile < 90th percentile pf
Return to oral diet 1 (0,3) 1 (0,1) 0.608
IV fluids stopped 1 (1,5.5) 1 (1,2) 0.590
Passage of flatus 3 (1.25,4.75) 2(1.5,3) 0.746
Passage of stool 5 (4,5.5) 5 (3,6) 0.770
Achieve discharge criteria 5 (4,7) 4 (3,5) 0.112
Length of hospital stay 10(7,11) 6 (5,7) 0.019
All values are median (interquartile range), fMann Whitney.
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4.4 Discussion
Postoperative gastrointestinal dysfunction is often considered an unavoidable
consequence of major abdominal surgery. Patients managed within an ERAS
programme of care often have improved postoperative gastrointestinal function and
an earlier tolerance of oral diet (Holte et al, 2000;Basse et al, 2002). The ERAS
protocol overall has been demonstrated to improve postoperative recovery, however,
future ERAS trials would hope to evaluate the contribution of individual elements to
this improved recovery. Current markers of postoperative gastrointestinal
function (first passage of stool) may not be sensitive enough to differentiate the
contribution of these specific protocol elements. Upper gastrointestinal function
recovers more quickly than lower gastrointestinal function following major abdominal
surgery (Catchpole, 1989), therefore gastric emptying time in the early postoperative
period may be a more useful measure of gastrointestinal recovery. Such a
measurement may predict the success of early postoperative feeding and may be of
use in assessing the efficacy of individual elements of a perioperative care pathway.
This chapter presents SIBT as an acceptable method of investigating gastric emptying
rate within days of major abdominal surgery. One patient complained of nausea
during the protocol, which correlated with a significantly delayed gastric emptying.
There were no other complications or side effects. This is in keeping with other
studies that have employed this method of assessment in children, neonates and the
critically ill (Chiolero et al, 2003;Braden et al, 2004). Nine patients refused the SIBT
but this was due to the test feed employed rather than the breath sampling protocol
itself. Oral sip feed (Fortisip, Nutricia®) was selected due to its availability but could
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be replaced with other test meals. The test was also impractical for fifteen patients
who had not yet been discharged from HDU as expected.
Although much of the available literature refers to gastric emptying of solids in the
present protocol it was more feasible to assess gastric emptying of liquids as patients
would tolerate fluids earlier. An energy rich liquid test meal (Nutricia Fortisip®) was
employed in this protocol. This test meal is readily available, inexpensive, is often
used in postoperative patients to supplement inadequate diet, is generally well
tolerated by patients and is available in a variety of flavours. A calorie rich liquid
empties more slowly than a non-calorie containing liquids (Hellstrom et al, 2006)
potentially facilitating clearer differentiation of gastric emptying rate between
subjects.
The protocol presented here uses a Na l3C-acetate tracer (Braden et al, 1995), which
imposes no risk due to ionizing radiation. The Stable Isotope Breath test can be
performed while the patient is sitting and even accommodates ambulation. This test is
therefore ideally suited for the early postoperative period. With sufficient refinement
of the protocol and adequate instruction it may even be possible for patients to collect
his or her own breath samples at the appropriate scheduled times. This facilitates
testing multiple patients simultaneously. As the analysis of the breath samples can be
performed after a delay of up to sixty days the IRMS facility does not have to be
nearby (Schoeller, 2005).
Although the '''C-acetate breath test is an inexpensive method to assess gastric
emptying it has not been universally accepted. This technique relies on rapid
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absorption and metabolism of the Na 13C-acetate tracer to produce a detectable
increase in 13CC>2 in exhaled breath. Pulmonary excretion of 13C as carbon dioxide
may be dependent on its passage through the blood bicarbonate system, resulting in
dilution and a breath signal that is delayed, blunted or reduced in comparison with
gastric emptying (Sanaka et al, 2008). The Bluck and Coward formula applied in this
chapter is self-correcting (Bluck et al, 2006) and accounts for the delay in appearance
of 13C02 in exhaled breath, however, it assumes that the bicarbonate kinetics can be
described using a single body pool. This system allows the whole of the gastric
emptying profile to be generated and is directly comparable with scintigraphy.
The stable isotope breath test has not been widely applied in the postoperative period.
Other techniques such as the paracetamol absorption have been applied (Avrahami et
al, 1999), however, they did not appear to correlate with postoperative gastrointestinal
symptoms such as PONV (Wattwil et al, 2002). Other techniques such as Magnetic
resonance imaging or scintigraphy may be considered gold standards, however, they
require greater inconvenience for the patient and are more expensive. These
techniques will also be obstructive to the other postoperative elements of the ERAS
programme.
Postoperative day 3 was chosen for the gastric emptying breath test as patients were
scheduled to move from the high dependency unit to a standard ward environment on
this day. This allowed easier patient access. Due to the pilot nature of this study there
was not any data to compare the specific timing of this test. It would be useful in
future studies to assess gastric emptying at different time points, especially earlier
after surgery. Ideally multiple time points should be assessed. The stable isotope
119
breath testing would be particularly suited to this as it is possible to repeat the test on
multiple occasions on the same individual and increasing the number of test would
have a negligible effect on overall expense.
The stable isotope breath test is a feasible and economical method of measuring
gastric emptying rate in the early postoperative period. This may provide a more
objective measure of recovery and therefore be a more suitable endpoint in future
ERAS studies. Further studies will be required to assess the relationship between
gastric emptying rate and overall functional recovery, however, it would appear that
an extremely delayed gastric emptying may be associated with a poorer tolerance of
oral diet and a longer requirement of inpatient care.
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Chapter 5. Development ofphysical activity monitoring as an outcome
measure
5.1 Background
Postoperative outcomes utilised in ERAS programmes often overlap as markers of
recovery and markers of protocol compliance. These outcomes are often subjective
and can be influenced by the direction of medical staff. Although it is expected that
patients achieving these postoperative protocol goals are likely to be the same patients
making a rapid recovery objective end points of recovery may provide more useful
evidence on which to refine future ERAS protocols.
The previous chapter of this thesis has explored the potential role of postoperative
gastric emptying, measured with stable isotope breath testing, as a novel, objective
assessment of postoperative recovery. This chapter will explore the potential role of
postoperative physical activity as measured with a patient worn electronic activity
meter as another objective measure of recovery
Early postoperative mobilisation is a well-established component of any postoperative
care programme (Fearon et al, 2005). Postoperative immobility contributes both to
postoperative complications and a prolonged convalescence after major abdominal
surgery. Spontaneous physical activity itself may be a surrogate marker of pain
control, strength, functional performance and overall wellbeing (Dahele et al, 2007).
It has become possible to accurately monitor spontaneous physical activity through a
new generation of small accelerometer devices. These devices are capable of
registering detailed aspects of activity including the duration of sitting and lying, time
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standing, time walking, number of up and down transitions, step cadence and
estimated energy expenditure providing an objective measure of postoperative
function over a period of up to a week. This device may be specifically useful in the
postoperative period and its results may be a more objective measure of actual
postoperative function.
As part of the study presented in Chapter 8, patients undergoing hepatic resection
were asked to wear a small lightweight activity meter (ActivPAL™) from
postoperative day three to day nine, then for a second period of five consecutive days
between postoperative days thirty and forty. The aims of this study were to assess the
acceptability, feasibility and patient compliance of wearing such a device and explore
the potential role of physical activity as an endpoint.
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5.2 Patients and methods
Patients taking part in this study were asked to wear a compact and
lightweight (35 x 53 x 7 mm and 20 g) accelerometer-based activity monitoring
system (ActivPAL™). The ActivPAL™ system was attached to the anterior thigh
region between two transparent medical dressings to waterproof the device. Patients
were asked to wear the ActivPAL™ activity meter between postoperative days three
and nine and for a further five days between postoperative days thirty and forty. Data
was transferred by an USB interface to a computer and specific software
(ActivPAL™ Professional version 5.8.2.3, Research Edition, ActivPAL™, Glasgow,
UK) was used to analyse data, display the outcome variables listed above for each day
of measurement and estimate energy expenditure. The meter analyses data on a
second by second basis to generate an activity profile. The mean activity per day of
recording (only complete 24h recording days were included) was calculated for all
participants and used in subsequent analysis.
The change in activity level in the early and late postoperative periods was assessed
by median daily step count. Median step count was compared with time to achieve
discharge criteria, length of hospital stay and average step count in the later
postoperative period. Discharge criteria: no requirement for IV fluids, no requirement
for parenteral analgesia and able to perform activities of daily living independently.
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5.3 Results
Between postoperative day three and nine following surgery, fifty patients
participated in wearing an activity meter for at least five days. Twenty-one of the
original fifty subjects wore the activity meter for a second period approximately thirty
days after surgery. For the group wearing activity meters in the early postoperative
period overall male to female ratio was 28:22 and the median (1QR) age was
62 (52,67) years. Forty-six patients (92 %) were treated for malignant disease and
there were thirty-eight major and twelve minor resections (Table 5.1).
The median (IQR) number of steps taken per day rose from 299 (85,727) on
postoperative day three to 1998 (1130,3062) on postoperative day nine (Fig 5.1). In
the later postoperative phase of recovery there was a large day-to-day variation in
median step count. The lowest median step count in this period was
2760 (2385.5,6023.5) and the highest 5723 (2152,10169) (Fig 5.2).
On postoperative day three patients achieving the greatest step count (>90th
percentile) had a significantly shorter length of hospital stay compared with the rest of
the patients. On the same day, patients with the lowest step count (<10th percentile)
had a significantly longer length of hospital stay. There were no significant
differences between the groups for time to achieve discharge criteria or activity rate in
the one-month postoperative period. There was also no significant difference between
the groups for extent of hepatic resection (Tables 5.2 - 5.5).
On postoperative day five patients achieving the greatest step count (>90th percentile)
also had a significantly shorter length of hospital stay compared with the rest of the
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patients but no significant differences between the groups for time to achieve
discharge criteria or activity rate in the one-month postoperative period. However on
postoperative day five patients with the lowest step count (<10th percentile) had a
significantly longer time to achieve discharge criteria, a significantly longer length of
hospital stay and a significantly lower activity level in the later postoperative period.
There was no significant difference between the groups for extent of hepatic resection
(Tables 5.6-5.9).
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Table 5.1. Overall demographics of 50 patients wearing ActivPAL™
activity meter in the early postoperative period (Days 3 - 9).
Overall group
n=5()
Age (years)* 62 (52,67)








Extent of hepatic resection
Major 38 (76)
Minor 12(24)
Values in parentheses are percentages unless indicated otherwise; *values are median
(interquartile range). ASA, American Society ofAnesthesiologists.
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Fig 5.1: Step count between postoperative days 3-9 for patients
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Fig 5.2: Step count between postoperative days 30 - 40 for 21 patients
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Table 5.2. Comparison of postoperative outcomes for patients with
significantly greater step count (>90th percentile) with patients with
typical step count (<90th percentile) on postoperative day three.
<90th percentile >90th percentile P
Time to achieve DC criteria* 4 (4,5) 3.5 (3,4) 0.1 lot
Length of stay* 6(4,7) 4 (4,4.75) 0.037J
Average step count in late 4923 (2175,6938) 9003 (4130,11173) 0.117{
period*
*Values are median (interquartile range). {Mann-Whitney U test.
Table 5.3. Comparison of extent of liver resection for patients with
significantly greater step count (>90th percentile) with patients with
typical step count (<90th percentile) on postoperative day three.
<90th percentile >90th percentile p*
Minor resection 6(16) 1 (25)
Major resection 32 (84) 3(75) 0.532
Values in parentheses are percentages. *Fisher's exact test.
128
Table 5.4. Comparison of postoperative outcomes for patients with
significantly lower step count (<10 percentile) with patients with
typical step count (>10th percentile) on postoperative day three.
<10th percentile >10th percentile P
Time to achieve DC criteria* 4.5 (4,7.25) 4 (3,5) 0.258J
Length of stay* 8.5 (7.25,11.25) 5 (4,6) 0.008J
Average step count in late 3900 (2093,5707) 6076 (2857,8977) 0.369+
period*
*Values are median (interquartile range). $Mann-Whitney U test.
Table 5.5. Comparison of extent of liver resection for patients with
significantly lower step count (<10th percentile) with patients with
typical step count (>10th percentile) on postoperative day three.
<10th percentile >10,h percentile p*
Minor resection 0(0) 7(18)
Major resection 4(100) 31(82) 1.0
Values in parentheses are percentages. *Fisher's exact test.
129
Table 5.6. Comparison of postoperative outcomes for patients with
significantly greater step count (>90th percentile) and patients with
typical step count (<90th percentile) on postoperative day five.
<90th percentile >90th percentile P
Time to achieve DC criteria* 4(4,5) 4(3.5,5) 0.849+
Length of stay* 6 (4.25,7) 4 (4,5) 0.043J
Average step count in late 5807 (2361,6967) 7949 (5122,10663) 0.1261
period*
*Values are median (interquartile range). {Mann-Whitney U test
Table 5.7. Comparison of extent of liver resection for patients with
significantly greater step count (>90th percentile) and patients with
typical step count (<90th percentile) on postoperative day five.
<90,h percentile >90th percentile p*
Minor resection 6(17) 1(25)
Major resection 30 (83) 3 (75) 0.552
Values in parentheses are percentages. *Fisher's exact test.
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Table 5.8. Comparison of postoperative outcomes for patients with
significantly greater step count (<10 percentile) and patients with
typical step count (>10th percentile) on postoperative day five.
<10th percentile >10th percentile
Time to achieve DC criteria* 5 (4.5,8) 4(3.25,5) 0.034$
Length of stay* 10(9,11.5) 5 (4,6) 0.001$
Average step count in late 2964(1393,5273) 6637 (3738,7913) 0.046$
period*
*Values are median (interquartile range). $Mann-Whitney U test
Table 5.9. Comparison of extent of liver resection for patients with
significantly greater step count (<10th percentile) and patients with
typical step count (>10th percentile) on postoperative day five.
<10th percentile >10th percentile p*
Minor resection 0(0) 7(19)
Major resection 4(100) 29(81) 1.0
Values in parentheses are percentages. *Fisher's exact test.
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5.4 Discussion
In the present study 50 patients wore the activity meter in the early postoperative
period without any reported difficulties. This demonstrates that a patient worn activity
meter in the postoperative period is acceptable to patients.
As many of the patients lived remotely to the hospital meters were returned by
prepaid, recorded delivery after recording the time and date of removal (this was
usually apparent from the data analysis itself). This method of return did restrict the
use of the meters (due to the number of meters available) and hence there were
insufficient meters for all patients to record activity data for the second observation
period at thirty days.
In the present protocol the activity meters were attached to the subjects by the author,
as the meter required activation and careful attachment to the subject. Again as many
of the subjects did not live locally to the hospital it was not possible for all subjects to
attend the hospital for this purpose. In the period one-month post surgery only twenty-
one of the original subjects wore the meter. This may present a problem with future
studies. Although the meters can be programmed and switched off allowing the
subject to attach the meters themselves this relies both on having additional meters
available and on the patients being able to attach the meter after one demonstration.
This risks data not being collected and potentially damage to the device itself if
exposed to water.
The results presented in this chapter highlight the rapid rise in activity level during the
early postoperative period. In the period one-month post surgery the trendline
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suggests that despite day-to-day variation, median number of steps taken per day is no
longer improving. This suggests that activity level one-month post surgery may be
approaching its preoperative level. It may be difficult to draw any firm conclusions
from the results in this later period as not all patients participated in this second phase
of activity monitoring. Moreover, it was not possible to obtain activity levels prior to
surgery for comparison.
The chapter also suggests that spontaneous activity level in the early postoperative
period (day three or five) may predict length of hospital stay. Patients with a reduced
step count (<10th percentile) on days three or five have a longer length of hospital stay
thand those with a higher step count (>90 percentile) have a shorter length of hospital
stay. Patients with a reduced step count (<10th percentile) on postoperative day five
also have a reduced activity level thirty days following surgery. The results in this
study may simply be highlighting patients who are doing well or less well following
surgery. However, this may allow a prediction of recovery rate very early in the
postoperative period. It is also possible that motivated patients who mobilise more
aggressively in the early postoperative period are improving their physical status
enough to get home from hospital earlier and have an improved activity level
approximately one month later. This would suggest that postoperative step count
might be useful both as a marker of early postoperative recovery and a predictor of
length hospital stay.
Previous studies have used wrist worn activity meters, which differentiate between
periods of rest, sleep and movement and generate an activity score (Zutshi et al,
2004;King et al, 2006). These studies compared laparoscopic with open surgery.
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Despite significant differences in postoperative outcomes such as length of hospital
stay there was no difference in median postoperative activity score. The ActivPAL™
activity meter is able to record duration of sitting and lying, the time standing, the
time walking, number of up and down transitions, step cadence and estimated energy
expenditure. This study assessed step count as it was felt that this would be the best
measure of spontaneous and intentional activity in the early postoperative period. In
less mobile patients up/down transitions or time standing may be of use to
differentiate patients with a lower activity level. As the ActivPAL™ activity meter is
leg mounted it measures only activity involving the lower limbs. It may therefore
underestimate energy expenditure from use of the upper limbs. In the present cohort
of patients this was not likely to be significant. Other activity recording systems
available include the Actireg® (Hustvedt et al, 2004) or the IDEEA® (Zhang et al,
2004). However, these systems require more hardware to be worn and may be more
restrictive to patients.
The time periods selected for assessment were arbitrary, however, day three was
when patients were scheduled to leave the high dependency unit. Prior to this day
patients were not able to leave the high dependency unit unescorted. There was not
any existing evidence on which to base selection of a particular time period for
assessment. In the present pilot study it was not feasible to gather preoperative
activity data due to the short notice at which surgery was often scheduled and the
distance that most patients had to travel from home, which was prohibitive to
additional hospital visits. In future studies it may be useful to compare postoperative
activity level with preoperative level, which will demonstrate the time to recovery of
preoperative activity level.
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The ActivPAL™ activity monitor is small and unobtrusive, it was tolerated by all of
the patients who wore it and did not hinder any of their normal activities. The use of
the transparent medical dressings allowed the device to be partially waterproofed and
able to withstand showering. Subjects wearing the device were asked not to submerge
the device in water, which precluded bathing.
The study presented in this chapter suggests that objective measurement of
postoperative activity level with a patient worn activity meter is feasible. The results
presented here provide a snapshot of postoperative activity level, which appears to
correlate with other markers of postoperative recovery. Although, due to their
exploratory nature, the results here have to be reviewed with caution, there appears to
be sufficient evidence to support further interest.
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SECTION E. PRECONDITIONING REGIMENS FOR
ERAS
Within many existing ERAS programmes, preoperative metabolic conditioning with a
carbohydrate rich beverage plays a prominent role. Carbohydrate and fluid loading
has been demonstrated to reduce preoperative thirst, hunger and anxiety (Hausel et al,
2001) and postoperative nausea (Hausel et al, 2005). Postoperative insulin resistance
is reduced (Soop et al, 2001) which maintains patients in an anabolic state, reducing
protein loss (Svanfeldt et al, 2007) and maintaining both muscle mass (Yuill et al,
2005) and muscle strength. It is also suggested that use of a carbohydrate and fluid
loading in colorectal surgery may be linked with an accelerated recovery and shorter
length of hospital stay (Nygren et al, 2001;Noblett et al, 2006). In the first chapter of
this section the feasibility and safety of applying such a carbohydrate rich beverage
within the context of active mechanical bowel preparation is explored. In the second
chapter of this section, the safety of administering a more complex pre-conditioning
regimen containing glutamine and antioxidants (as well as carbohydrate) is explored
in relation the need for complete gastric emptying immediately prior to surgery.
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Chapter 6. Combination of mechanical bowel preparation with fluid
and carbohydrate loading within the ERASprotocol
6.1 Background
As previously stated in this thesis, preoperative oral carbohydrate (CHO) and fluid
loading is a common component of enhanced recovery programmes. It has been
shown to maintain postoperative nutritional status by reducing postoperative insulin
resistance (Nygren et al, 1998;Soop et al, 2001), reduce nitrogen loss and aid overall
postoperative recovery (Nygren et al, 2001;Yuill et al, 2005;Noblett et al, 2006).
Within the context of traditional perioperative care, administration of oral nutritional
supplements in the preoperative period has been shown to maintain perioperative
nutritional status and reduce postoperative weight loss (Smedley et al, 2004). Oral or
enteral nutritional support administered in the early postoperative period has been
shown to reduce both infectious complications and length of hospital stay (Lewis et
al, 2001;Andersen et al, 2006). Use of preoperative CHO loading to reduce
postoperative insulin resistance may further optimise the benefits of such early
postoperative feeding.
Traditional periods of preoperative fasting beyond that recommended by National
Anaesthesia Societies and recent meta-analysis (Brady et al, 2003) are still
prevalent (Hannemann et al, 2006) and are often prolonged due to the concomitant
use of mechanical bowel preparation (MBP). Prolonged fasting decreases the capacity
to cope with the surgical stress response, increases postoperative insulin resistance
and may affect adversely length of stay (Thorell et al, 1999). Such fasting may also
further compromise the fluid and electrolyte balance of patients receiving mechanical
bowel preparation (Rothman et al, 1991).
Although it has been demonstrated that routine mechanical bowel preparation has no
proven benefit in relation to anastomotic leak rate following colonic resection there
are still incidences where it may be of benefit (Guenaga et al, 2009). Bowel
preparation may aid in the identification of small tumours, will allow on table
colonoscopy and would seem appropriate if a defunctioning ileostomy is to be
created. The situation is less clear for patients undergoing rectal resection. Although
the incidence of symptomatic anastomotic leaks was similar in the absence of
mechanical bowel preparation there was more significant pelvic sepsis associated
with a leak (Bretagnol et al, 2007). In general the use ofMBP in colorectal surgery is
still relatively common (Nygren et al, 2005) and often directed by surgical
preference (Lassen et al, 2005). In the present study Oral Nutritional supplements
were administered the day before surgery in place of solid food (which would be
precluded with MBP).
Although pre-operative fasting for six hours is required for solids, it is accepted that
clear fluids should be encouraged up to two hours prior to surgery (Brady et al,
2003;Ljungqvist et al, 2003). Specially designed polymeric CHO beverages can also
be administered up to two hours prior to surgery as they have been demonstrated to
empty from the stomach within 90 minutes (Nygren et al, 1995) and as glucose
absorption occurs rapidly in the upper gastrointestinal tract and is unaffected by
administered prokinetic agents (Brunetto et al, 1990) it is unlikely to be affected by
MBP.
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This aim of this chapter is to demonstrate that patients can comply with routine
preoperative conditioning with oral nutritional supplements, an oral carbohydrate
solution and mechanical bowel preparation prior to elective left colonic or rectal
resection.
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6.2 Patients and methods
This study was conducted in the colorectal unit at the Western General Hospital in
Edinburgh, UK. Ethical approval was obtained from Lothian Research Ethics
committee and written consent obtained from each patient after verbal and written
information had been provided in a clinic visit prior to admission. Patients undergoing
elective left colonic or rectal resection for benign or malignant disease were recruited
and were prescribed preoperative MBP (2 sachets of Picolax®). Patients followed an
Enhanced Recovery After Surgery protocol as previously described (Fearon et al,
2005). As part of the ERAS protocol the ERAS research nurse either provided the
drinks / instructions at the preadmission clinic or for inpatients requested that the
surgical house officer prescribed the following regimen on the patients drug chart:
200 ml of an Oral Nutritional Supplement (ONS: Fortijuice®, Nutricia) prior to the
first sachet of bowel preparation and another 200 ml of ONS prior the second sachet
of bowel preparation. Non-diabetic patients were prescribed oral CHO/fluid as 400-
800 ml of a 12.5% clear beverage (Nutricia Preop®) at 8 pm the evening before
surgery and a further 400 ml 2 - 3 hour before surgery (Fig 6.1). Compliance with the
protocol was audited prospectively.
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6.3 Results
Between March 2002 and April 2006 one hundred and forty seven patients underwent
elective left colonic (n=42) or rectal resection (n=105) within an ERAS programme of
care but received MBP. There were 70 males and 77 females. Mean (sd) age was 64
(14.2). Twenty-two patients were diabetic and therefore not eligible to receive
preoperative CHO/fluid loading. One patient did not receive the CHO loading due to
an allergy to lemon-flavoured drinks. There were 124 patients eligible to undertake
the protocol. The protocol failed in 14 patients (eight regimen not prescribed by the
medical staff, six regimen not dispensed by the nursing staff). Of the patients that
were eligible to undertake the protocol, 99 (80 %) completed the prescribed volume
of CHO / fluid loading with no adverse effects. Eleven patients did not complete the
CHO drinks, seven patients did not tolerate them, two refused to try them, one patient
vomited and in one case the reason was not recorded. 103 (83 %) completed the full-
prescribed volume of ONS and 92 patients completed the combined regimen of ONS
and CHO drinks. In summary, 92 (74 %) of 124 patients that were eligible tolerated
the drinks and completed the regimen (Fig 6.2).
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Fig 6.2 Consort diagram for 147 patients receiving preoperative oral
fluid/carbohydrate loading and oral nutritional supplements in
conjunction with MBP prior to elective left colonic or rectal
resection.
CHO: Carbohydrate and fluid loading (Preop®, Nutricia)
ONS: Oral nutritional supplement (Fortisip®, Nutricia)
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6.4 Discussion
The study presented in this chapter demonstrates that 84 % of patients completed and
tolerated preoperative oral fluid / CHO loading and ONS in conjunction with MBP
prior to elective left colonic or rectal resection. A previous study by Tjandra and
colleagues examined oral CHO / electrolyte replacement in conjunction with MBP
prior to colonoscopy and demonstrated a similar level of tolerance (Tjandra et al,
2004). Taken together, these findings suggest it is feasible to prescribe simultaneous
MBP and CHO / fluid loading and that patients will comply well with both regimens.
Interestingly, a recent study by Noblett and co-workers examining the role of
preoperative CHO / fluid loading demonstrated a high level of patient compliance and
earlier functional recovery following colorectal surgery. It was not clear whether
patients had received concomitant MBP in the study (Noblett et al, 2006).
The protocol used in our study was designed to account for the fact that during MBP
patients cannot eat solid food and require extra oral fluids to counteract dehydration.
Recent evidence from Ljungqvist and co-workers (the group that originally
demonstrated the benefits of preoperative oral CHO/fluid loading) has shown that
400 ml oral CHO / fluid loading 2 hours prior to induction of anaesthesia is sufficient
to reduce postoperative insulin resistance if the patient takes normal food until 10 pm
on the previous day. The 800 ml oral CHO / fluid loading the evening before surgery
does not add to the improved metabolic status and decreased postoperative insulin
resistance (Svanfeldt et al, 2005). In the light of these recent findings it might be
possible to omit the CHO/ fluid loading at 8-10 pm the night before surgery and
replace this with further ONS (as MBP would preclude solid food).
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In this study approximately 15% of all patients were 'ineligible' for oral CHO loading
due to the presence of diabetes. Diabetes is, however, only a relative contra¬
indication (Gustafsson et al, 2008). A second issue raised by the present study is that
of protocol failure. Clearly the present regimen represents a more complex form of
preoperative preparation than simply starving the patient for 12 hours. Protocol
failure (11 %) was due either to failure to prescribe the regimen or failure to dispense
the regimen. This occurred almost exclusively in those patients who received MBP as
inpatients. Clearly similar issues are more easily avoided in patients prepared at home
and admitted on the same day as surgery.
The haemodynamic and metabolic benefits of preoperative carbohydrate and fluid
loading are clear and should not be denied to patients receiving mechanical bowel
preparation. From the present study it is apparent that with a clearly defined protocol
patients undergoing MBP are capable of completing a regimen of CHO / fluid loading
combined with ONS prior to surgery.
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Chapter 7. Safety evaluation (gastric emptying) of a novel nutritional
preconditioning regimen in healthy volunteers
7.1 Background
Enhanced Recovery After Surgery programmes have dramatically improved the speed
of postoperative recovery and reduced postoperative morbidity (Fearon et al,
2005;Wind et al, 2006). Within these programmes patients are encouraged to take
clear fluids up until two hours before anaesthesia and up to six hours before solid
food, in keeping with modern anaesthetic guidelines (American Society of
Anesthesiologists, 1999;Brady et al, 2003;Soreide et al, 2006;Woods et al, 2007).
Preoperative metabolic conditioning with 400 ml of a clear carbohydrate drink (CCD)
two hours before the induction of anaesthesia, has been shown to reduce;
postoperative insulin resistance, postoperative nausea and vomiting, preoperative
discomfort and anxiety, and to improve patient wellbeing (Nygren et al, 1995;Hausel
et al, 2001;Nygren, 2006). Data from a randomised trial suggests that preoperative
carbohydrate loading in patients undergoing colorectal surgery results in a shorter
length of hospital stay (Noblett et al, 2006). This volume of CCD empties completely
from the stomach within 90 minutes and therefore does not increase aspiration risk
during induction of anaesthesia (Nygren et al, 1995). One currently available CCD,
[Nutricia preOp® (Nutricia Clinical Care, Trowbridge, UK)], has already been shown
to be safe in a large number of patients undergoing major abdominal surgery (Nygren
et al, 1995;Yuill et al, 2005;Breuer et al, 2006;Noblett et al, 2006).
Following surgery there is a well-recognised period of insulin resistance similar to
non-insulin dependent diabetes mellitus (Thorell et al, 1999). During this period
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despite elevated levels of insulin there is decreased glucose uptake in skeletal and
adipose tissue and increased glucose release. Administration of 400 ml of clear liquid
containing 50 g of complex carbohydrate, such as Nutricia Preop®, stimulates an
endogenous insulin release that is comparable to insulin release following a mixed
meal (McMahon et al, 1989). This carbohydrate load increases the action of insulin by
about 50 % three hours after ingestion and the enhanced action of this insulin surge at
the onset of anaesthesia is likely to explain the postoperative effect on insulin
resistance (Svanfeldt et al, 2005). Postoperative insulin resistance is attenuated, and
both glucose disposal in peripheral tissues and oxidative glucose metabolism are
improved. Overall insulin resistance is reduced by 50 % on postoperative day 1 (Soop
et al, 2001).
The use of additional metabolic conditioning agents such as glutamine and
antioxidants may be of further benefit to patients undergoing major abdominal
surgery. Glutamine is a conditionally essential amino acid, which improves both
gastrointestinal perfusion and immune function (Roth, 2008). Glutamine and
antioxidant supplementation has been demonstrated to improve morbidity and
survival in critically ill patients (Houdijk et al, 1998;Jones et al, 1999;Dechelotte et al,
2006;Berger et al, 2007). When used in major gastrointestinal surgery it may
modulate the immune-inflammatory response (van Stijn et al, 2010), reducing
postoperative complications and length of hospital stay (Beale et al, 1999;Heys et al,
1999;Heyland et al, 2001;Montejo et al, 2003). These benefits have been
demonstrated in both undernourished (Braga et al, 2002) and well nourished gastric
cancer patients (Braga et al, 2002;Gianotti et al, 2002) and its role is promoted in
ESPEN guidelines (Weimann et al, 2006). When used in combination with
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carbohydrate loading glutamine may also reduce oxidative stress (Awad et al, 2010).
A new product containing glutamine and antioxidants in addition to carbohydrate
[Oral Nutrition Supplement (ONS), Fresenius Kabi, Bad Homburg, Germany] may,
therefore, provide additional benefits for patients undergoing major abdominal
surgery. However, as gastric emptying is affected by volume, nutrient content,
viscosity (Marciani et al, 2001) and osmolality (Horowitz et al, 1994) the time taken
for this beverage to empty from the stomach and, therefore, the safe time frame for
preoperative administration, is not known.
Measurements of gastric emptying have been employed to study gastrointestinal
function in a number of conditions, but results may differ according to the
methodology (Lin et al, 2005;Bratten et al, 2006). Scintigraphic techniques have been
regarded as the benchmark for such studies, but magnetic resonance imaging (MRI) is
now becoming increasingly available and may be a more versatile option (Schwizer et
al, 1992;Boulby et al, 1997;Feinle et al, 1999).
In the study presented in this chapter MRI was used to compare the gastric emptying
times of two different types of preoperative metabolic conditioning drinks [ONS
(Fresenius Kabi, Bad Homburg, Germany) and CCD (Nutricia preOp® (Nutricia
Clinical Care, Trowbridge, UK))] in healthy volunteers. As the gastric emptying of
400 ml CCD has been determined previously using scintigraphy (Nygren et al, 1995),
we compared identical volumes (400 ml) of the two drinks with the recommended
dose of administration of ONS (300 ml).
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7.2 Patients and methods
This was a randomised, double blind, three-way crossover study on healthy adult
volunteers and was approved by the University of Nottingham Medical School
Research Ethics Committee (approval K/5/2007). Informed written consent was
obtained from all volunteers prior to enrolment and a system to report adverse events
was in place.
Twenty healthy adult volunteers (10 male and 10 female, aged 18-45 years) were
studied. All were suitable for MRI scanning (e.g. no metal implants in the body), had
a normal body mass index (20-26 kg/ m2) and no previous abdominal surgery or
gastrointestinal disorders. Female volunteers were included only if they were not
pregnant. A medical questionnaire was administered and a clinical examination
performed prior to recruitment. Any volunteer who wished to withdraw from the
study was entitled to do so at any time without giving a reason.
Each volunteer was randomised in a crossover manner to ingest 400 ml of a clear
carbohydrate drink ((Nutricia preOp®) 50 g carbohydrate, 0 g protein) (CCD), 70 g
ONS (50 g carbohydrate and 15 g glutamine) dissolved in water to a total volume of
400 ml (ONS400) and 70 g ONS dissolved in water to a total volume of 300 ml
(ONS300). Volunteers reported for the studies at 0830 h after an overnight fast, on
three separate occasions, each 7 days apart. They were instructed to abstain from
alcohol and medications for 24h, and caffeine and strenuous exercise for 18 h.
Baseline measurements included height, weight, body mass index and a fasting MRI
scan.
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The constituents and physical properties of the three test drinks are listed in Table 7.1.
The drinks were reconstituted on the morning of each study and placed into identical
opaque plastic bottles by a person not involved in the study. Volunteers were asked to
ingest the drink from the bottle within 5 minutes and the time at which the drink was
completed defined the zero time point.
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Table 7.1 Composition of three preoperative conditioning
preparations tested in 20 healthy volunteers.
CCD ONS400 ONS300



















Vitamin C 750mg 750mg
Vitamin E 250mg 250mg
Green tea extract lg lg
fi Carotene 5mg 5mg
Zinc lOmg lOmg
Selenium 150pg 150(xg
Energy 200 kcal (836kj) 234 kcal (978 kj) 234 kcal (978 kj)
Dry matter content 11.3% 16.3% 21.8%
pH 4.9 3.9 3.9
Density 1.049 g/ml 1.06 g/ml 1.079 g/ml
Viscosity [at
y=l(l/s)]
2.30m/Pa 180 mPa 627 mPa
Osmolarity 228mOsm/kg 508 mOsm/kg 698 mOsm/kg
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MRI scanning was performed on a 1.5 T Philips Achieva scanner (Philips Healthcare,
Eindhoven, The Netherlands) at the University of Nottingham). Each volunteer was
positioned supine in the scanner with a sensitivity encoding (SENSE) body coil
wrapped around the abdomen. First, a coarse, scout scan was performed to locate the
position of the abdominal organs and position of the image planes followed by a
calibration scan allowing automatic setup of the scanner specific to the volunteer. To
assess gastric emptying a balanced turbo field echo (BTFE) imaging sequence was
used to acquire 40 transverse (perpendicular to the longitudinal axis of the body)
images with acquired planar resolutions of 2.50 mm x 1.56 mm (reconstructed to 1.56
mm x 1.56 mm) and slice thickness of 10 mm. This BTFE sequence (TR = 2.4 ms,
TE = 1.19 ms, flip angle 45°) visualises fluid containing structures (hydrated test
meals) with bright contrast against the surrounding organs. Each image set was
acquired during a breath-hold of 17.6 seconds. MRI scans were performed in the
fasted state (baseline), immediately after ingesting the drink (time 0), and then at 20-
minute intervals until the stomach was empty.
The data set from each time point was recalled on a UNIX workstation and viewed to
locate the gastric lumen and its contents. An example of a series through the abdomen
of one subject is shown in Figs. 7.1. On such transverse sections, Analyze 6
(Biomedical Imaging Resources, Mayo Clinic, Rochester, MN) was used to trace
manually around the region of interest (ROI) of the gastric contents on each slice.
After this the volume of the gastric contents at each time point was calculated by
summing across all ROIs. The totals for each time point were then tabulated and
plotted onto spreadsheets in Microsoft Excel (Microsoft Corporation) to determine the
gastric emptying kinetics. Individual gastric emptying curves were fitted on Microsoft
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Excel to calculate the gastric half emptying time, T50. The volume remaining in the
stomach at t = 60, 120 and 180 min were measured using MRI to assess complete
gastric emptying.
The primary end point of the study was time to half gastric emptying (T50) of the
three test drinks as measured by MRI. Secondary end points were residual gastric
volumes at 60, 120 and 180 minutes Based on pilot scans, we anticipated a mean
difference in T50 gastric emptying time of 30 minutes with a standard deviation of 30
minutes between CCD and ONS400. Assuming an a error of 0.01 and a power of
90%, the sample size was calculated to be 18. We recruited 20 subjects, making
allowance for a 10 % drop out rate.
The order of administration of the three test drinks was determined using a web-based
random number generator (http://www.randomizer.org/). Allocations were then
concealed in sequentially numbered sealed opaque envelopes in triplicate, and were
opened before each leg of the study by a person not involved in the study. That person
then reconstituted the drinks and transferred them to opaque bottles before handing
them to the investigators. Both the subjects and the investigators were blinded to
group allocation. The randomisation code was broken after completion of the
statistical analysis.
Statistical analysis
As the data were distributed normally, all results were expressed as mean (95% CI) or
mean (SE). Differences between groups were tested for significance using the Student
t-test (paired and unpaired), and were considered significant at P < 0.05. Statistical
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analysis was performed using SPSS for Windows version 16.0 (SPSS Inc., Chicago,
IL, USA) and graphs were plotted on Microsoft Excel.
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Fig 7.1 Sequential axial MRI scans in one subject before and after
ingestion of test drink with gastric content highlighted
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7.3 Results
The mean (SE) age, weight, height and body mass index (BMI) of the 20 volunteers
were 29.4 (1.7) years, 68.1 (2.1) kg, 1.70 (0.02) m and 23.4 (0.4) km/m2 respectively.
Corresponding values for the 10 male volunteers were 33.0 (2.5) years, 75.3 (2.3) kg,
1.74 (0.03) m and 24.7 (0.3) km/m2 and for the 10 female volunteers 25.8 (2.0) years,
60.8 (1.4) kg, 1.66 (0.02) m and 22.1 (0.6) km/m2. All subjects completed the three
arms of the study. One subject experienced mild nausea after ingesting ONS300, but
there were no other side effects. Residual gastric volume, as measured by MRI, after
an overnight fast, ranged from 0 to 95 ml (Table 7.2).
Mean (95% CI) T50 gastric emptying times were significantly lower (p < 0.001) with
CCD, being 47 (39-55) min compared with 81 (69-93) and 81 (70-92) min for
ONS400 and ONS300 respectively. Although T50 gastric emptying times were
respectively longer in females than males, these differences were not statistically
significant (Fig 7.2). The residual gastric volumes at 60, 120 and 180 minutes are
shown in Figs. 7.3 - 7.5. At 120 minutes, the residual volume for CCD was not
significantly different to the fasting residual volume (p = 0.33). At 120 minutes the
residual volumes of ONS400 and ONS300 were significantly greater than there
equivalent fasting residual volumes (p < 0.001) and (p = 0.004) respectively. The
residual volumes of ONS400 and ONS300 had returned to baseline by 180
minutes (Fig 7.6).
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Table 7.2 Fasting residual gastric volumes for 10 male and 10 female






(400 ml Nutricia preOp®)
21 (12-30) 21 (6-35) 21(7-35)
Before ONS400
[70 g Oral Nutrition Solution dissolved 29(17-41) 27 (7-47) 31 (12-49)
in water to a total volume of 400 ml]
Before ONS300
[70 g Oral Nutrition Solution dissolved 32 (22-42) 34 (23-46) 30(11-49)
in water to a total volume of 400 ml]
Total 27 (21-33) 28 (19-36) 27 (18-36)
All values are mean (95% CI) ml. None of the differences were statistically
significant.
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Fig 7.2 T50 Gastric emptying time of 10 male and 10 female subjects


































CCD ONS 400 ONS 300
All values are mean (95% CI) minutes.
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Fig 7.3 Mean gastric residual Gastric Volume at 0, 60, 120, 180 for 20
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All values are mean (95% CI).
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Fig 7.4 Mean gastric residual Gastric Volume at 0, 60, 120, 180 for 20
patients given a 400 ml carbohydrate drink with 50g of maltodextrin
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All values are mean (95% CI).
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Fig 7.5 Mean gastric residual Gastric Volume at 0, 60, 120, 180 for 20
patients given a 300 ml carbohydrate drink with 50g of maltodextrin
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Fig 7.6 Comparison of return to fasting gastric residual volume after
administration of three different carbohydrate rich, metabolic
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7.4 Discussion
The study presented in this chapter confirms earlier work that a clear, carbohydrate
rich drink will completely empty from the stomach in about 90 minutes (Nygren et al,
1995) and further supports guidelines that promote the administration of
carbohydrates rich, clear fluids up to two hours before the induction of
anaesthesia (Brady et al, 2OO3;S0reide et al, 2006;Woods et al, 2007). More complex
liquid suspensions containing carbohydrate and amino acids, however, cannot be
safely administered in the same time frame, as it would require up to three hours to
empty form the stomach. This study also demonstrates that even after an overnight
fast, the stomach is never completely empty. The residual volume in healthy
volunteers can range from 0 to 95 ml with a mean of 27 ml as demonstrated with
MRI.
With regard to the different metabolic conditioning preparations the CCD, which is a
clear solution and contains no fat or protein, emptied at a significantly quicker rate
than ONS400 and ONS300, which were suspensions. Despite the difference in
volume, osmolarity, viscosity and density, the rates of emptying of the ONS400 and
ONS300 drinks were similar. These findings suggest that the gastric emptying of
liquids is more dependent on the presence of particulate matter and the nutrient
content rather than general physical properties such as volume, osmolarity, viscosity
and density.
The rate of gastric emptying was slower in female subjects than in males for all three
drinks, although statistical significance was not reached due to the relatively small
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sample size. These gender differences have been described previously and may be due
to the effect of female sex hormones, especially progesterone, on gastric smooth
muscle (Datz et al, 1987;Degen et al, 1996;Lobo et al, 2002). These differences were
relatively small and it is uncertain whether gender related differences are clinically
relevant.
MRI evaluation of gastric emptying has been validated against scintigraphic
techniques (Feinle et al, 1999). The gastric emptying results for the CCD presented in
this chapter are very similar to the results obtained with the same drink by Nygren et
al (Nygren et al, 1995) using scintigraphy. However, the measurements made by the
two techniques are, in fact, slightly different. Scintigraphy measures the residual
isotope in the stomach and not the volume of the contents, while MRI measures the
actual volume of the gastric contents, which is the sum of the volume of the drink
administered and the volume of oro-gastric secretions. The gastric volume measured
by MRI may, therefore, be increased by feeds that increase gastric secretion
significantly. Amino acids stimulate gastrin release (Taylor et al, 1982) and, hence,
gastric secretion (Kidd et al, 1998) and therefore may increase gastric volumes
resulting in the appearance of a delayed gastric emptying rate.
The gastric residual volume had returned to the fasting baseline within 120 minutes of
ingesting CCD, once again confirming that it is safe to administer such clear liquids
up to two hours prior to the induction of anaesthesia. However, for ONS400 and
ONS300 the mean residual gastric volumes at 120 min were still significantly greater
than the baseline fasting levels, suggesting that a two-hour preoperative fast after
ingesting these drinks may not be adequate. At 180 min the residual gastric volumes
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had returned to baseline for both ONS400 and ONS300, suggesting that
administration of these drinks three hours prior to induction of anaesthesia may be
safe. We can, therefore, recommend that unless significant comorbidity is present, the
period of preoperative fasting after ingestion of 300 - 400 ml of a liquid suspension
should be between three and four hours.
Although the present data was from a study of healthy volunteers the results can be
extrapolated to other groups. Preoperative anxiety in surgical patients has been shown
to have no effect on gastric emptying time (Nygren et al, 1995) and morbidly obese
patients have been shown to have similar gastric emptying patterns to lean
patients (Maltby et al, 2004). Diabetic patients with autonomic neuropathy can,
however, have delayed gastric emptying, increasing the risk of aspiration (Kong et al,
2005) therefore results obtained from healthy subjects may not be applicable to this
group of patients. However, patients with uncomplicated type-2 diabetes can have
gastric emptying times comparable with the subjects of the present study and a
previous study on preoperative carbohydrate loading did not find an increased
aspiration rate in type-2 diabetic patients (Breuer et al, 2006). Therefore it may be
possible to extrapolate the results of this Chapter to otherwise health type-2 diabetic
patents (Gustafsson et al, 2008).
The benefit of carbohydrate loading itself appears to be a result of an enhanced action
of a 'postprandial' insulin surge at the start of surgery. The postprandial rise in
glucose following such a carbohydrate load lasts for up to two hours in non-diabetic
patients, which then enhances the action of insulin by approximately 50 % at three
hours (Nygren et al, 1998). The additional delay between administration of the
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carbohydrate load of the new drink and induction of anaesthesia and its slower gastric
emptying profile is likely to alter the timing and the magnitude of this improved
insulin response. Further studies will be required prior to recommendation of this
novel product in place of a carbohydrate only preparation.
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SECTION F. INTERACTION OF NUTRITIONAL
CONDITIONING AND LAXATION COMPONENTS OF
THE ERAS PROTOCOL: A PROSPECTIVE
RANDOMISED TRIAL
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Chapter 8. Randomised clinical trial of laxatives and oral nutritional
supplements within an enhanced recovery after surgery protocol
following liver resection
8.1 Background
Major abdominal surgery has a profound negative effect on patients' physiology and
nutritional status. Left unchecked the metabolic response to injury can result in a
prolonged recovery period, increased postoperative morbidity and longer length of
hospital stay (Desborough, 2000;Nygren et al, 2005). The key components that are
thought to delay postoperative recovery include postoperative pain, gastrointestinal
dysfunction and immobility (Fearon et al, 2005). Enhanced Recovery After
Surgery (ERAS) programmes combine a series of interventions to target these factors.
Such protocols have been shown to be safe and effective, accelerate postoperative
recovery and reduce length of hospital stay following aortic aneurysm repair (Podore
et al, 1999), oesophagectomy (Cerfolio et al, 2004) and most notably colorectal
resection (Basse et al, 2000). Within Chapter three of the present thesis the
effectiveness of such a protocol is also demonstrated for patients undergoing hepatic
resection.
Evidence for the efficacy of many of the individual protocol elements within an
ERAS programme is often extrapolated from traditional care pathways (Fearon et al,
2005). The rate of morbidity and length of hospital stay following liver resection are
relatively predictable. Thus, liver resection provides a suitable human model for
testing the contribution of the individual elements within an ERAS programme in a
randomised controlled trial (Belghiti et al, 2000).
Reduced gastrointestinal function after surgery is a major factor that limits the overall
success of an enhanced recovery programme. Current enhanced recovery protocols
employ a multi-modal package with elements that include; continuous thoracic
epidural anaesthesia, enforced mobilisation and avoidance of excessive saline load.
All of which, in the context of traditional perioperative care, have been shown
individually to reduce postoperative ileus (Lobo et al, 2002;Fotiadis et al,
2004;Nisanevich et al, 2005). In addition to these factors, early feeding after open
elective abdominal surgery is associated with earlier passage of flatus and
stool (Stewart et al, 1998). Despite the widespread use of laxatives in non-surgical
patients there are limited data regarding their routine use in the postoperative period.
The administration of magnesium hydroxide, a known osmotic purgative, has been
described in an unblinded, non-randomised study and has been employed in ERAS
programmes, however, there is limited evidence to justify routine use (Fanning et al,
1999;Basse et al, 2000;Hansen et al, 2007). It has also been suggested that
preoperative carbohydrate loading may promote earlier return of gastrointestinal
function (Noblett et al, 2006). Within an ERAS protocol, metabolic conditioning and
early provision of oral nutritional supplements may interact with laxatives to enhance
gastrointestinal function further in the early postoperative phase.
Early recovery of gastrointestinal function allows early oral intake, discontinuation of
intravenous fluids and hence accelerated recovery. Early food intake may attenuate
postoperative catabolism. Preoperative oral carbohydrate loading has also been shown
to reduce the postoperative catabolic response and insulin resistance (Nygren et al,
1998;Soop et al, 2001). By improving the ability of a patient to respond to anabolic
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stimuli in the postoperative period, metabolic preconditioning may promote greater
benefit from early postoperative nutritional intake. The perioperative administration
of oral nutritional supplements (ONS) has been shown to improve nutritional status
and reduce minor complications within the context of traditional perioperative
care (Beattie et al, 2000;Smedley et al, 2004). It is not known if the provision of
combined metabolic conditioning / early oral nutritional support along with early
recovery of gastrointestinal function achieved with magnesium hydroxide, can
promote further improvements in the rate of overall functional recovery within an
ERAS protocol.
The aim of the Optimised Recovery Accelerated Nutrition and Gastrointestinal
Enhancement (ORANGE) study presented in this chapter was to determine, within an
ERAS protocol designed for hepatic resection, whether postoperative bowel
stimulation with magnesium hydroxide and / or metabolic conditioning / oral
nutritional supplements are effective in promoting early return of gastrointestinal
function and overall postoperative recovery.
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8.2 Patients and methods
The results presented in this chapter were obtained as part of a prospective
randomised controlled trial with a two-by-two factorial design assessing the effect of
routine postoperative laxation and its interaction with early administration of oral
nutritional supplements for patients undergoing hepatic resection within an ERAS
care protocol. This trial was conducted with the approval of Lothian Research Ethics
committee. All recruited patients were programmed to undergo hepatic resection for
benign or malignant conditions at the Liver Unit at Edinburgh Royal Infirmary
Edinburgh, UK or Maastricht University Medical Centre, The Netherlands, between
July 2006 and June 2008. All were aged between 18-80 years of age, had a BMI of
between 18 and 30 Kg / m2 and had no pre-existing limitations to mobility or
underlying cirrhotic liver disease. Informed, written consent was obtained from all
patients recruited.
Suitable patients were recruited during an outpatient pre-assessment visit at least one
week prior to hospital admission allowing a suitable time for reflection prior to
providing written, informed consent. Patients received preoperative information packs
and counselling related to the perioperative ERAS care pathway. They were informed
about the protocol and the importance of both early mobilisation and early oral intake.
Following recruitment and prior to hospital admission patients were randomised to
one of four groups (Control, Laxation, ONS and Laxation & ONS) using
consecutively sealed, opaque envelopes created in advance through block
randomisation with a random numbers table. Patients randomised to the laxation
group received lg ofMagnesium hydroxide orally twice daily from the day of surgery
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until the day of discharge. Patients randomised to ONS group received 800 ml of a
carbohydrate loading drink (Nutricia Preop® Nutricia Clinical Care, Trowbridge,
UK.) at 10 pm the night before surgery and 400 ml at 6 am on the morning of surgery.
In addition, they received ONS (two cartons per day comprising 400 ml, 600 kcal,
24 g protein, Nutricia Fortisip®; Nutricia Clinical Care). Patients randomised to the
laxation & ONS received the combined elements of the laxation group and the ONS
group. Owing to the nature of the study interventions (nutritional supplements
available in a variety of flavours to encourage compliance and magnesium hydroxide
suspension produced by the hospital pharmacy), a suitable placebo was not feasible
and so the type of treatment could not be masked. All patients followed a standardised
perioperative and anaesthetic regimen based on previously published ERAS
protocol (Fearon et al, 2005). The study groups are summarised in Table 8.1.
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Table 8.1: Summary of four different group protocol following
randomisation within 2x2 factorial study
Control Laxation
1 gram of magnesium hydroxide twice




800 ml of oral carbohydrate-loading
drink at 10 pm the night before surgery
and 400 ml at 6 am on the morning of
surgery
Postop
Two cartons of oral nutritional




A standardised perioperative and anaesthetic regimen based on a published colorectal
ERAS protocol, was followed (Fearon et al, 2005). This multi-modal, enhanced
recovery programme described in Chapter 3 of the present thesis was modified to
cover all aspects of liver resection. Notably, liver tissue sealant (TachoSil®,
Nycomed, Zurich, Switzerland) was used to minimise bile leakage and haematoma
formation, routine perihepatic drainage was avoided and paracetamol used at the
discretion of the surgeon in cases of extended resection. Patients were normally
scheduled for surgery in the morning and were nursed in a high dependency unit.
Details of the ERAS liver protocol are shown in Table 8.2.
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Table 8.2: Care plan for patients undergoing liver resection within
ERAS Protocol
Day before surgery Normal feeding until midnight
No preanesthetic medication
Day of Surgery Mid-thoracic epidural analgesia (local anaesthetic and low-
dose opioid)
Short acting anaesthetic agent
No naso-gastric tube (if used removed immediately after
surgery)
Warm IV fluids and body warming device
Avoidance of excessive IV fluids
No routine drainage of peritoneal cavity
Oral intake of water/nutrition started immediately ad
libatum
Patients out of bed for 2 hours
Postoperative day 1 Patient mobilised
IV fluids discontinued
Patient to drink at least 1 litre of fluid
Normal diet
Continue mid-thoracic epidural analgesia
1 g of Paracetamol QDS
Postoperative day 2 Continue mid-thoracic epidural analgesia
1 g of Paracetamol QDS
Normal diet
Patient mobilised
Postoperative day 3 Stop epidural
Commence NSAIDs if appropriate
Remove urinary catheter
Encourage full oral intake and mobilisation
Review discharge criteria
Postoperative day 4 Encourage full oral intake and mobilisation
Review discharge criteria
The above table is based on Table 3.1 in the present thesis, however, preoperative
carbohydrate loading, postoperative oral nutritional supplements and postoperative
magnesium hydroxide were administered according to randomisation.
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Seven specialist liver surgeons performed all resections between the two centres.
Extent of resection was classified according to Brisbane 2000
Terminology (International Hepato-Pacreato-Biiary Association, 2000). Subcostal
incisions were used and the transection plane determined by preoperative imaging and
using intraoperative ultrasonography. Resection was performed using the Cavitron
Ultrasonic Surgical Aspirator (CUSA®; Valleylab, Boulder, Colorado, USA) and
argon beam coagulation. After removal of the liver specimen, the raw surface of the
liver remnant was subjected to Argon beam coagulation and sealed with TachoSil®.
Abdominal drains were not placed routinely and the abdomen was closed with a
standard running suture.
Study data were documented prospectively during the hospital stay and 30 days after
surgery at an outpatient visit. Return of gastrointestinal function was determined by
first passage of stool post surgery. Patients were assessed for return of GI function
(passage of flatus/stools) on a daily basis. Secondary outcomes were: postoperative
oral nutritional intake on postoperative days 1-3, functional recovery and length of
hospital stay.
Oral nutritional intake
A senior dietician, in cooperation with the patient and ward nursing staff, recorded
postoperative oral intake daily for all patients on a standard diet sheet. This was
converted to energy intake (in kilocalories) intake and the recommended nutritional
intake (RNI) for each subject was estimated using CompEat Pro® for Windows®
(Nutrition Systems, Banbury, England). The percentage RNI achieved on
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postoperative days 1 - 3 for each of the subjects was used in comparisons between the
study groups.
Functional recovery criteria
Functional recovery was defined as in Chapter 3. Adequate pain control requiring
only oral analgesia, adequate oral intake with no IV fluid requirement, independent
mobility sufficient to perform activities of daily living and blood results (liver
function tests and inflammatory markers) returning towards normal ranges. Criteria
were assessed on a daily basis. An experienced clinician determined readiness for
hospital discharge. Time to achieve functional recovery, initial length of stay (defined
as the number of nights spent in hospital after surgery, excluding readmissions) and
all adverse events up to 30 days were recorded. Morbidity was documented
prospectively according to criteria described previously (Copeland et al, 1991;Lang et
al, 2001). Other data recorded for each patient included mortality, readmissions and
use of preoperative chemotherapy.
Statistical analysis
Retrospective data (P.O. Hendry and K.C.H. Fearon, unpublished results) indicated
that the mean (s.d) time to passage of stool was 5.3 days +/- 1.3 days. This study was
powered (a = 0.05, (3 = 0.80) on the primary outcome to detect a 20 % difference in
time to passage of stool, the primary outcome. Based on this calculation, fourteen
patients were required in each of the four groups (56 patients overall). The secondary
endpoints were of an exploratory nature. Continuous data are expressed as
median (IQR) and categorical variables as incidence (percentage). For comparison
between the study groups, data were analysed using Mann-Whitney test, chi-squared
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test or Fisher's exact test where appropriate. P < 0.05 was considered statistically




Between July 2006 and June 2008, 74 patients were recruited and randomised within
the ORANGE study, sixty-six in Edinburgh and eight in Maastricht. Six patients did
not undergo hepatic resection and were excluded. The remaining 68 patients were
managed within the ORANGE protocol as outlined previously (Fig 8.1).
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Fig 8.1: Consort diagram for patients undergoing liver resection
within an ERAS protocol and randomised in a 2 x 2 factorial design
to Control, Laxation, ONS and Laxation or ONS.
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Demographics for the four study groups are shown in Table 8.3. Overall the male to
female ratio was 4:3 and the median (IQR) age was 62 (53,69) years. Sixty-two
patients (91 %) were treated for malignant disease. There were no significant
differences across the study groups for sex, American Society of
Anesthesiologists (ASA) Grade, pathology, malignancy, body mass index, use of
neoadjuvant therapy or extent of liver resection (Table 8.3). There were 53 major and
15 minor resections (Table 8.4).
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Time to functional recovery and initial length of hospital stay [median (IQR)] were 4
days (3,5) and 6 days (4,7) respectively and were not significantly different between
the study groups. The postoperative morbidity was 25%, and did not differ
significantly between the groups (Table 8.5). Two patients required reoperation due to
postoperative haemorrhage. Five patients required readmission to hospital (intra¬
abdominal collection, 2; severe constipation, 1; bile leak, 1; pneumonia, 1). There
were two deaths due to myocardial infarction within 30 days of surgery. Discharge
from hospital was delayed in some patients for reasons outlined in Table 8.6.
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Table 8.6: Reasons for hospital stay beyond achievement of
functional recovery criteria
Reason No of patients
Caution over discharge due to earlier complication or extensive 5
surgery
Patient did not feel confident to be discharged 4
Transport/social problems 2
Patient boarded to another ward prior to discharge 1
Patient drowsy due to analgesia administered 1
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Oral fluid intake was resumed on the day of surgery in 94 % of patients.
Reintroduction of diet was achieved on day one in 37 % of patients and day two in
91 %. Intravenous fluids were discontinued on postoperative day one in 51 % of
patients and by day two in 78 %. Mid-thoracic epidural anaesthesia was commenced
before surgery in 99 % of patients and continued for at least 48 hours post-surgery in
93 % of patients, 4 epidurals failed on day one. Drains were used in nine patients
(13 %). Nineteen patients (28 %) achieved mobilisation on the day of surgery. Sixteen
patients (24 %) had a urinary catheter in situ beyond discontinuation of epidural
analgesia and 32 (47 %) of patients received non-protocol IV fluids in the
perioperative period.
Overall, the median (IQR) time to passage of stool was 5 (4,6) days. Patients
randomised to ONS showed a trend to shorter time to passage of stool (4 (3,5) vs
5 (4,7) days: p=0.076). Patients randomised to laxation had a significantly reduced
time to passage of stool (4 (3,5) vs 5 (4,6) days: p=0.034). Patients randomised to the
combination regimen also had a significantly reduced time to passage of stool (3 (3,4)
vs 6 (4,7) days: p = 0.013). There was no evidence of interaction between laxatives
and ONS (Fig 8.2).
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Fig 8.2: Diagram of potential interaction between laxatives and oral
nutritional supplements (ONS) in sixty-eight patients undergoing
liver resection within an ERAS protocol of care randomised in a 2 x 2
factorial design to Control, Laxation, ONS and Laxation or ONS.
Values are median with interquartile range.
188
Oral intake of at least fifty percent of recommended nutritional requirement was
achieved at a median (IQR) of 1 (1,2) days after surgery for the whole group. This
was not significantly different between groups. Total calorie intake (including ONS)
on postoperative days 1 - 3 for those randomised to the ONS was not significantly
different from that in patients who did not receive ONS (Fig 8.3). The median (IQR)
percentage change in body weight from preoperative level for all subjects
was +1.8% (-1.4,5.8) and -2.0% (-4.7, -0.3) on postoperative day five and day thirty
respectively and there were no significant differences between the groups (p = 0.166
and 0.200 respectively).
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Fig 8.3: Total calorie intake during the first 3 days after liver
resection for sixty-eight patients following an ERAS protocol of care
receiving ONS supplements or no ONS supplements.
90
NoONS ONS NoONS ONS NoONS ONS
Day 1 Day 2 Day 3
Study group/Postoperative day
Values are median with interquartile range. ONS = oral nutritional supplements
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8.4 Discussion
Within the study presented in this chapter, laxatives significantly decreased the time
to passage of stool after liver surgery. Patients randomised to the combination
regimen also had a significantly reduced time to passage of stool but with no evidence
of interaction between laxation and ONS. There were no differences in the secondary
outcomes between groups.
Previous studies have suggested that early restoration of food intake can result in a
more rapid return of gut function in the postoperative period (Stewart et al, 1998). In
the present study, the total calorie intake (food plus ONS) of the groups randomised to
ONS was not significantly different from patients who did not receive ONS,
suggesting that ONS in the early postoperative phase suppressed normal food intake
to the point at which there was no net benefit. The lack of interaction between
laxation and ONS could therefore be explained on the basis that ONS did not alter
overall calorie intake and may also explain the lack of effect of ONS on the secondary
outcomes.
Patients following the ERAS protocol recommenced oral fluid intake on the day of
surgery, started eating the day after surgery, were mobile by the third postoperative
day and achieved discharge criteria on the fourth postoperative day. Median length of
hospital stay was 6 days, which is significantly shorter than the 8-14 days reported in
other centres following a more traditional pattern of perioperative care (Jarnagin et al,
2002;Dimick et al, 2004;Capussotti et al, 2006;Petrowsky et al, 2006). The results in
this chapter are in keeping with those in Chapter 3 and provide further evidence to
support the use of an ERAS pathway following liver resection to accelerate
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postoperative recovery and shorten length of hospital stay. In the present study,
functional recovery was achieved a median of four days following surgery, a median
of two days before actual discharge from hospital. It may be possible to achieve a
shorter overall hospital stay by further tightening the care pathway elements of the
protocol (Maessen et al, 2007).
In this study, the overall morbidity rate was 25 %, readmission rate 7.4 % and
mortality rate 2.9 %. Morbidity rates in the present study were lower and mortality
rates in keeping with those published from other countries following traditional care
pathways (38-45 % and 2.7-3.1 % respectively) (Jarnagin et al, 2002;Petrowsky et
al, 2006;Nikfarjam et al, 2009).
All patients received preoperative counselling and there was a high level of
compliance with most elements of the protocol. Ninety-nine percent of patients
received preoperative epidural anaesthesia. Intraoperative drainage was only used in
cases considered to have a higher risk of a bile leak (13 %), in keeping with current
evidence (Fong et al, 1996;Burt et al, 2002).
In the early postoperative period, adherence to the protocol was lower than that
observed in the preoperative and intraoperative phases. This is in keeping with the
earlier findings in the present thesis and supported by other published data (Maessen
et al, 2007). Intravenous fluids were discontinued on the day after surgery in only half
of the patients. Saline (0.9 %) was prescribed by out-of-hours medical staff, less
familiar with the study protocol, 47 % of patients received at least 200 ml of IV
saline. Only 28 % of patients were mobilised on the day of surgery. This was usually
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due to epidural-related hypotension or late return to the high dependency unit. Future
ERAS protocols may overcome the issue of late return to the ward by initiating
postoperative mobilisation in the recovery room. Postoperative variables are both
markers of protocol compliance and markers of recovery and therefore patients
achieving these protocol goals are those likely to achieve a faster overall recovery.
Within the context of multimodal therapy it is difficult to separate the effect of one
protocol component from another. A two-by-two factorial design is an efficient way
of assessing two different factors and evaluating their potential interaction. The
statistical design of the study presented in this chapter meant that there was a potential
confounder in 50 per cent of each group under description; this reflects the
exploratory nature of the evaluation of potential interactions.
The present study has shown that laxatives can hasten return of colonic function in
patients undergoing hepatic resection, ffowever, there was no evident interaction with
ONS. More importantly, there seemed to be no benefit in terms of enhanced oral
intake or overall functional recovery. Thus the benefit for the patient of routine
laxatives or ONS is difficult to gauge. Clearly the present findings cannot be
extrapolated directly to patients with an intestinal anastomosis. Future studies might
also evaluate the interaction between the present variables and other measures
designed to improve upper gastrointestinal function and oral intake.
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SECTION G. GENERAL DISCUSSION
Chapter 9. Conclusions
9.1 Enhanced Recovery After Surgery
It is important that perioperative care continues to evolve and incorporate an evidence
base to its practice. Despite the widespread discussion of enhanced recovery after
surgery protocols, ward level practice is often based on outdated aphorisms. Even
within ERAS programmes themselves much of the evidence for the individual
elements is taken in isolation from traditional care pathways, consensus review or
simply accepted standards of care [as described in Chapter 1.3,1.4], Little evidence is
available concerning the importance of each element when considered within the
context of an enhanced recovery pathway. There is extensive literature in the area of
Enhanced Recovery After Surgery, however, only a limited number of randomised
controlled trials have been reported (Spanjersberg et al, 2011). Further refinement of
the ERAS protocol will rely on evaluation of the individual protocol elements within
randomised controlled trials, improved protocol compliance and audit of objective
postoperative outcomes. Length of hospital stay itself has been questioned as an
appropriate measure of protocol success (Maessen et al, 2008). Outcomes such as
gastric emptying rate or activity level may represent feasible, objective markers of
recovery (Chapters 4 and 5) along with more accurate measures of postoperative
morbidity and will allow individual or combinations of components of the ERAS
protocol to be tested within clinical trials.
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9.2 The application of an ERAS care pathway to high-risk patients.
Modern surgical care has to account for an aging population with increasingly
complex comorbidity and undernutrition. The multimodal ERAS protocol of care
represents a potential solution. Chapter 2 of this thesis presents a mixed group of over
one thousand patients undergoing colorectal resection within such a programme. In
this group almost one in five were over eighty years old, one in five had an ASA of 3
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or more and one in twelve a BMI of under 20 kg / m . Despite this, hospital stay was
6 days, overall morbidity was 28.4 % and mortality 1.6 %. Morbidity was
significantly lower than that predicted by the P-POSSUM system and both morbidity
and mortality were lower than rates published by other European centres following
traditional perioperative care pathways (Braga et al, 2002;Alves et al, 2005). Length
of stay was also shorter than that published for open (Nygren et al, 2005) or
laparoscopic techniques (Guillou et al, 2005;Veldkamp et al, 2005) following
traditional care. This attests to the general safety and potential benefits of the ERAS
approach to perioperative care.
The same study demonstrated that neither BMI below 20 kg/m2 nor age 80 years or
more were independent predictors of postoperative 30-day morbidity or mortality.
This is in contrast with traditional perioperative care (Polanczyk et al, 2001) and
mortality (Alley, 2000;Tekkis et al, 2003). Mortality rate for those aged 80 years or
above (3.1 %) [Chapter 2], compared favourably with published figures (1.1-
11.3 %) (Heriot et al, 2006;0ng et al, 2008). Therefore, within the context of an
enhanced recovery programme the surgeon may not need to individualise
postoperative morbidity or mortality risk assessment for elderly or undernourished
patients as relatively stress-free surgery and minimisation of organ dysfunction appear
to translate into reduced morbidity and the apparent attenuation of the increased
surgery risk.
Postoperative complications in the elderly have been shown to be independent
predictors of decreased long-term survival (Manku et al, 2003) therefore,
improvement in 30 day morbidity is of increased significance in this group of
patients. If older patients make it through the immediate postoperative period 5-year
survival in those aged 80 years or more is similar to that of the younger group (Smith
et al, 2002). The favourable outcomes reported for patients over 80 years old, in the
present thesis may reflect some degree of selection bias. However, this seems unlikely
given that the patient series was consecutive. In this thesis, age was related to time to
mobilisation and length of hospital stay. In this age group a prolonged length of
hospital stay itself may also reflect difficulties in arranging social care post
discharge (Maessen et al, 2007;Maessen et al, 2008).
Comorbidity is still a significant factor in predicting postoperative outcomes in both
traditional care and enhanced recovery pathways. However, the present study
demonstrates lower rates of morbidity within an ERAS protocol despite one in five
patients having significant comorbidity (ASA 3 or more), which suggests that this
comorbidity is modulated by the ERAS approach.
Within Chapter 2 it is demonstrated that the ERAS protocol represents an overall
strategy to condition all patients and to improve all aspects of perioperative care. This
should be easier to implement than the provision of specialised care for a difficult-to-
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define group of individual patients. The improved postoperative outcomes achieved
with the ERAS protocol would appear to be an improved rate of morbidity in
potentially high risk patients alongside reduced recovery period and length of hospital
stay in patients with lower perioperative risk profiles.
There are limitations to the results in this chapter. Although the results of this chapter
were gathered from a large, multicentre, prospective database of over a thousand
consecutive, unselected patient, the original aim of the database was to audit
improvement in length of hospital stay as each unit introduced an ERAS programme
and became more familiar with its day-to-day application. The initial database did not
aim to differentiate between the postoperative outcomes of higher risk groups of
patients: elderly, malnourished and those with major comorbidity.
Perioperative Nutrition is an important factor in the ERAS protocol and within the
existing database BMI was recorded as a measure of nutritional status. BMI is a
useful measure of nutritional status as it is universal, easily understood and does not
require measurements outwith those normally recorded at hospital admission. It can,
however, be flawed notably in overweight patients with unplanned significant weight
loss and athletic patients who despite a low BMI will be physiologically optimal.
Similarly although ASA is a robust and universally measure of categorising higher
and lower risk patients it is more likely that risk is overestimated. There are more
detailed and more objective scoring systems such as APACHE II that may provide
more detailed evaluation of patients' comorbidity and surgical risk.
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Further evaluation of the specific benefit of an ERAS programme of care for higher
risk patient groups will require both a larger cohort of patients (ideally from a greater
number of centres) and more detailed identification of the higher risk patients.
Although the evaluation of age will not change, with the overall increase in average
patient age our definition of elderly may rise. Moreover, in these groups a reduced
length of hospital stay is less important as the most significant risks is from
postoperative morbidity. Specific attention to postoperative complications is more
desirable in these groups as this is often linked to longer-term survival. With
complications such as surgical site infections and anastomotic leaks there is also a risk
that early discharge pushes the diagnosis and initial management of such
complications onto the primary care physician. It is particularly significant in this
group to ensure that patients are beyond the high-risk period of such events prior to
discharge. Although complications outwith the hospital environment can never be
excluded discharge criteria should take into consideration potential early warning
signs such as elevated CRP on postoperative day four (Warschkow et al, 2011). This
would limit discharge to a minimum of four days after surgery.
The Malnutrition Universal Screening Tool (MUST) (BAPEN, 2003), could be used
to assess nutritional status in more detail. This screening tool has already been shown
to be user friendly and can identify undernourished and over nourished patients.
Detailed food diaries could be used to compare preoperative and postoperative oral
intake. Anthropometry (Percentage body fat, Lean body mass, mid arm muscle
circumference and Triceps skinfold thickness) could provide much more detailed
evaluation of nutritional status. Although anthropometry will require more time and
specialist training it is likely to be the most useful measure of nutritional status before
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and after surgery. Similarly for patient comorbidity from objective scoring systems
such as P-POSSUM or APACHE II may allow a more objective assessment of the
benefits ofERAS programmes for patients with significant comorbidity.
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9.3 Hepatic resection as a model for enhanced recovery trials.
It is apparent that randomised controlled trials are necessary to further refine the
ERAS protocol. Due to its predictable outcomes hepatic surgery is a suitable model in
which to run such trials. In Chapter 3 the benefits of an Enhanced Recovery After
Surgery programme are demonstrated in patients undergoing hepatic resection.
Patients managed within the ERAS protocol were discharged from hospital a median
of 6 days after surgery with half the cohort discharged within 5 days. This is
considerably shorter than the length of stay reported by other European centres for
traditional perioperative care (Jarnagin et al, 2002;Dimick et al, 2004;Capussotti et al,
2006). Adverse outcomes following liver resection (hospital readmissions,
postoperative complications and deaths) were similar to the control group and
complication rates in keeping with those published for traditional care (Jarnagin et al,
2002;Petrowsky et al, 2006;Schroeder et al, 2006;Benzoni et al, 2007;Figueras et al,
2007). Although, compared with the control group, the morbidity rate was higher in
the ERAS group, the study was not sufficiently powered to determine statistical
differences in the incidence of complications.
Preoperative elements of the ERAS protocol were readily accepted and implemented
especially carbohydrate loading prior to surgery (Nygren et al, 1995;Brady et al,
2003). This was a dramatic improvement on the nil by mouth from midnight policy
practiced in many surgical units. This trend towards ready adoption of new elements
of the ERAS protocol is highlighted again in Chapter 6 where a complicated regimen
of preoperative metabolic conditioning in combination with mechanical bowel
preparation was applied. The present thesis, however, also highlights how slow some
elements of perioperative care are to evolve. Despite evidence that in traditional
perioperative care nasogastric tubes are unnecessary and can result in more
pulmonary complications (Cheatham et al, 1995;Nelson et al, 2007;Pessaux et al,
2007) they were still commonly used during surgery in the traditional perioperative
care cohort from Maastricht [Chapter 3]. With the introduction of the ERAS protocol
they were removed immediately after surgery, which was an improvement in clinical
routine.
In the present thesis [Chapter 3] oral intake of water was tolerated within four hours
of surgery and oral diet recommenced on the day after surgery in the ERAS group.
Delayed return of gastrointestinal function (>7 days) occurred in 3 (5 %) of patients,
which was not significantly different from the control group. However, the sample
size was small and it is likely that complications such as this would be more closely
assessed in the prospective ERAS group and may have been underestimated in the
retrospective control group. Mobilisation on the day of surgery was possible in
Edinburgh however, proved more difficult in Maastricht as the recovery unit did not
contain the appropriate facilities or nursing staff required. Early oral intake, restrictive
fluid IV therapy and early mobilisation are significant factors in the reduction of
postoperative gastrointestinal dysfunction (Lewis et al, 2001;Kehlet et al, 2002;Lobo
et al, 2002). Reduction in postoperative gastrointestinal dysfunction is likely to be a
key factor in improving rate of functional recovery; therefore adherence to these
elements is significant.
Chapter 3 demonstrates that patients with otherwise normal liver function can
undergo curative resection of primary or secondary liver tumours within a multimodal
enhanced recovery programme and achieve the same benefits demonstrated in
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colorectal surgery. Increased familiarity with the programme and improved protocol
compliance may lead to further reductions in length of stay. The ready transfer of the
ERAS protocol from the colorectal practice to a hepatic resection model also suggests
that the protocol is inherently robust for abdominal surgery and could be adopted
more widely in General surgical practice.
ERAS Protocols are now being adapted for upper GI and pancreatic
surgery (M.Braga, Italy and K Lassen, Norway, personal communication). Clearly
each operative site has specific areas of concern, for example, management of feeding
jejunstomies, radiological imaging of the oesophageal anastomosis in relation to
restarting oral intake or use of surgical drains. Further randomised controlled trials are
required to refine the ERAS protocol and the present thesis supports the continued use
of a hepatic resection model in which to evaluate changes in the ERAS protocol. Due
to the lack of intestinal anastomosis hepatic surgery is specifically suited to protocol
elements that evaluate gastrointestinal recovery and gastrointestinal recovery is likely
to be one of the main determinants of improved overall recovery.
Issues to address in future ERAS studies are both blinding of interventions and
improved compliance with the postoperative protocol elements. It is not feasible to
blind interventions such as mobilisation and early feeding, however, the benefit of
these elements has already been accepted. The challenge is how to deliver these
elements and improve patient compliance. Future studies may examine different
mobilisation protocols such as more specific mobilisation targets. They may be able
to introduce a dedicated physiotherapist or use of a family member or friend to act as
a postoperative mobilisation coach. A tailored postoperative menu could be
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employed. Smaller, more frequent meals served at patients' request may be difficult
to achieve, however, serving additional nutritious snacks outwith meal times would
seem an appropriate way to maximise oral intake. It is likely that within ERAS
programmes both of these elements are surrogate markers for improved analgesia,
reduced nausea and maintained postoperative muscle strength. Therefore poor oral
intake or lack of mobilisation may in itself be a warning sign of an underlying issue
such as inadequate pain control or patient nausea.
There are several issues that have delayed the adoption and implementation of the
ERAS protocol. Hospital infrastructure or staffing numbers will continue to be
difficult to overcome. Overcoming existing surgical doctrine and preconceptions
about rate of postoperative recovery will also continue to be significant. Protocol
compliance and the success of future ERAS protocols will depend on continued
education of all staffmembers that are involved in patient care. Implementation of an
ERAS programme requires a widespread dissemination of its benefits and an
inclusion of all staff members that participate in the patients' perioperative journey.
Education should specifically include the staff members that have most day-to-day
contact with the patient. It has been previously highlighted that the patient retains
ownership of their recovery, however hospital staff must also feel that they are
contributing to the improvements in rate of patient recovery. It is important that all
staff members that have patient contact feel part of the ERAS team. Employment of a
specific specialised ERAS nurse has the benefits of allowing audit and providing an
additional staff member to facilitate both dissemination of the protocol and assist in
achieving compliance notably with postoperative mobilisation when lack of nursing
staffmay be an issue.
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9.4 Potential role of gastric emptying rate and physical activity level as
objective markers of postoperative recovery.
It is clear that current postoperative endpoints used to assess the efficacy of ERAS
protocols overlap as both markers of protocol compliance and endpoints of
recovery (Maessen et al, 2007). Many of the measures employed are subjective and
outcomes such as length of hospital stay can be influenced by variables outwith the
care pathway (Maessen et al, 2008). This thesis (Section D) presents pilot assessments
of two novel markers of postoperative recovery. Both are demonstrated to be feasible
in the early postoperative period and may predict a shorter or prolonged length of
hospital stay.
Recovery of gastrointestinal function has been used previously as a surrogate measure
of postoperative recovery in clinical trials (Avrahami et al, 1999;Lobo et al, 2002).
However, the general application of this as a suitable endpoint is limited by the
techniques employed to assess gastric emptying. MRI and scintigraphy can be
expensive, require specialist equipment and personnel, and exposure to potentially
harmful radiation. The present thesis suggests stable isotope breath testing (SIBT) as a
safe and economical alternative that can be performed at the bedside. All patients that
participated tolerated this test in keeping with other studies that have employed this
method of assessment in children, neonates and the critically ill (Chiolero et al,
2003;Braden et al, 2004). Nine patients refused the SIBT as they found the 200ml of
oral sip feed (Fortisip®, Nutricia) unpalatable and the test was also impractical for
fifteen patients who had not yet been discharged from HDU as expected. Both issues
that could be addressed in future studies. The correlation between patients with a
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prolonged gastric emptying time and those requiring a prolonged hospital stay suggest
that a delayed gastric emptying may predict a slower postoperative recovery.
There are, however, limitations with SIBT. The accuracy of this SIBT, compared to
MR, may be reduced when gastric emptying is more rapid (Fruehauf et al, 2009) and
optimal accuracy may depend on frequent breath samples over a prolonged period (at
least six hours) (Choi et al, 1997;Choi et al, 1998;Clegg et al, 2010). Achieving this
degree of accuracy in the postoperative period may make the test less desirable and it
may limit both oral intake and mobilisation. It is unlikely that SIBT would be suitable
to assess subtle changes in gastric emptying which may occur as a result of changes in
the ERAS protocol. It is, however, a robust, easily performed test, which would be
useful in identifying patients with significantly, delayed gastric emptying
times (Delbende et al, 2000).
One of the limitations of the study presented in Chapter 4 was that Stable Isotope
Breath Testing was performed on postoperative day 3. As patients' were usually
discharged from the High Dependency Unit on day 3 this allowed easier access and
space to perform the breath test. It is feasible that, at this time point, gastrointestinal
function had already significantly recovered. This was a pilot study therefore the
protocol and timing of the breath test was not based on any preceding data. It would
be of interest to assess gastric emptying much earlier in the postoperative
period (Day 1) and on repeated occasions (Days 1,3 and 5) to assess recovery of
gastric emptying rate following major abdominal surgery. Despite its limitations SIBT
is one of the few techniques that could be employed to perform repeated tests in the
postoperative period.
205
Early return to normal activity level in the postoperative period is one of the goals of
the ERAS programme of care (Basse et al, 2005;Fearon et al, 2005), however, current
methods of classifying postoperative activity are often subjective. The ActivPAL™
activity meter used in this thesis presents a novel and objective method of quantifying
postoperative activity [Chapter 5], The ActivPAL™ activity monitor is small and
unobtrusive, it was tolerated by all of the patients who wore it and it did not hinder
any of their normal activities. Unfortunately the current protocol required patients to
attend hospital to have the meter activated, this resulted in a high dropout rate. The
data from the activity meters highlighted the initial, rapid rise in activity level
following surgery, which appeared to have settled thirty days later. Data from the
activity meters (step count) appeared to correlate with length of hospital stay.
Specifically those with a prolonged hospital stay (>10th percentile) and those with a
shorter hospital stay present (<10th percentile). Although there was only a small
number of participants in the present study there appears to be sufficient evidence to
support further interest in the role of these meters.
Within the ERAS programme there is a clear question about postoperative
mobilisation. Are the activity meters measuring the improved mobility of patients that
have recovered more rapidly or is achieving the increased postoperative mobilisation
in itself the intervention that improves rate of recovery. The activity meters can have a
role in delineating this further. They would be specifically useful in comparing level
of activity in the postoperative period with the level of encouragement / targets set by
an individual ERAS protocol. As patients achieving a rapid recovery would be
expected to mobilise more than patients whose recovery was delayed, a comparison
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could be made between spontaneous, patient initiated mobilisation and activity that
was initiated or supported by hospital staff as part of a protocol.
From the data presented in the present thesis (Chapter 5) activity meters can be useful
in both auditing the success of postoperative mobilisation and predicting patients who
are more likely to have a shorter length of hospital stay.
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9.5 Safe administration of preoperative metabolic conditioning drinks
Despite anaesthetic guidelines prolonged preoperative fasting is still prevalent (Brady
et al, 2003;Hannemann et al, 2006). In colorectal surgery this is often compounded
with preoperative mechanical bowel preparation (Lassen et al, 2005;Nygren et al,
2005). Preoperative oral, liquid and carbohydrate loading facilitates a safe reduction
in the fasting period (Nygren et al, 1995) and allows patients to undergo surgery in
the metabolically fed state. Preoperative metabolic conditioning with 400 ml of a
clear carbohydrate drink (CCD) two hours before the induction of anaesthesia, has
been shown to reduce; postoperative insulin resistance, postoperative nausea and
vomiting, preoperative discomfort and anxiety, and to improve patient
wellbeing (Nygren et al, 1995;Hausel et al, 2001;Nygren, 2006). Chapter 6
demonstrates that preoperative carbohydrate loading and oral nutritional supplement
administration can be combined with mechanical bowel preparation when required.
In the study reported in Chapter 6, 84 % of patients following an ERAS programme
tolerated a regimen that combined preoperative oral fluid / CHO loading and ONS in
conjunction with MBP prior to elective left colonic or rectal resection. This is in
keeping with previous studies examining CHO / electrolyte replacement in
conjunction with MBP prior to colonoscopy (Tjandra et al, 2004). This regimen
presents a feasible method of providing the extra oral fluids required, counteracting
dehydration and potentially the deleterious affects of MBP. Although the regimen
presented is more complex than standard preoperative care and the protocol failed in
11 % of cases, this occurred almost exclusively with inpatients. Failure was due to the
regimen not being prescribed by medical staff or not being administered by nursing
staff, therefore, this is likely to improve with increased familiarity with the regimen.
Equally it reinforces the trend towards putting patients in charge and engaging them
in their own care and recovery. Within a clearly defined protocol patients undergoing
MBP are capable of completing a regimen of CHO / fluid loading combined with
ONS, which currently is best performed as an outpatient prior to hospital admission
on the day of surgery.
Within colonic resection routine administration ofMBP does not reduce anastomotic
leak rate (Wille-Jorgensen et al, 2003;Slim et al, 2004;Bucher et al, 2005;Ram et al,
2005;Contant et al, 2007;Jung et al, 2007). It may, however, provide a benefit in
rectal resection. Although Cochrane review suggests no difference in the anastomotic
leak rate when MBP was omitted prior to low anterior resections (Guenaga et al,
2009) recent evidence suggests that it may protect against anastomotic leaks requiring
reoperation (Platell et al, 2006). Moreover, mechanical bowel preparation still has a
role when a defunctioning ileostomy may be required, to facilitate the identification of
small tumours and to allow on table colonoscopy.
There are clear benefits for patients undergoing surgery in the metabolically fed state.
In the presence ofMBP, where solid food is precluded, feeding can be achieved in the
form of ONS and clear carbohydrate drink prior to surgery. Clearly to minimise
aspiration risk it is essential to know that complete gastric emptying has occurred
prior to anaesthesia. Although MR imaging has been validated against
scintigraphy (Schwizer et al, 1994;Feinle et al, 1999) they differ in their assessment of
gastric emptying. MR imaging measures directly the volume of gastric content. In
contrast scintigraphy measures the presence of a radioactive isotope remaining in the
stomach therefore MR1 will account for all additional oro-gastric
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secretions (Konturek et al, 1978;Taylor et al, 1982;Kidd et al, 1998). MRI is therefore
the method of choice when assessing completeness of gastric emptying. For example,
in relation to preoperative metabolic conditioning when it may be necessary to give a
drink prior to the induction of general anaesthesia.
In Chapter 7 a novel preoperative carbohydrate drink combined with glutamine and
antioxidants was assessed as it has been proposed that additional metabolic agents
such as glutamine and antioxidants along with the carbohydrate may further benefit
patients undergoing major abdominal surgery (Berger et al, 2007;Roth, 2008). MR
imaging clearly demonstrated that these complex suspension drinks did not empty
from the stomach within the two-hour time frame that was possible for the existing
carbohydrate only drink. Instead it required a three-hour window. Thus the study
demonstrates that it would be unsafe to give the suspension two hours prior to
anaesthesia. This has major implications for the overall strategy of adding other
nutrients to enhance the metabolic preparation provided by the carbohydrate load
alone.
It is established that improved postoperative insulin sensitivity is dependent on
surgery taking place shortly after the insulin peak provoked by the preoperative
carbohydrate load. Therefore having to wait three hours or more before undertaking
anaesthesia would potentially lose the benefit of the carbohydrate load within the
complex preconditioning regimen. It is unclear if a delayed gastric emptying rate
would delay the timing of the insulin peak or reduce its magnitude.
Further refinement of the composition of the complex drink itself may improve
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gastric emptying rate and allow concurrent administration of glutamine with the
preoperative carbohydrate load. It is likely, however, that the amino acid itself delays
gastric emptying (Taylor et al, 1982;Kidd et al, 1998). To avoid a negative impact on
the benefits of the carbohydrate load it may be that additional nutrients such as
glutamine should be administered independently in the days leading up to surgery.
The ERAS model of care clearly provides an ideal setting in which to evaluate both
the overall benefits and the safety (gastric emptying) of such a regimen.
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9.6 Enhanced recovery of gastrointestinal function combined with use of
oral nutritional supplements and preoperative carbohydrate and fluid
loading.
In this thesis it is demonstrated that, within an ERAS protocol, patients randomised to
receive routine postoperative laxatives had a significantly decreased time to passage
of stool after liver resection (4 (3,5) vs 5 (4,6) days: p = 0.034). Patients randomised
to ONS showed a trend to shorter time to passage of stool (4 (3,5) vs 5 (4,7) days:
p = 0.076) but there was no evidence of interaction between laxation and
ONS [Chapter 8]. The present study was only designed to assess the individual effect
ofmagnesium hydroxide to promote an earlier return of bowel function as marked by
earlier passage of stool following surgery, therefore the number of patients in the
individual subgroups was relatively small [control 19, laxation 19, supplements 15,
combination of laxation and supplements 15]. However, with current data a larger
study could be planned to evaluate the interaction of oral supplements and
postoperative laxation with magnesium hydroxide. In the study presented here
patients randomised to receive routine ONS in the early postoperative period did not
intake any more calories than those who were not, in contrast with previous published
studies (Stewart et al, 1998). This may account for the fact that ONS did not shorten
time to recovery of gastrointestinal function and suggests that in the early
postoperative phase routine ONS suppresses normal food intake to the extent that
there may be no overall net benefit.
These findings are in keeping with recent trials examining the role of postoperative
laxation, which highlight a hastened recovery of colonic function (first passage of
stool) but no difference in tolerance of oral diet or time to hospital discharge (Hansen
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et al, 2007;Zingg et al, 2008). As postoperative gastrointestinal dysfunction is one of
the key causes of delayed recovery, future success of ERAS is likely to be achieved
through further optimisation of early postoperative gastrointestinal function. Currently
the ERAS care package (epidural, reduction in systemic opioids, restrictive IV fluid
and sodium, early oral in take and mobilisation) has been shown to minimise
postoperative gut dysfunction. Within traditional postoperative care no single
pharmacological agents is available that has been demonstrated to further reduce
postoperative gastrointestinal dysfunction. Cisparide is the only agent to have been
shown to reduce postoperative ileus, however, due to cardiac side effects it is no
longer available (Brown et al, 1999). Despite expectations of metoclopramide and
erythromycin neither have been shown to be clinically effective (Holte et al, 2000). It
is most likely that further improvement in early postoperative gastrointestinal function
will rely on a combination of elements. This may consist of a prokinetic agent, such
as metoclopramide to stimulate the upper GI tract and a laxative (magnesium
hydroxide) to promote early colonic function. The interaction with ONS also needs
further study as mentioned above.
Within the present thesis the role of postoperative magnesium hydroxide was
examined within an ERAS package of care, which included epidural analgesia and
avoidance of systemic opiates. Epidural analgesia may not be appropriate or desirable
in all patients and systemic opiates may be required (Levy et al, 2011). In such a
group of patients the potential benefit of routine laxation may be more significant.
The study design in Chapter 8 specifically chose a model without colorectal
anastomosis, however, there is no evidence that postoperative laxatives increase the
risk of postoperative anastomotic leak (Basse et al, 2000;Zingg et al, 2008).
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Systemic opiate dose has been shown to correlate with recovery of bowel
function (Cali et al, 2000) and as such within ERAS protocols an opiate-sparing
regimen is employed. Selective peripherally acting p-receptor antagonists and K-
receptor agonists have been shown to reduce this opiate induced postoperative
ileus (Riviere et al, 1993). Currently these agents are expensive and their use limited
in the postoperative period. One commercially available preparation Targinact®
combines an oral opioid (oxycodone) with naloxone (p-receptor antagonists).
Naloxone has been show to reverse the negative gastrointestinal effect of opioids,
however, as it crosses the blood brain barrier and therefore can also reverse the
analgesic effect of opioids. As an oral preparation first pass metabolism is estimated
at 97% therefore restricting its action to the bowel itself. This may be suited to
patients requiring systemic opioids specifically those not suitable for epidural
analgesia. Alvimopan, (another p-receptor antagonists) does not cross the blood-brain
barrier and has been shown to reduce time to gastrointestinal recovery after open
colorectal resection (Ludwig et al, 2008). Further combination with laxatives may be
interesting. Combining this agent or other K-receptor agonists such as Asimadoline or
Fedotozine with the ERAS package of care may reduce postoperative gastrointestinal
dysfunction (specifically opiate related ileus). As part of such a package the addition
of a laxative may again be more significant, specifically with respect to improved
outcomes such as increased calorie intake or earlier functional recovery.
The overall outcomes documented in Chapter 8 of the present thesis further
demonstrate the benefit of an ERAS package of care for patients undergoing liver
resection. Patients recommenced oral fluid intake on the day of surgery, started eating
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the day after surgery and were mobile by the third postoperative day. Functional
recovery was achieved a median of four days following surgery and overall median
hospital stay was six days, which is shorter than the 8-14 days reported in other
centres following a traditional care (Jarnagin et al, 2002;Dimick et al, 2004;Capussotti
et al, 2006;Petrowsky et al, 2006). Morbidity rates were lower and mortality rates in
keeping with those published from other countries following traditional care
pathways (38 - 45 % and 2.7 - 3.1 % respectively) (Jarnagin et al, 2002;Petrowsky et
al, 2006;Nikfarjam et al, 2009).
Compliance with postoperative elements of the protocol remains an area of difficulty,
specifically mobilisation in the early postoperative period. In the study presented in
Chapter 8 only 28 % of patients mobilised on the day of surgery. The delay in
mobilisation was often attributed to a delayed return from theatre recovery, lack of
ward staff or epidural-related hypotension. It is desirable that patients following an
ERAS protocol are placed first on an operating. There are, however, competing
interests for this position and undergoing surgery later in the day should not preclude
participation in an ERAS programme. Mobilisation could begin in theatre recovery if
a protracted stay is expected. Increase familiarity with ambulatory epidurals and
availability of medical staff with an expertise in managing epidural analgesia is likely
to be the most effective method of maintaining effective analgesia and minimising
side effects such as postural hypotension. Within the study presented in Chapter 8 oral
ephedrine was employed prior to mobilisation but careful monitoring of fluid balance
is also required. The availability of a dedicated ERAS nurse may provide the extra
support and manpower required to encourage mobilisation for the first time after
surgery. It is still viewed as a labour intensive action and if the high dependency ward
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is busy it is likely that encouraging and assisting ERAS patients to mobilise may be
neglected. A staff member dedicated to implementing the ERAS protocol may
provide the relevant manpower to ensure postoperative elements such as early
mobilisation are not neglected.
Previous ERAS studies have highlighted a delay in hospital discharge beyond
functional recovery (Maessen et al, 2008). This is again apparent in chapter 8 where
hospital stay was a median of 2 days beyond achievement of functional recovery.
Removing this delay would allow a significant reduction in length of hospital stay.
There will continue to be social issues associated with certain groups of patients,
which can often frustrate hospital discharge. To overcome this forward discharge
planning should take place. Patients likely to require additional help at home should
be highlighted and suitable support organised before functional recovery is complete.
This has already been highlighted as an area of significance, independently of the
ERAS programme and has been shown to reduce patients stay and with improved
patients satisfaction though mainly in medical patients (Shepperd et al, 2004).
Within Chapter 8 the main reasons for this delay beyond achieving discharge criteria
were that the patient did not feel ready or that medical staff had concerns related to
earlier complications. Continued education of both patients and medical staff may
provide the key to reduce this delay. The ERAS protocol is likely to be the first
occasion in which a written discharge criteria is presented to doctors, nurses and
patients. Outwith this protocol, readiness for discharge is subjective. Continued
education will serve to change expectations of required length of hospital stay and
improved familiarity with the protocol and audit of patient outcomes will serve to
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reassure medical staff of the safety of discharging patients 'as per protocol' as soon as
functional recovery is achieved. The overall success of the ERAS protocol will be
improved by the effective dissemination ofERAS protocol. Hospital staff and patients
must feel that they have an ownership both of the protocol and the results
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9.7 Summary of conclusions
The present thesis adds to the growing evidence supporting Enhanced Recovery After
Surgery protocols and their application to all patients undergoing major abdominal
surgery. It highlights the benefits for high-risk surgical patients (undernourished and
elderly) undergoing colorectal resection and the improved outcomes for patients
undergoing hepatic surgery within such a protocol. The ability of the ERAS protocol
to adapt to variations in practice is also highlighted through the feasibility of
carbohydrate / fluid loading in spite of preoperative mechanical bowel preparation.
The main study presented in the present thesis [Chapter 8] demonstrates that within an
ERAS protocol of care routine laxation with magnesium hydroxide results in an
earlier recovery of colonic function (passage of stool). Although this study did not
demonstrate any further improvement in functional recovery (earlier achievement of
meeting discharge criteria or discharge form hospital) previous studies have
highlighted a link between both time to passage of stool / tolerance of oral diet and
length of hospital stay (Delaney et al, 2006). Therefore, return of colonic function
may represent half of the equation to achieve earlier functional recovery and future
studies should aim to combine the success of this study with protocol elements that
target improved calorie intake in the early postoperative period.
The randomised trial in this thesis also presents a model, which can be utilised to
assess the individual contribution of protocol elements towards the overall benefits
achieved with ERAS. The feasibility of new, objective outcome measures (gastric
emptying and postoperative activity level) have been demonstrated and appear to
show correlation with other traditional markers of recovery. These show promise as
objective markers of recovery for future studies.
The ERAS package of care provides support to the surgical patient through every
aspect of their journey from hospital entrance to hospital exit and importantly returns
ownership of recovery back to the patient on departure from the operating room.
Overall it has been shown to be robust and applicable to different domains of major
abdominal surgery. Its benefits are applicable to all patients including those
traditionally considered high-risk. It is adaptable and evolves to include surgical
advances such as minimal access surgery, where appropriate further benefit is
demonstrated. It must continue to be combined with audit of protocol compliance and
significant objective outcomes notably postoperative morbidity, activity and nutrition.
Where possible more objective markers of physiological and gastrointestinal recovery
should be further refined for this group.
In the surgical department there is a common goal of safely shortening postoperative
recovery time. The ERAS pathway provides a safe method of achieving this and
hastening return to preoperative functional level. These protocols are streamlined and
patient centred and in many centres it represents the most accessible dissemination of
evidence-based practice to medical, nursing and auxiliary staff. Enhanced Recovery
After Surgery provides state of the art perioperative care for patients resulting in a
faster postoperative recovery, reduced length of hospital stay and reduced
consumption of resources. It incorporates the evolving evidence base and rejects
outdated, unfounded surgical doctrine and will therefore continue to improve
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Abstract
Objective Preoperative conditioning with oral fluid and
carbohydrate (CHO) loading allows the patient to
undergo surgery in the fed state and is associated with
reduced postoperative insulin resistance. Further benefit
may accrue from oral nutritional supplements (ONS) to
counteract the fasting associated with mechanical bowel
preparation (MBP). In this study we assess the ability to
prescribe, dispense and have patients comply with a
protocol combining preoperative ONS and CHO/fluid
loading during MBP.
Method One hundred and forty-seven patients under¬
going elective left colonic or rectal resection were
recruited to an Enhanced Recovery after Surgery
(ERAS) programme. All patients were prescribed
MBP (2 sachets Picolax). On the daytime prior to
surgery, eligible patients were prescribed 2 x 200 ml of
ONS (Fortijuice®, Nutricia) and in the evening 800 ml
oral CFIO/fluid loading (Preop®, Nutricia,). Patients
were prescribed a further 400 ml of oral/CHO/fluid
on the morning of surgery 2 h prior to induction of
anaesthesia. Protocol compliance was audited prospec¬
tively.
Results One hundred and forty-seven patients received
MBP. Twenty-three patients were ineligible for oral
CHO/fluid loading [diabetes (n = 22), allergy to lemon
flavoured drinks (n = 1)]. Fourteen patients did not
receive the preoperative CHO drinks due to failure to
prescribe (n = 8) or dispense (n = 6). One hundred and
ten patients were dispensed the combined ONS and
CHO/fluid loading regimen, compliance rates were 83%
with ONS, 80% with CHO/fluid loading and 74% with
both.
Conclusion Approximately 74% of patients undergoing
MBP can comply with preoperative conditioning with
ONS and CHO/fluid loading. Prescription and dispens¬
ing requires close attention to detail.
Keywords Enhanced recovery after surgery, preoperative
conditioning, carbohydrate loading, mechanical bowel
preparation, investigation
Introduction
Preoperative oral carbohydrate (CHO) and fluid loading
is a common component of enhanced recovery after
surgery (ERAS) programmes and is thought to maintain
postoperative nutritional status by reducing postoperative
insulin resistance [1], Preoperative fluid and CHO
loading has been shown to reduce postoperative hyper-
glycaemia and nitrogen loss and to aid postoperative
Correspondence to: Mr Paul O. Hendry, University Department of Surgery,
Clinical and Surgical Sciences (Surgery), Royal Infirmary, 51 Little France,
Crescent, Edinburgh EH 16 4SA, UK.
E-mail: paul.hendry@ed.ac.uk
recovery [2], Within the context of traditional perioper¬
ative care, early postoperative oral or enteral nutritional
support has been shown to reduce both infectious
complications and length of stay [3], Use of preoperative
CHO loading to reduce postoperative insulin resistance
may further optimize the benefits of such early postop¬
erative feeding.
Traditional periods of perioperative fasting beyond
that recommended by National Anaesthesia Societies are
still prevalent [4] and are often prolonged due to
concomitant use of mechanical bowel preparation
(MBP). Prolonged fasting decreases the capacity to cope
with the surgical stress response, increases postoperative
insulin resistance and may affect adversely length of stay
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[5], Such fasting may also compromise further the fluid
and electrolyte balance of patients receiving MBP [6],
The use of MBP in colorectal surgery is common [7].
This is often due to surgical preference [8] despite recent
evidence that questions the benefit of MBP [9]. Whilst
preoperative fasting for 6 h is required for solids, clear
fluids should be encouraged up to 2 h prior to surgery
[10]. Specially designed polymeric CHO beverages can
also be administered up to 2 h prior to surgery as they are
safe and will empty from the stomach within 120 min
[11] and as glucose absorption occurs rapidly in the
upper gastrointestinal tract and is unaffected by admin¬
istered prokinetc agents [12] it is unlikely to be affected
by MBP.
The aim of this study was to demonstrate that patients
can comply with routine preoperative conditioning with
an oral CHO solution in conjunction with MBP prior to
elective left colonic or rectal resection.
Method
This study was conducted in the colorectal unit at the
Western General Hospital in Edinburgh, UK. Ethical
approval was obtained from Lodtian Research Ethics
committee and written consent obtained from each
patient after verbal and written information had been
provided in a clinic visit prior to admission. Patients
undergoing elective left colonic or rectal resection for
benign or malignant disease were recruited and were
prescribed preoperative MBP (2 sachets of Picolax®
(Picolax®, Ferring Pharmaceuticals (UK), Langley,
UK)). Patients followed an ERAS protocol as previously
published [13]. As part of the ERAS protocol the ERAS
research nurse either provided the drinks/instructions at
the preadmission clinic or for in-patients requested the
surgical house officer to prescribe the following regimen
on the patients drug chart: 200 ml of an oral nutritional
supplement (ONS: Fortijuice®, Nutricia Clinical Care,
Trowbridge, UK) prior to the first sachet of bowel
preparation and another 200 ml of ONS prior the
second sachet of bowel preparation. Nondiabetic pa¬
tients were prescribed oral CHO/fluid as 400-800 ml
of a 12.5% clear beverage (Preop®, Nutricia Clinical
Care, Trowbridge, UK) at 8 p.m. the evening before
surgery and a further 400 ml 2-3 h before surgery
(Fig. 1). Compliance with the protocol was audited
prospectively.
Results
One hundred and forty seven patients underwent elective
left colonic (n = 42) or rectal resection (n = 105) and
received MBP. There were 70 males and 77 females.
Mean (SD) age was 64 (14.2). Twenty-two were diabetic
and were not eligible to receive preoperative CHO/fluid
loading. One patient did not receive the CHO loading
due to an allergy to lemon flavoured drinks. There were
124 patients eligible to undertake the protocol. The
protocol failed in 14 patients (eight regimen not
prescribed by the medical staff, six regimen not dispensed
by the nursing staff). Of the patients that were eligible to
undertake the protocol, 99 (80%) completed the pre¬
scribed volume of CHO/fluid loading with no adverse
effects. Eleven patients did not complete the CHO
drinks, seven patients did not tolerate them, two refused
to try them, one patient vomited and in one case the
reason was not recorded. One hundred and three (83%)
completed the full prescribed volume of ONS and 92
patients completed the combined regimen of ONS and
CHO drinks. In summary, 92 (74%) of 124 patients that
were eligible tolerated the drinks and completed the
regimen (Fig. 2).
10 am 2 pm
First Second
sachet of sachet of
MBP(c) MBP(c)
8-10 pm




400 ml of CHO
/fluid (a) "iffi
Figure I Preoperative protocol, (a) CHO/fluid: carbohydrate and fluid loading (Preop®, Nutricia). (b) ONS: oral nutritional
supplement (Fortijuice®, Nutricia). (c) MBP: mechanical bowel preparation (Picolax).
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Figure 2 Consort diagram. CHO/fluid: carbohydrate and fluid
loading (Preop®, Nutricia). ONS: oral nutritional supplement
(Fortisip®, Nutricia).
Discussion
In this study, we have shown that 84% of patients can
tolerate preoperative oral fluid/CHO loading and ONS
in conjunction with MBP prior to elective left colonic or
rectal resection. A previous study by Tjandra and Tagka-
lidis [14] examined oral CHO/electrolyte replacement in
conjunction with MBP prior to colonoscopy and dem¬
onstrated a similar level of tolerance. Taken together,
these findings suggest it is feasible to prescribe simulta¬
neous MBP and CHO/fluid loading and that patients
will comply well with both regimens. Interestingly, a
recent study by Noblett et al. [15] used preoperative
CHO/fluid loading and showed a high level of compli¬
ance and earlier functional recovery following colorectal
surgery but it was not clear whether patients had received
concomitant MBP.
The protocol used in our study was designed to
account for the fact that during MBP patients cannot eat
solid food and require extra oral fluids to counteract
dehydration. Recent evidence from Ljungqvist et al. (the
group that originally demonstrated the benefits of
preoperative oral CHO/fluid loading) has shown that
400 ml oral CHO/fluid loading 2 h prior to induction of
anaesthesia is sufficient to reduce postoperative insulin
resistance if the patients take normal food until 10 p.m.
on the previous day. The 800 ml oral CHO/fluid loading
the evening before surgery does not add to the improved
metabolic status and decreased postoperative insulin
resistance [16], In the light of these recent findings it
might be possible to omit the CHO/fluid loading at 8-
10 pm the night before surgery and replace this with
further ONS and clear fluids.
In the present study approximately 15% of all patients
were 'ineligible' for oral CHO loading due to the
presence of diabetes. Diabetes, is, however, only a relative
contra-indication and CHO loading in diabetic patients is
currently the subject of at least one randomized study
(O. Ljungqvist, Ersta Hospital, Stockholm, Sweden,
personal communication). A second issue raised by the
present study is that of protocol failure. Clearly the
present regimen represents a more complex form of
preoperative preparation than simply starving the patient
for 12 h. Protocol failure (11%) was due either to failure
to prescribe the regimen or failure to dispense the
regimen. This occurred almost exclusively in those
patients who received MBP as inpatients. Clearly similar
issues are more easily avoided in patients prepared at
home and admitted on the same day as surgery.
The haemodynamic and metabolic benefits of preop¬
erative CHO and fluid loading are clear and should not
be denied to patients receiving MBP. From the present
study it is apparent that with a clearly defined protocol
patients undergoing MBP are well able to complete a
regimen of CHO/fluid loading combined with ONS.
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Background: Accelerated recovery from surgery has been achieved when patients are managed within a
multimodal Enhanced Recovery After Surgery (ERAS) protocol. This study evaluated the benefit of an
ERAS programme for patients undergoing liver resection.
Methods: The ERAS protocol of epidural analgesia, early oral intake and early mobilization was studied
prospectively in a consecutive series of61 patients. Outcomes were compared with those in a consecutive
series of 100 patients who underwent liver resection before the start of the study. Endpoints were
postoperative length of hospital stay, postoperative resumption of oral intake, readmissions, morbidity
and mortality.
Results: Fifty-six patients (92 per cent) in the ERAS group tolerated fluids within 4 h of surgery
and a normal diet on day 1 after surgery. Median hospital stay, including readmissions, was 6-0 days
compared with 8-0 days in the control group (P < 0-001). There were no significant differences in rates
of readmission (13 and 10-0 per cent respectively), morbidity (41 and 31-0 per cent) and mortality (0 and
2-0 per cent) between ERAS and control groups.
Conclusion: The ERAS fast-track protocol is safe and effective for patients undergoing liver resection.
It allows early oral intake, promotes faster postoperative recovery and reduces hospital stay.
Preliminary results of this study were presented to the 27 th Congress of the European Society of Clinical Nutrition and
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Introduction
hi the past two decades, the application of multimodal
perioperative care protocols, commonly referred to
as fast-track or enhanced recovery programmes, has
achieved significant improvements in the outcome of a
variety of surgical procedures. By targeting factors that
delay postoperative recovery (pain, gut dysfunction and
immobility), and combining a series of interventions to
The Editors are satisfied that all authors have contributed significantly
to diis publication
reduce perioperative stress and organ dysfunction, such
programmes have been shown to accelerate postoperative
recovery and reduce length of hospital stay. This can
be achieved with an unaltered or even reduced rate
of postoperative complications1. Protocols based on
postoperative pain control through continuous mid-
thoracic epidural anaesthesia, stimulation of gut motility,
early physical reactivation, and limited use of catheters,
tubes and drains have resulted in improved convalescence
for many surgical procedures, including colonic surgery,
open aortic aneurysm repair and oesophageal surgery2-'.
In the past 5 years, the protocol in elective colonic surgery
Copyright © 2008 British Journal of Surgeiy Society Ltd
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established by the Enhanced Recovery After Surgery
(ERAS) Group has led to a reduction in median hospital
stay from 9 to 5 days6.
Within a traditional perioperative care pathway median
hospital stay following liver surgery ranges from 8 to
14 days8"11. Morbidity is reasonably predictable, with
haemorrhagic complications occurring predominantly dur¬
ing surgery or in the early postoperative phase, and biliary
complications, intra-abdominal abscess or liver failure in
the later postoperative phase12'13. It was hypothesized
that application of an enhanced recovery programme for
patients undergoing liver surgery would result in acceler¬
ated recovery and a shorter hospital stay. The main aim
of the present study was to test the feasibility, safety and
effectiveness of an ERAS protocol in patients undergoing
liver surgery in two tertiary referral liver units in Europe.
Methods
The ERAS liver studywas initiated within the collaborative
ERAS Group, and conducted in two units that perform
high-volume liver surgery. The study was a prospective
case series implementation study comparing outcomeswith
those in a historical control group.
The ERAS patient group comprised a consecutive series
of 61 patients admitted to either the liver unit ofMaastricht
University Medical Center, The Netherlands, between 15
February 2005 and 31 August 2006, or the liver unit of the
Royal Infirmary of Edinburgh, UK, where patient recruit¬
ment started on 1 February 2006. The control group
consisted of a consecutive series of 100 patients who had
liver resection in one of the two units between 1 July
2003 and 31 December 2004 (50 consecutive patients from
each unit), when a more traditional care pathway was still
in use. Patient and outcome data were derived from a
prospectively collected database of all liver resections per¬
formed since 1 January 2000 in both units. In both groups,
patients undergoing elective liver resection for primary or
secondary tumours were considered eligible for the study
if they had normal underlying liver function. Patients were
excluded if they required biliary reconstruction or had
emergency surgery.
In both units, the same group of liver surgeons per¬
formed the liver resections in the ERAS group as well as
in the control group. In Maastricht more fellows with hep-
atopancreatobiliary training operated in the ERAS group.
Bilateral subcostal transverse abdominal incisions were
used. The transection plane was determined by intraopera¬
tive ultrasonography. To avoid excessive blood loss central
venous pressure was reduced to below 5 mmHg during
transection using the Cavitron Ultrasonic Surgical Aspi¬
rator (CUSA®; Valleylab, Boulder, Colorado, USA) and
argon beam coagulation. The portal pedicles supplying and
veins draining the sectors to be resected were divided and
ligated with a running polypropylene suture. After removal
of the liver specimen, the raw surface of the liver remnant
was subjected to argon beam coagulation and sealed with
TachoSil® (Nycomed, Zurich, Switzerland). In accordance
with the protocol, no abdominal drains were placed in the
ERAS group and the abdomen was closed with a standard
running suture.
Before the introduction of the ERAS programme neither
of the institutions had a written, agreed perioperative
care pathway. There were no specific measures to
avoid prolonged preoperative and postoperative fasting,
nasogastric decompression, excessive use of intravenous
fluids and systemic opioids, prophylactic abdominal drains
and postoperative immobilization. This conventional
postoperative care programme emphasized prolonged rest
for both the patient and the gastrointestinal tract.
The ERAS multimodal evidence-based recovery pro¬
gramme protocol, which was designed originally for elec¬
tive colonic surgery, was modified to cover all aspects of
elective liver resection2. Details of the ERAS liver protocol
are given in Table 1.
In both groups, data were obtained prospectively
during the hospital stay and for 90 days after surgery.
Data recorded for each patient included morbidity,
defined as complications related to the liver surgery,
mortality, readmissions, postoperative hospital stay, use
of preoperative chemotherapy, duration of surgical
procedure, blood loss, anaesthetic agents used and type
of hepatectomy, defined according to the Brisbane 2000
terminology14. In the ERAS group, data on location of the
epidural catheter, removal of the nasogastric tube if used,
and time to resumption of oral intake and mobilization
were also noted.
The primary endpoint of the study was total length
of hospital stay, defined as the number of nights spent
in hospital, including nights after readmission within
30 days after surgery. To facilitate objective assessment
of clinical outcome and to prevent discharge too soon,
predefined discharge criteria were used in the ERAS group
('Table 2). Patients were informed about the protocol at a
preadmission counselling session, where the importance
of early mobilization and early oral intake were explained.
Patients were discharged only if they met the discharge
criteria and follow-up within 3 days was possible in the
outpatient clinic. Patients were given the mobile telephone
number of the operating consultant surgeon to allow direct
communication and safe deployment of the protocol.
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Table 1 Care plan of patients undergoing liver resection in the
Enhanced Recovery After Surgery programme
Patients in the control group were discharged without
formal discharge criteria.
The following secondary endpoints were evaluated:
resumption of oral intake, defined as oral intake of
Table 2 Discharge criteria in Enhanced Recovery After Surgery
liver protocol
Normal or decreasing serum bilirubin
Good pain control with oral analgesia only
Tolerance of solid food
No intravenous fluids
Mobile independently or at the preoperative level
All of the above and willing to go home
Table 3 Patient demographics
ERAS Control
(n = 61) (n = 100)
Median (range) age (years) 62 (24-82) 60 (20-81)
Sex ratio (M: F) 35:26 51 :49
ASA grade
I 11 (18) 14(14-0)
II 42 (69) 64 (64 0)
III 8(13) 22 (22 0)
Liver pathology
Colorectal metastasis 51 (84) 72 (72 0)
Other metastasis 2(3) 4 (4 0)
Hepatocellular carcinoma or 4(7) 9 (9 0)
cholangiocarcinoma
Benign lesion 4(7) 14(140)
T4 invasive tumours in liver 0(0) 1 (10)
Values in parentheses are percentages unless indicated otherwise. ERAS,
Enhanced Recovery After Surgery; ASA, American Society of
Anesthesiologists.
water or normal food without discontinuation for at
least 24 h, readmissions, total morbidity, death and
length of primary hospital stay, defined as the number
of nights spent in hospital after surgery, excluding
readmissions. Complications were registered during the
primary admission or at subsequent outpatient clinic visits,
after at least 6 and 30 days, using departmental liver registry
databases.
Statistical analysis
Continuous data are expressed as median (range). Hospital
stay, time to resumption of oral intake and postoperative
duration of epidural analgesia were analysed using the
Mann-Whitney U test. Readmission, complication and
mortality rates were analysed using y2 test or Fisher's
exact test. P < 0-050 was considered to be statistically
significant. Data were analysed using SPSS® version 13.0
forWindows® (SPSS, Chicago, Illinois, USA).
Day before surgery
Normal oral nutrition until midnight
No preanaesthetic medication
Day of surgery
Carbohydrate drinks up to 2 h before surgery
Mid-thoracic epidural analgesia (local
anaesthetic + low-dose opioid)
Short-acting i.v. anaesthetic agent
No nasogastric drainage; if used, remove immediately
after surgery
Warm i.v. fluids, and upper and lower body air-warming
device
Avoidance of excessive i.v. fluids (preoperative and
peroperative CVP < 5 mmHg)
No routine drainage of the peritoneal cavity
Patient sent to recovery ward
Restart oral intake of water/nutrition ad libitum
Postoperative day 1
Patient sent to surgical ward
Patient mobilizes a minimum of four times a day
Discontinuation of intravenous fluids
Patient drinks at least 1 -5 litres
Normal diet
Continue portable epidural analgesia (local
anaesthetic + low-dose opioid)
1000 mg paracetamol every 6 h
1000 mg magnesium oxide twice daily
Laboratory tests
Postoperative day 2
Continue portable epidural analgesia with local
anaesthetic
Stop low-dose opioids
Continue mobilization a minimum of four times per day










Outpatient appointment made on postoperative day
10, 11 or 12
Postoperative day 4
Check discharge criteria (Table 2)
Patient receives mobile telephone number of operating
hepatopancreatobiliary surgeon
Discharge
i.v., intravenous; CVP, central venous pressure; NSAID, non-steroidal
anti-inflammatory drug.
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Table 5 Outcome data
ERAS Control
(n = 61) (o = 100)
Hemihepatectomy 20 (33) 38 (38-0)
Hemihepatectomy + > 1 metastasectomies 6(10) 16(16-0)
Extended hemihepatectomy 7(11) 3 (3 0)
Multiple segmentectomy (> 2 segments) 17(28) 18(180)
Central resection/trisegmentectomy 1(2) 4 (4 0)
Metastasectomy or monosegmentectomy 10(16) 21 (21 -0)
Repeat hepatectomy 7(11) 5 (5-0)
ERAS Control P
Maastricht onlyt (o = 47) (o = 50)
NGT 37 (79) 48 (96) 0-013$
Removal of NGT on day of 34 of 37 (92) 0(0) <0-001
surgery
Maastricht and Edinburgh (0 = 61) (o = 100)
Epidural analgesia 58 (95) 89 (89 0) 0-184$
Abdominal drain 1 (2) 66 (66 0) <0-001$
Complications 25 (41) 31 (31 -0) 0-197$
Death 0(0) 2 (2 0) 0526
Readmission 8(13) 10(100) 0-543$
Total hospital stay, including 6 (3-82) 8 (4-68) <0 001
readmissions (days)*
Primary hospital stay (days)* 6 (3-82) 8 (4-55) < 0 001
Values in parentheses are percentages. ERAS, Enhanced Recovery After
Surgery.
Results
Patient characteristics were similar in the ERAS and
control groups (Table 3). Types of liver resection are
shown in Table 4. A higher proportion of patients in the
ERAS group had repeat liver resections (11 per cent verms
5 0 per cent in control group; P = 0-214) and resections
after intensive chemotherapy (62 versus 33-0 per cent;
P < 0 001).
The median (range) duration of surgery was 220
(60-420) min in the ERAS group and 270 (106-510) min
in the control group (P < 0-001), and blood loss during
surgery was 750 (0-5000) and 800 (0-6000) ml respectively
(P = 0-758). Abdominal drains were used significantly
less often in the ERAS group (2 versus 66-0 per cent;
P < 0-001).
In Edinburgh, the use of a nasogastric decompression
tube in patients having partial liver resection had already
been discontinued before 1 July 2003. In Maastricht,
nasogastric decompression tubes were still used in most
control patients. A nasogastric tube was inserted at
induction in 37 of 47 patients in the ERAS group,
significantly less frequently than in the control group
(96 per cent) (P = 0-013). In the ERAS group, the
nasogastric tube was removed at the end of surgery or
in the recovery ward within 4 h of surgery.
Oral intake was resumed within 4 h after surgery in 56
patients (92 per cent) in the ERAS group. Two patients
required reinsertion of a nasogastric tube. The median
(range) time to successful resumption of normal diet was
1 (0-3) day in the ERAS group, compared with 3 (0-14)
days in controls (P < 0-001). Three patients in the ERAS
group (5 per cent) became constipated after postoperative
day 3, despite initial tolerance of normal food, but this
resolved within 5 days by restricting intake.
In the ERAS group, 58 patients (95 per cent) fol¬
lowed the anaesthetic protocol of mid-thoracic epidu¬
ral analgesia commencing before surgery (0-1 per cent
Values in parentheses are percentages unless indicated otherwise; *values
are median (range). fNasogastric tubes (NGTs) were used in Maastricht
only; they were used in neither group in Edinburgh. ERAS, Enhanced
Recovery After Surgeiy. P values by Fisher's exact test, except ix2 test.
bupivacaine 4- 2 pg/ml fentanyl) with maintenance isoflu-
rane or sevoflurane inhalation anaesthesia, or intravenous
propofol, as described previously1'. After operation epidu¬
ral analgesia comprising 0-1 per cent bupivacaine and
2 gg/ml fentanyl was administered for at least 3 days via
a portable patient-controlled device (GemStar®1 Infusion
Systems; Hospira, Lake Forest, Illinois, UK) at a rate
of 4-10 ml/h, combined with oral non-opioid analgesics.
This differed from anaesthesiological management in the
control group, where 89 patients (89-0 per cent) received
epidural analgesia combined with isoflurane or sevoflurane
inhalation anaesthesia. In the postoperative period epidu¬
ral analgesia consisting of 0-1 per cent bupivacaine and
2 pg/ml fentanyl was administered without a specific time
schedule at a daily fixed dose of4-10 ml/h, combined with
intramuscular opioids (mainly piritramide) and oral anal¬
gesics. Postoperative epidural analgesia was continued for
a median (range) of 3 (1-5) days in the ERAS group and 2
(0-6) days in the control group (P < 0-001). Epidural anal¬
gesia was discontinued earlier in the control group, and
intramuscular or intravenous opioids (piritramide) were
used more widely.
Outcome data are summarized in Table 5. There were
no deaths in the ERAS group and one patient died within
30 days in the control group. A further control patient
died after 62 days. Overall morbidity rates (percentage
of patients with at least one complication) were 41 and
31 -0 per cent in the ERAS and control groups respectively
(P = 0-197) {Table 6). All complications in the ERAS group
were managed by non-surgical means. Readmission rates
in ERAS and control groups were similar (13 versus
10-0 per cent respectively; P = 0-610).
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(n = 100) P*
No. with complications 25 (41) 31 (31 0) 0.197t
Bile leak 4(7) 4 (4 0) 0.479
Liver failure 3(5) 1 (1-0) 0.153
Sepsis 0(0) 1(1-0) 1.00
Abdominal abscess 5(8) 7(7-0) 0.779t
Delayed GI function (< 7 days) 3(5) 1 (10) 0.153
Pneumonia 3(5) 2 (2-0) 0.368
Pleural effusion 2(3) 2 (2 0) 0.634
Pulmonary embolism 0(0) 1 (10) 0.433
Myocardial infarction 2(3) 3 (3-0) 0.921
Wound infection 9(15) 5 (5 0) 0.033t
Other minor 3(5) 16(16-0) 0.018t
Values in parentheses are percentages. ERAS, Enhanced Recovery After



















Fig. 1 Total length of hospital stay, including readmissions, in
Enhanced Recover)' After Surgery (ERAS) and control groups.
Horizontal lines within boxes, boxes and error bars represent
median, interquartile range and total range respectively.
P < 0-001 (Mann-Whitney U test)
Fifty-two (85 per cent) of 61 patients in the ERAS group
were completely mobile on the third day after operation
and 29 (48 per cent) were discharged from hospital within
5 days. Median (range) total postoperative hospital stay,
including readmissions, was 6 0 (3-82) days in the ERAS
group and 8-0 (4-68) days in the control group (P < 0-001)
(Fig. /)-
Discussion
The present study showed that use of an evidence-
based multimodal enhanced recovery programme after
liver resection accelerated postoperative recovery and led
to a significantly shorter hospital stay. Patients managed
according to the ERAS protocol were able to drink fluids
within 4 h of liver resection and eat normal food on the day
after surgery. Most patients were completely mobile after
3 days and, as a consequence, almost half of the patients
were discharged from hospital within 5 days. Median total
hospital stay (including readmissions) was reduced from 8
to 6 days, which is considerably shorter than the 8-14 days
reported by other European centres8-10. Application of
the ERAS protocol did not have any detrimental effect on
safety in liver resection.
Based on previous experience of enhanced recovery
implementation studies within these units, and attempts
to randomize between fast-track and traditional care in
a multicentre abdominal surgery trial616, a randomized
clinical trial comparing fast-track and traditional care was
considered impractical. Both units had implemented ERAS
protocols over the previous few years and, in view of the
growing evidence base for such programmes, a traditional
perioperative protocol was felt to represent suboptimal
care. More importantly, it would have been necessary
for nursing and surgical staff to return to traditional
perioperative care pathways. Therefore, this feasibility
study was designed as a prospective case series with a
historical control group.
Several important issues have become apparent from this
study. Importantly, adverse outcomes, assessed in terms of
readmissions, complications and deaths, were similar in
the ERAS and control groups. The complication rate in
the ERAS group is in keeping with recently published
rates of 23-52 percent10'17-20. Although the morbidity
rate appeared to be higher in the ERAS group, the
study was not sufficiently powered to determine statistical
differences in the incidence of complications. Moreover,
complications directly related to liver surgery, such as
bleeding, bile leakage or temporary liver failure, are
unlikely to be influenced by postoperative care. Avoidance
of abdominal drains in this study might arguably have
influenced the complication rate, but the authors consider
this unlikely because the incidence of bile leak and
intra-abdominal abscess was similar in the two groups.
Prophylactic drains are employed in many centres to detect
early complications such as postoperative haemorrhage
or bile leakage, to remove intraperitoneal fluids and to
prevent abscess formation. However, there is evidence that
abdominal drainage after liver resection does not reduce the
incidence of reinterventions for these complications21-23.
Some studies have even noted higher rates of infected
collections when drainage was used13-21'24. This suggests
that drains might be detrimental to clinical outcome
by providing a route for ascending infections. Another
disadvantage of drains within an enhanced recovery setting
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is that they represent a significant impediment to achieving
early mobilization.
A few elements have proven difficult to implement
universally. The use of carbohydrate drinks before surgery
reduces thirst, hunger and anxiety, and is safe up to
2 h before abdominal surgery25. However, a preoperative
fasting policy of 'nil by mouth from midnight' is still
common. Owing to tradition in the anaesthesia department
nasogastric decompression tubes were still used extensively
during surgery in both groups in Maastricht, but were
removed immediately after surgery in the ERAS group.
This practicemeant a major change in clinical routines, and
did not appear to result in more pulmonary complications
in the present study. In general, nasogastric decompression
is still used widely following abdominal surgery26, despite
evidence that it is unnecessary and can result in more
pulmonary complications. Further support for avoidance
of nasogastric tubes specifically in liver surgery has been
published recently11.
Early postoperative enteral nutrition compared with 'nil
by mouth' improves clinical outcome27. In the present
study, oral intake of water within 4 h after surgery and
institution of normal nutrition on the day after operation
were well tolerated in the ERAS group. Early resumption
of normal diet in combination with other elements of
the enhanced recovery programme is designed to reduce
the occurrence of delayed gastrointestinal function after
surgery and even promote appetite. Therefore, the ability
of the patient to tolerate normal food is an outcome
in itself. A period of delayed gastrointestinal functioning
after operation, observed in a few patients, was registered
as a complication. It might also be argued that a delay in
gastrointestinal functioning is a physiological phenomenon
that occurs after abdominal surgery in many patients. A
restrictive perioperative intravenous fluid regimen may
help to reduce the occurrence of delayed gastrointestinal
functioning28. Fluid restriction may well be an important
issue in hepatic surgery and is the subject of ongoing
research in the authors' units.
It is important that surgical patients are treated in
an environment that encourages early mobilization4.
Mobilization on the day of surgery was possible in
Edinburgh, but was not achieved in Maastricht because
the recovery unit did not contain the appropriate facilities.
Adequate pain control and a substantial effort by nursing
staff are required to achieve early mobilization.
In conclusion, a multimodal enhanced recovery pro¬
gramme for patients undergoing liver resection for primary
and secondary tumours, but with otherwise normal hep¬
atic function, is feasible and effective. Patients were able
to drink within 4 h of surgery, eat on the following day
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and were usually mobile by the third day after operation.
This is indicative of earlier recovery and was accompa¬
nied by a 2 5 per cent reduction in postoperative hospital
stay. The fact that only half of the patients were dis¬
charged within 5 days indicates that there is further room
for improvement.
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Determinants of outcome after colorectal resection within an
enhanced recovery programme
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Background: Postoperative outcomes were studied in relation to adverse nutritional risk (body mass
index (BMI) below 20 kg/rn2), advanced age (80 years or more) and co-morbidity (American Society of
Anesthesiologists (ASA) grade III-IV) in patients undergoing colorectal resection within an enhanced
recovery after surgery programme.
Methods: Outcomes were audited prospectively in 1035 patients. Morbidity and mortality were
compared with those predicted using the Portsmouth Physiological and Operative Severity Score
for the enumeration of Mortality and morbidity, and a multivariable model was used to determine
independent predictors of outcome.
Results: Postoperative morbidity was lower than predicted (observed to expected 0-68; P < 0-001).
Independent predictors of delayed mobilization were ASA IH-IV (P < 0-001) and advanced age
(P = 0-025). Prolonged hospital stay was related to advanced age (P = 0-002), ASA III-IV (P < 0-001),
male sex (P = 0-037) and rectal surgery (P < 0-001). Morbidity was related to ASA III-IV (P = 0-004),
male sex (P = 0-023) and rectal surgery (P = 0-002). None of the factors predicted 30-day mortality.
Conclusion: Age and nutritional status were not independent determinants of morbidity or mortality.
Pre-existing co-morbidity was an independent predictor of several outcomes.
Presented in part to a conference of the European Society for Clinical Nutrition and Metabolism in Prague, Czech
Republic, September 2007
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Introduction
Patients undergoing major abdominal surgery are thought
to be at increased risk of delayed recovery, morbidity
and death owing to factors such as age, undernutrition
and co-morbidity. This increased risk may be due to
the combined effects of tissue wasting, impaired immune
function, impaired healing and organ dysfunction1,2. The
links between advanced age or poor nutritional status and
adverse surgical outcome have long been recognized1 ~5.
Although it may be argued that modern surgery with
prophylactic antibiotics, better analgesia, improved suture
materials and high-dependency postoperative care might
The Editors are satisfied that all authors have contributed significantly
to this publication
avoid such adverse outcomes, recent studies involving
traditional perioperative care show a similar relationship6,'.
Indeed, a recent study showed that in-hospital mortality for
patients aged over 85 years undergoing colorectal surgery
was nine times higher than that for those aged 65 years or
less8.
Although recent epidemiological evidence suggests that
there is an epidemic of obesity9, a significant proportion
of the surgical population remain undernourished and
potentially at increased risk10. Likewise, it is evident that
the general population is getting older. In the USA life
expectancy is 7 years for the average 80-year-old man
and nine years for the average 80-year-old woman11. In
such elderly patients, increased morbidity and mortality
after surgery is thought to result from a lack of organ
function and/or reserve to sustain the patient in the
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event of complications4. However, it is often difficult to
discriminate between the risks attributable primarily to a
single factor (for example age) and the compounding effects
of other co-variables (such as increased co-morbidity with
old age).
Enhanced recovery after surgery (ERAS) protocols are
designed to reduce the surgical stress response and support
basic body functions by the use ofoptimized analgesia, early
mobilization and early return to normal diet12,13. These
interventions have been shown to improve postoperative
outcomes14'15. The elderly appear to be at particular risk of
death once a postoperative complication has developed7. It
is therefore of interest that a recent systematic analysis of
enhanced recovery has suggested that an ERAS programme
may favourably influence postoperative morbidity15 and so
might be a particularly useful prophylactic measure for
elderly patients.
As part of a study examining the feasibility, efficacy
and safety of an ERAS protocol for elective open
colorectal surgery, observed morbidity and mortality rates
were compared with rates predicted by the Portsmouth
Physiological and Operative Severity Score for the
enumeration ofMortality and morbidity (P-POSSUM)16.
In addition, the prognostic value of bodymass index (BMI),
age, American Society of Anesthesiologists (ASA) grade,
malignancy status, sex and operation type was investigated.
Methods
Between March 2002 and December 2005 patients aged
18-94 years undergoing elective open colorectal surgery
with formation ofan anastomosis (at or above the peritoneal
reflection) were included. The upper limit of the rectum
was considered to be level with the sacral promontory.
Patients with rectal cancer were included if the tumour was
in the upper third of the rectum and allowed anastomosis in
the middle third of the rectum (at or about the level of the
peritoneal reflection). Patients requiring total mesorectal
excision were excluded. Most sigmoid and all rectosig¬
moid and upper rectal tumours underwent formal anterior
resection with high ligation of the vessels and take-down
of the splenic flexure. Patients with benign or malignant
pathology and with an ASA grade of I-IV were included
in the study. Four departments of surgery in Northern
Europe (University Hospital, Maastricht, The Nether¬
lands; University Hospital Northern Norway, Tromso,
Norway; Karolinska Institute at Ersta Hospital, Stock¬
holm, Sweden; Western General Hospital, Edinburgh,
UK) participated for a minimum of 12 months. Ethical
approval and informed written consent was obtained from
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all patients in centres where de-identification of data did
not provide dispensation of this obligation.
All patients followed an ERAS protocol based on
continuous thoracic epidural anaesthesia/analgesia, early
mobilization and resumption of diet, and nutritional
supplements as described previously1- (Fig. 1). Mechanical
bowel preparation was not used routinely, but was applied
mainly before left-sided or anterior resections. Compliance
was audited prospectively.
Measurements
In all centres data were collected prospectively on a
computerized database as described previously17. Data
included patient demographics (including preoperative
BMI), surgical procedures and postoperative outcomes
(including time to achieve targetedmobility, total length of
hospital stay, complications and 30-day mortality). Follow-
up for morbidity and mortality was verified either during
the primary admission, by telephone contact at 30 days or
at subsequent outpatient clinic visits.
Time to achieve targeted mobilization was defined
as the number of days after surgery until the patient
was out of bed for more than 6 h per day and at the
same level of independence with respect to daily living
as before surgery. Total hospital stay was defined as
the number of nights spent in hospital after surgery,
including nights after readmission within 30 days after
surgery. To determine the influence of complications on
postoperative recovery and hospital stay, all adverse events
in the postoperative period were recorded prospectively
as described previously18. The postoperative course was
considered complicated if any complication by accepted
standard definitions occurred19'20.
Patients were grouped according to preoperative BMI
(World Health Organization categories9) as an indicator
of preoperative nutritional status. Given the elderly nature
of the overall population a BMI below 20 kg/m2 was
considered to indicate a risk of undernutrition. Patients
were also grouped according to age (less than 80 years, 80
or more years) and ASA grade (low, I—II; high, III-IV).
Morbidity and mortality analysis
Predicted (expected, E)morbidity and mortalitywere based
on P-POSSUM scoring16 and compared with observed
(O) morbidity and mortality recorded up to 30 days after
surgery. Results were expressed as O: E ratios. Missing
values (less than 5 per cent of all variables) for P-POSSUM
were assumed to be normal.
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Fig. 1 Summary of enhanced recovery after surgery (ERAS) protocol elements. Bair Hugger®, Arizant, Wakefield, UK. NSAID,
non-steroidal anti-inflammatory drug
Statistical analysis
Spss® version 16 for Mac (SPSS, Chicago, Illinois,
USA) was used for data analysis. Data were collected
prospectively to assess the efficacy of the ERAS pro¬
gramme and included all patients undergoing elective
colorectal resection with an ASA grade I-IV. Before
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introduction of this ERAS programme there were few
morbidity and mortality data on which to base a sam¬
ple size calculation, and no such calculation was under¬
taken.
The data set was analysed using time to achieve
mobilization, total hospital stay, complication rates and
30-day mortality as the main outcome variables. Factors
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possibly influencing these variables included: sex, age
(less than 80 years, 80 or more years), type of surgery
(colonic, rectal), presence of malignancy, BMI (less than
20 kg/m2, at least 20 kg/m2) and co-morbidity (ASA I—II,
III-IV). Univariable analysis was initially undertaken
to assess the relationship between each factor and the
outcome variables. Comparisons were made using the
X2 test or Fisher's exact test, as appropriate, for all
categorical variables and the Mann-Whitney U test for
continuous variables. Multivariable analysis, using binary
logistic regression for categorical variables and linear
regression of log transformed continuous variables, was
then performed for all variables with a significant or near-
significant difference (P < 0-150) in univariable analysis.
In multivariable analysis non-significant factors were
excluded sequentially and the model re-run. P < 0-050
was considered statistically significant.
Results
A total of 1035 patients followed the ERAS protocol.
Compliance with preoperative and intraoperative elements
of the protocol was high; 87-5 per cent of patients received
preoperative counselling and instruction, 63-4 per cent
completed carbohydrate loading and 87-6 per cent received
epidural analgesia/anaesthesia. Protocol compliance in the
postoperative phase was lower; intravenous fluids were
discontinued on the day after surgery in 44-3 percent,
39-2 per cent were out of bed on the day of surgery, and
61-4 per cent resumed a full diet on the day after surgery.
Overall demographics and outcomes are shown in Table 7.
The male to female ratio was 498:537 and 68-6 per cent
were treated for malignant disease. There were 724 colonic
and 311 rectal resections. Some 7-9 per cent of patients
had a BMI below 20 kg/m", 18-7 per cent were aged
80 years or more, and 20-6 per cent had an ASA grade
of III-IV.
The overall median time to achieve targeted mobiliza¬
tion was 3 days and total hospital stay was 6 days. The
overall readmission rate was 8-6 per cent, the reoperation
rate was 7-4 per cent and the anastomotic leak rate was
5 • 1 per cent. The morbidity rate for the whole group was
significantly lower than that predicted by P-POSSUM
(O : E 0-68; P < 0-001), whereas 30-day mortality was not
significantly different from the predicted value (O : E 0-68;
P= 0-212). Patients undergoing rectal resection had a
longer hospital stay and a higher overall complication rate
than those having colonic surgery. In contrast, O : E mor¬
bidity and mortality tended to be higher in the colonic
group.
Complications are summarized in Table 2. The
most frequent complications were infective, includ¬
ing wound and urinary tract infections. Patients
most commonly developed only a single complica¬
tion. A higher proportion of patients developed one
or more complications after receiving mechanical bowel
Table 1 Patient demographics and outcomes
All patients (n = 1035)
Sex ratio (M: F) 498:537
Age (years)* 59 (69-78)
ASA grade
I 177 (17-1)
II 645 (62 3)
III 203(19-6)
IV 10(1-0)
Malignant disease 710(68 6)
Neoadjuvant therapy 15(1-4)
Time to mobilization (days)* 3 (2-5)
Total hospital stay (days)* 6 (4-8)
Readmission 86 (8 6)
Anastomotic leak 53(5-1)
Reoperation 77 (7 4)
30-day morbidity 294 (28 4)
30-day mortality 17(1-6)
Expected morbidity 430 (41 -5)
Expected mortality 25 (2 4)
O: E morbidity 068
O: E mortality 0 68
Colonic (n = 724) Rectal (n = 311) Pt
340:384 158:153 0-257*
71 (59-79) 65 (57-75) <0-0011)
107 (14 8) 70 (22 5)
464 (64 1) 181 (58 2)
144(19-9) 59 (19 0)
9(1-2) 1 (0 3) < 0 0011
501 (69 2) 209 (67-2) 0-4811
5 (0 7) 10(3-2) 0-004*
3 (2-5) 3 (2-5) 0-191§
6 (4-8) 7 (5-10) < 0-001 s
57 (7 9) 29 (9-3) 0-4444
37 (5 1) 16(5-1) 0-9824
56 (7 7) 21 (6 7) 0-5634
185(25-6) 109(35 0) <0-001 +
14(1-9) 3(1-0) 0-423+
259 (35-8) 171 (55-0) <0-001*
14(1-9) 11 (3 5) 0-156*
0-71 0-64
1 00 0-27
Values in parentheses are percentages unless indicated otherwise; 'values are median (interquartile range). ASA, American society of Anesthesiologists;
O: E, observed to expected. tColonic versus rectal; ip test; §Mann-Whitney U test; Jfisher's exact test.
Copyright © 2009 British Journal of Surgery Society Ltd
Published by John Wiley & Sons Ltd
wwxv.bjs.co.uk British Journal ofSurgery 2009; 96: 197-205
Colorectal resection within an enhanced recovery programme 201
Table 2 Complications in 1035 patients
No. of
patients
Respiratory failure 23 (2 2)
Pulmonary oedema 4 (0 4)
Pulmonary embolism 6 (0 6)
Cardiac failure 22 (21)
Acute myocardial infarction 3 (0 3)
Stroke 2 (0-2)
Deep vein thrombosis 1 (01)
Acute renal failure 6 (0-6)
Wound dehiscence 28 (2-7)
Postoperative bleeding 29 (2-8)
Anastomotic leak 53 (51)
Wound infection 128(12-4)
Pneumonia 24 (2 3)
Chest infection 15(1-4)
Sepsis 18(1-7)
Urinary tract infection 67 (6-5)
Values in parentheses are percentages. A total of 741 patients had no
complication; 213, 45, 23, eight and five patients had one, two, three, four
and five complications respectively.
preparation (184 (30-9 per cent) of 596 versus 106
(24-9 per cent) of 42 5 patients having no mechanical bowel
preparation; P = 0-041). There were no differences in
anastomotic leak rates or 30-day mortality between those
who did or did not receive mechanical bowel preparation.
The results of univariable analysis of the relationship
between outcomes and potential outcome predictors are
shown in Table 3. BMI category was not related to any
of the outcome variables. Age had an influence on time
to achieve mobilization (P < 0-001) and total hospital stay
(P < 0-001). There was a significant relationship between
ASA grade and mobilization (P < 0-001), total hospital stay
(P < 0-001) and postoperative morbidity rate (P = 0-003).
Sex influenced postoperative morbidity rate (P = 0-011).
Operation type affected total hospital stay (P < 0-001) and
postoperative morbidity rate (P = 0-002). The presence of
malignancy did not relate to any of the outcomes.
In multivariable analysis independent predictors of
prolonged mobilization were age 80 years or more (P =
0-025) and ASA grade III—IV (P < 0-001). Prolonged total
length of hospital stay was predicted by age 80 years or
more (P = 0-002), ASA grade III-IV (P < 0-001), male sex
(P = 0-037) and rectal surgery (P < 0-001). Postoperative
morbidity was predicted by ASA grade III-TV (P = 0-004),
male sex (P = 0-023) and rectal surgery (P = 0-002).
Mortality was not related to any of the factors.
Table 3 Univariable analysis of postoperative outcomes
No. of patients Time to mobilization (days)* Total hospital stay (days)* 30-day morbidity* 30-day mortality!
Body mass index (kg/m2)
<20 82 3 (2-4) 6 (4-8) 27 (33) 1(1)
>20 953 3 (2-5) 6 (4-8) 267 (28 0) 16(1-7)
P 0-791 4 0-8204 0-344$ 10001
Age (years)
oCOV 839 3 (2-5) 6 (4-8) 229 (27-3) 11 (13)
>80 194 4 (2-6) 7(5-11) 64 (33-0) 6 (3 -1)
P <0-0014 <0-0014 0-113$ 0-1091
ASA grade
l-ll 822 3(2-5) 6 (4-8) 216(26-3) 11 (1-3)
III-IV 213 4 (3-6) 7 (5-12-5) 78 (36-6) 6 (2-8)
P <0-0014 <0-0014 0-003$ 0-1331
Sex
M 498 3 (2-5) 6 (4-9) 160(32-1) 11 (2-2)
F 537 3 (2-5) 6 (4-8) 134(25-0) 6(1-1)
P 09861 0-1234 0-011$ 0-1681
Type of surgery
Colonic 724 3 (2-5) 6 (4-8) 185 (25 6) 14(1 -9)
Rectal 311 3 (2-5) 7(5-10) 109 (35 0) 3(1-0)
P 0-1914 <0-0014 0-002$ 0-255$
Type of lesion
Malignant 313 3 (2-4) 6 (4-8) 88 (28 1) 2 (0 6)
Benign 710 3 (2-5) 6 (4-9) 203 (28 6) 13(1 -8)
P 00674 0-1614 0876$ 0-2541
'Values are median (interquartile range); fvalues in parentheses are percentages. ASA, American society of Anesthesiologists. iMann Whitney U test;
§ X2 test; <1Fisher's exact test.
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Discussion
In this study the overall morbidity rate was 28-4 per cent
and the mortality rate was 1 -6 per cent after colorectal
resection. Morbidity was significantly lower than that
predicted by the P-POSSUM system whereas mortality
was similar to the predicted value. Morbidity and mortality
rates in this cohort were lower than those published for the
same units before the introduction of an ERAS protocol
(35 and 2 per cent respectively)18 and for other European
units following traditional care pathways (35-38-3 and up
to 3-4 per cent respectively)21-22. These findings attest to
the safety and potential benefits of the ERAS approach
to perioperative care. Median length of hospital stay was
6 days, which is below that published for similar series
using traditional care in combination with either open18
or laparoscopic21- -24 techniques. The readmission rate of
8-6 per centwas higher than that associated with traditional
perioperative care18, but was considerably lower than the
rate of 20-25 per cent reported for the seminal fast-track
programme in Denmark25.
There was good compliance with the preoperative and
intraoperative elements of the programme, but adherence
to the protocol fell in the postoperative phase, as noted
previously17. Postoperative variables are both markers of
protocol compliance and markers of recovery. Patients
achieving the postoperative goals of the protocol are likely
to be those making good progress and potentially an
accelerated postoperative recovery.
Against a background of favourable clinical outcomes
obtained with the ERAS protocol, the present study
demonstrated that neither BMI below 20 kg/m" nor
age 80 years or more was an independent predictor
of postoperative 30-day morbidity or mortality. The
present results therefore suggest that in the context of
an enhanced recovery programme the surgeon does not
need to individualize postoperative morbidity or mortality
risk assessment for elderly or undernourished patients.
In contrast, co-morbidity was a consistent independent
determinant for a range of outcomes.
The mortality rate for those aged 80 years or above was
3-1 percent in this study. The outcome from elective
colorectal surgery in such elderly patients is variable,
with reported rates from single institutions as low as
1 • I per cent26 and from national studies as high as
11-3 per cent27. When patients have been managed using
traditional perioperative care, age has been demonstrated
repeatedly to be a significant independent predictor
of increased mortality after colorectal surgery, even
when elderly patients have been selected as 'fit for
surgery'28-29. Advanced age has also been related to
increased postoperative morbidity6, and postoperative
Copyright © 2009 British Journal of Surgery Society Ltd
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pulmonary and renal complications in the elderly have
been shown to be independent predictors of decreased
long-term survival30. However, for older patients who
make it through the immediate postoperative period, 5-
year survival of those aged 80 years or more is similar to that
of the younger group31. This has led to a call for improving
perioperative care ofelderly patients, includingmeasures to
minimize in-hospital postoperative complications"0. The
results of the present study suggest that age is no longer
an independent risk factor for mortality when patients are
managed within an enhanced recovery programme. This
is in keeping with a recent meta-analysis15, and suggests
that the principles of relatively stress-free surgery and
minimization of organ dysfunction translate into reduced
morbidity and decreased risk of surgery in the elderly.
Elderly patients are a heterogeneous group and the use
of age to predict surgical outcome may be confounded
by differences in cancer stage29, tumour site and, most
significantly, increased co-morbidity. However, age is not
always associated with increased co-morbidity and excellent
outcomes after major surgery in the elderly have been
documented26. In this present series, age was significantly
related only to time to achieve targeted mobilization and
total hospital stay. The increase in length of hospital
stay might be attributed to delayed discharge related to
difficulties in arranging social care17-32.
In the UK, current guidelines suggest that all patients
admitted for major abdominal surgery should undergo
nutritional screening (National Institute for Health and
Clinical Excellence perioperative guidelines3 '). The basis
for this recommendation lies in the observation that
malnourished patients are at increased risk ofpostoperative
morbidity and mortality, and that nutritional support
might attenuate such risk. However, routine preoperative
nutritional screening has been difficult to achieve and one
UK study noted that it took place in only 33 per cent of
patients . The present study demonstrated that low BMI
is not an independent risk factor for adverse outcome when
patients are managed within an ERAS programme and so
nutritional screening may not be required. Indeed, the
metabolic and nutritional elements of the ERAS protocol
are designed to minimize catabolism35. However, there are
clear limitations to the use ofBMI for screening nutritional
status. Some patients weigh less than is usual for their
height but are otherwise fit and healthy, and a normal BMI
does not exclude the presence of malnutrition. Despite
these limitations, BMI is regarded generally as a robust
'field' method, especially within a large population. BMI is
used as part of the nutritional assessment guidelines of the
European Society for Clinical Nutrition and Metabolism36
and in the Malnutrition Universal Screening Tool37
www.bjs.co.uk British Journal ofSurgery 2009; 96: 197-205
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published by the British Association for Parenteral and
Enteral Nutrition.
Co-morbidity is a significant predictor of postoperative
outcomes after open surgery (with traditional perioperative
care) as evidenced by its use in the POSSUM scoring
system16, the ASA risk stratification system and, most
recently, the simplified risk stratification system38. The
present study confirms such findings for open surgery
combined with enhanced recovery. It has been suggested
previously that ERAS programmes might benefit those
with significant cardiorespiratory or renal co-morbidity39,
and this benefit might be most evident in vulnerable
subgroups such as the elderly. The present study
demonstrated lower morbidity rates with use of an
ERAS protocol even though 20-6 per cent of patients
had significant co-morbidity (ASA III or IV). Thus,
although co-morbidity is still a highly relevant predictor
of outcome, it may be modulated beneficially by the ERAS
approach.
Rectal surgery and male sex were identified as
independent predictors of total length of hospital stay
and postoperative morbidity. These associations could
be explained by the known increased risk in rectal
surgery itself and the greater difficulties of dissection
in the male pelvis40. The present data set was initiated
at a time when there was uncertainty about the value
of mechanical bowel preparation. Patients who received
mechanical bowel preparation had a significantly greater
complication rate than those who did not, consistent
with the current literature41. The ERAS protocol now
recommends the use ofmechanical bowel preparation only
in specific circumstances (such as low anterior resection
with a covering ileostomy).
An ERAS protocol represents an overall strategy to
condition all patients, and to improve all aspects of
perioperative care and outcome. The present study lends
support to this approach. The challenge remains how to
optimize the ERAS protocol further. These results suggest
that a focus on improvement oforgan function impaired by
common causes ofco-morbiditymay be one route forward.
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Colon lipoma mimicking appendicitis
A 62-year-old patient was admitted with suspected appendicitis. On the preoperative CT
scan, a 4 x 6 x 8 cm lipoma was found with suspicion of invagination of part of the ileum. A
right hemicolectomy was done; the lipoma was ulcerated at the apex which explained the
symptoms. The patient had an uneventful recovery and was discharged on the 5 th
postoperative day.
Sadowski-Cron C, Tharakan S, Muff B.: Department of General Surgery, Spital Biilach, CH - 8180 Biilach,
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Gastric emptying of three liquid oral preoperative metabolic preconditioning
regimens measured by magnetic resonance imaging in healthy adult volunteers:
A randomised double-blind, crossover study
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SUMMARY
Background & aims: Preoperative starvation has many undesirable effects but the minimum length of
fasting is limited by gastric emptying, which may be dependent on nutrient content, viscosity and
osmolarity of the feed. We compared the gastric emptying of two types of preoperative metabolic
preconditioning drinks [Oral Nutritional Supplement (ONS) (Fresenius Kabi, Germany) and preOp®
(Nutricia Clinical Care, UK)] in healthy volunteers.
Methods: Twenty (10 male, 10 female) healthy adult volunteers were studied on 3 separate occasions in
a randomised crossover manner. Volunteers ingested 400 ml preOp®, which is a clear carbohydrate drink
(CCD) (50 g carbohydrate, Og protein), 70 g ONS (50 g carbohydrate and 15 g glutamine) dissolved in
water to a total volume of 400 ml (ONS400) and 300 ml (ONS300). Gastric emptying time was measured
using magnetic resonance imaging.
Results: Mean (95% CI) T50 and T100 gastric emptying times for CCD were significantly lower
(p< 0.001) compared with ONS400 and ONS300. T50 was 47 (39-55), 78 (69-87) and 81 (70-92) min
for CCD, ONS400 and ONS300 respectively. Correspondingly T100 was 94 (79-110), 156 (138-173) and
162 (140-184) min. Residual gastric volumes returned to baseline 120 min after CCD and 180 min
after ONS400 and ONS300.
Conclusions: The faster gastric emptying for CCD compared to ONS400 and ONS300 signifies that gastric
emptying may be more dependent on nutrient load than volume or viscosity in healthy volunteers.
While it is safe to give CCD 2 h preoperatively, ONS400 and ONS300 should be given at least 3 h
preoperatively.
© 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
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Modern perioperative care, in particular the introduction of
Enhanced Recovery After Surgery programmes, has dramatically
improved the speed of postoperative recovery and reduced
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postoperative morbidity.1 Within these programmes patients are
no longer starved for 12 h prior to major surgery but instead follow
current anaesthetic guidelines which recommend intake of clear
fluids up until two hours before initiation of anaesthesia and a six
hour fast for solid food.2"4 As part of current fasting guidelines,
preoperative metabolic conditioning with 400 ml of a clear carbo¬
hydrate drink (CCD) two hours before the induction of anaesthesia
has been shown to reduce postoperative insulin resistance, post¬
operative nausea and vomiting and preoperative discomfort and
anxiety, and improve patient well-being.5"8 This volume of CCD
empties completely from the stomach within 90 min and does not
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increase aspiration risk during induction of anaesthesia.5 One
currently available CCD, [Nutricia preOp® (Nutricia Clinical Care,
Trowbridge, UK)], has already been shown to be safe in a large
number of patients undergoing major abdominal surgery.5'9"12
The use of additional metabolic conditioning agents such as
glutamine and antioxidants may be of potential benefit to patients
undergoing major abdominal surgery. Glutamine is a conditionally
essential amino acid, which improves both gastrointestinal perfu¬
sion and immune function.13 Antioxidant supplementation has
been demonstrated to improve morbidity and survival in critically
ill patients.14 A new product containing glutamine and antioxidants
in addition to carbohydrate [Oral Nutrition Supplement (ONS),
Fresenius Kabi, Bad Homburg, Germany] may, therefore, provide
additional benefits, beyond carbohydrate loading alone, to surgical
patients. The time taken for ONS to empty from the stomach and,
therefore, the safe time frame for preoperative administration, is
not known. Gastric emptying is affected primarily by nutrient
content, although volume, viscosity15 and osmolality of the feed16
also play a part. It is, therefore, important to control for these
aspects.
Measurements of gastric emptying have been employed to
study gastrointestinal function in a number of conditions, but
results may differ according to the methodology.17,18 Scintigraphic
techniques were regarded as the gold standard for such studies, but
magnetic resonance imaging (MRI) is now becoming established
rapidly as the benchmark test as it provides a direct measure of
gastric volume in real time.19"22
In this study we compared the gastric emptying time, using MRI,
of two different types of preoperative metabolic conditioning
regimes [ONS and CCD (preOp®)] in healthy volunteers. As the
gastric emptying of 400 ml CCD has been determined previously
using scintigraphy,5 we compared identical volumes (400 ml) of the
two drinks with the recommended dose of administration of ONS
(300 ml).
2. Subjects and methods
2.1. Study design, setting and ethics
The protocol for this randomised, double-blind, three-way
crossover study on healthy adult volunteers was approved by the
University of Nottingham Medical School Research Ethics
Committee (approval K/5/2007) and informed written consent was
obtained from all volunteers prior to enrolment. The study was
carried out according to the principles of the Declaration of Helsinki
of the World Medical Association (http://wma.net). A system to
report adverse events was in place.
2.2. Subjects
We studied 20 healthy adult volunteers (10 male and 10 female,
aged 18-45 years), suitable for MRI scanning (e.g. no metal
implants in the body), with a normal body mass index (20-26 kg/
m2) and with no history of abdominal surgery or gastrointestinal
disorders. Female volunteers were included only if they were not
pregnant. A medical questionnaire was administered and a clinical
examination performed prior to recruitment. Any volunteer who
wished to withdraw from the study was entitled to do so at any
time without giving a reason.
2.3. Interventions
Each volunteer was randomised in a crossover manner to ingest
400 ml preOp® (50 g carbohydrate, 0 g protein) (CCD), 70 g ONS
(50 g carbohydrate and 15 g glutamine) dissolved in water to a total
volume of 400 ml (ONS400) and 70 g ONS dissolved in 250 ml
water to a total volume of 300 ml (ONS300). Volunteers reported
for the studies at 0830 h after an overnight fast, on three separate
occasions, each 7 days apart. They were instructed to abstain from
alcohol and medications for 24 h, and caffeine and strenuous
exercise for 18 h. Baseline measurements included height, weight,
body mass index and a fasting MRI scan.
The constituents and physical properties of the three test drinks
are listed in Table 1. The drinks were reconstituted on the morning
of each study and placed into identical opaque plastic bottles by
a person not involved in the study. Volunteers were asked to ingest
the drink from the bottle within 5 min and time zero was defined as
the end of ingestion of the drink.
2.4. Magnetic resonance imaging (MRI)
MRI scanning was performed on a 1.5 T Philips Achieva scanner
(Philips Healthcare, Eindhoven, The Netherlands) at the University
of Nottingham. Each volunteer was positioned supine in the
scanner with a sensitivity encoding (SENSE) body coil wrapped
around the abdomen. First, a coarse scout scan was taken to locate
Table 1
Composition of the drinks.
CCD - clear carbohydrate ONS400 [70 g Oral Nutrition ONS300 [70 g Oral Nutrition
drink (400 ml Nutricia preOp®) Supplement (ONS) dissolved in Supplement (ONS) dissolved in
water to a total volume of 400 mlj 250 ml water to a total
volume of 300 ml]
Carbohydrate
Maltodextrin + saccharose + - 50 g 50 g
modified starch + gum arabic
Maltodextrin + fructose 50.4 g - -
Glutamine - 15g 15g
Vitamin C - 750 mg 750 mg
Vitamin E - 250 mg 250 mg
Green tea extract - 1 g 1 g
3 carotene - 5 mg 5 mg
Zinc - 10 mg 10 mg
Selenium - 150 pg 150 pg
Energy 200 kcal (836 kj) 234 kcal (978 kj) 234 kcal (978 kj)
Dry matter content 11.3% 16.3% 21.8%
pH 4.9 3.9 3.9
Density 1.049 g/ml 1.06 g/ml 1.079 g/ml
Viscosity [at y = 1 (l/s)[ 2.30 mPa 180 mPa 627 mPa
Osmolarity 228 mOsm/kg 508 mOsm/kg 698 mOsm/kg
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the position of the abdominal organs and plan the position of the
image planes followed by a calibration scan allowing automatic
setup of the scanner specific to the volunteer.
For the gastric emptying a balanced turbo field echo (BTFE)
imaging sequence was used to acquire 40 transverse (perpendic¬
ular to the longitudinal axis of the body) images with acquired
planar resolutions of 2.50 mm x 1.56 mm (reconstructed to
1.56 mm x 1.56 mm) and slice thickness of 10 mm. This BTFE
sequence (TR = 2.4 ms, TE = 1.19 ms, flip angle 45°) visualises fluid
containing structures (hydrated test meals) with bright contrast
against the surrounding organs. Each image set was acquired
during a breath-hold of 17.6 s. MRI scans were performed in the
fasted state (baseline), immediately after ingesting the drink (time
0), and then at 20 min intervals until the stomach was empty.
The data set from each time point was recalled on a UNIX
workstation and viewed to locate the gastric lumen and its
contents. An example of a series through the abdomen of one
subject is shown in Fig. 1. On such transverse sections, Analyze 6
(Biomedical Imaging Resources, Mayo Clinic, Rochester, MN) was
used to trace manually around the region of interest (ROl) of the
gastric contents on each slice. After this the volume of the gastric
contents at each time point was calculated by summing across all
ROls. The totals for each time point were then tabulated and plotted
onto spreadsheets in Microsoft® Excel (Microsoft® Corporation) to
determine the gastric emptying kinetics. Individual gastric
emptying curves were fitted on Microsoft® Excel to calculate the
gastric half emptying time, T50. The curves were then extrapolated
to baseline in a linear manner to calculate Tioo- The volume
remaining in the stomach at t= 60, 120 and 180 min were also
measured using MRI.
2.5. End points and sample size
The primary end point of the study was time to half gastric
emptying (T50) of the three test drinks as measured by MRI.
Secondary end points included Tioo gastric emptying time and
residual gastric volumes at 60, 120 and 180 min. Based on pilot
scans, we anticipated a mean difference in T50 gastric emptying
time of 30 min with a standard deviation of 30 min between CCD
and ONS400. Assuming an a error of 0.01 and a power of 90%, the
sample size was calculated to be 18. We recruited 20 subjects,
making allowance for a 10% drop out rate.
2.6. Randomisation and blinding
The order of administration of the three test drinks was deter¬
mined using a web-based random number generator (http://www.
randomizer.org/). Allocations were then concealed in sequentially
numbered sealed opaque envelopes in triplicate, and were opened
before each leg of the study by a person not involved in the study.
That person then reconstituted the drinks, transferred them to
opaque bottles and handed them to the investigators. Both the
subjects and the investigators were blinded to group allocation. The
randomisation code was broken after completion of the statistical
analysis.
2.7. Statistical analysis
As the data were distributed normally, all results were
expressed as mean (95% CI) or mean (SE). Differences between
groups were tested for significance using the Student t-test (paired
and unpaired), and were considered significant at P< 0.05. Statis¬
tical analysis was performed using SPSS forWindows® v 16.0 (SPSS
Inc., Chicago, 1L, USA) and graphs were plotted on Microsoft® Excel.
2.8. Role of sponsors of the study
This was an investigator initiated study and the sponsors did not
have any role in the study design, data collection, analysis and
interpretation, writing of the paper or in the decision to submit the
paper for publication.
3. Results
The mean (SE) age, weight, height and body mass index (BM1) of
the 20 volunteers were 29.4 (1.7) years, 68.1 (2.1) kg, 1.70 (0.02) m
and 23.4 (0.4) km/m2 respectively. Corresponding values for the 10
male volunteers were 33.0 (2.5) years, 75.3 (2.3) kg, 1.74 (0.03) m
Fig. 1. Sequential axial MRI scans in one subject before and after ingestion of the drink.
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Table 2
Residual fasting gastric volume.
All subjects Male subjects Female subjects
(n = 20) (n = 10) (" = 10)
Before CCD (400 ml Nutricia preOp®) 21(12-30) 21(6-35) 21(7-35)
Before ONS400 [70 g Oral Nutrition Solution (ONS) 29(17-41) 27(7-47) 31 (12-49)
dissolved in water to a total volume of 400 ml)
Before ONS300 [70 g Oral Nutrition Solution (ONS) 32(22-42) 34 (23-46) 30(11-49)
dissolved in 250 ml water to a total volume of 300 ml]
Total 27(21-33) 28(19-36) 27 (18-36)
All values are mean (95% CI) ml. None of the differences were statistically significant.
and 24.7 (0.3) km/m2 and for the 10 female volunteers 25.8 (2.0)
years, 60.8 (1.4) kg, 1.66 (0.02) m and 22.1 (0.6) km/m2. All subjects
completed the three arms of the study and none had to be with¬
drawn. One subject experienced mild nausea after ingesting
ONS300, but there were no other side effects. Residual gastric
volume, as measured by MRI, after an overnight fast, ranged from
0 to 95 ml (Table 2). Mean (95% CI)Tso gastric emptying times were
significantly lower (p < 0.001) with CCD, being 47 (39-55) min
compared with 78 (69-87) and 81 (70-92) min for ONS400 and
ONS300 respectively. Corresponding Tioo times were 94 (79-110),
156 (138-173) and 162 (140-184) min (Figs. 2 and 3). Although T50
and Tioo gastric emptying times were 11-14 min and 22-28 min
respectively longer in females than males, these differences were
not statistically significant. The residual gastric volumes at 60,120
and 180 min are shown in Fig. 4. At 120 min, the residual volume
for CCD was equivalent to the fasting residual volume (p = 0.84),
while this volume was significantly greater than the fasting residual
volume for ONS400 (p < 0.001) and ONS300 (p = 0.004). The
residual volume for ONS400 and ONS300 had returned to baseline
by 180 min.
4. Discussion
This study has confirmed earlier work that a clear liquid con¬
taining carbohydrate but no protein or fat completely empties from
the stomach in about 90 min5 and, therefore, further supports the
evidence base for the guidelines that patients can have clear fluids
containing carbohydrates up to 2 h before the induction of anaes¬
thesia.2"4,6 However, equally, it has been demonstrated that it may
not be safe to let patients have a liquid suspension containing
carbohydrate and amino acids 2 h prior to anaesthesia and that
a safe duration for ingesting such liquids is 3-4 h preoperatively.
Even after an overnight fast, the stomach is never completely
empty and using direct measurements of gastric content volume, we
have shown that the residual volume in healthy volunteers can range
from 0 to 95 ml with a mean of 27 ml. Fasting residual gastric
volumes were not significantly different when males and females
were compared. CCD, which is a clear solution that contains no fat or
protein, emptied at a significantly quicker rate than ONS400 and
ONS300,which were suspensions. Despite there being a difference in
volume, osmolarity, viscosity and density, the rates of emptying of
drinks ONS400 and ONS300 were similar. These findings suggest that
the gastric emptying of liquids is more dependent on the presence of
particulate matter and the nutrient content rather than general
physical properties such as volume, osmolarity, viscosity and density.
The rate of gastric emptying was slower in female subjects than
in males for all three test drinks, although statistical significance
was not reached due to the relatively small sample size. These
gender differences have been described previously23"25 and may be
due to the relaxational effect of female sex hormones, especially
progesterone, on gastric smooth muscle.23,24 However, given the
relatively small differences in gastric emptying times, it is uncertain
whether these gender differencess are clinically relevant.
Although measurements of gastric emptying time using MRI
have been validated with scintigraphic techniques,21 and our study
has shown that the emptying of CCD using MRI was very similar to
the results obtained with the same drink by Nygren et al.5 using
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Fig. 2. T50 gastric emptying time. All values are mean (95% CI) minutes. For all subjects,
ONS400 vs. ONS300 not significant; CCD vs. ONS400 and CCD vs. ONS300, p < 0.001.
Differences between males and females for each drink were not significant. CCD - clear
carbohydrate drink: 400 ml Nutricia preOp®, ONS400: 70 g Oral Nutrition Supplement
(ONS) dissolved in water to a total volume of 400 ml, ONS300: 70 g Oral Nutrition









































Fig. 3. T100 gastric emptying time. All values are mean (95% CI) minutes. For all
subjects, ONS400 vs. ONS300 not significant; CCD vs. ONS400 and CCD vs. ONS300,
p < 0.001. Differences between males and females for each drink were not significant.
CCD - clear carbohydrate drink: 400 ml Nutricia preOp®, ONS400: 70 g Oral Nutrition
Supplement (ONS) dissolved in water to a total volume of 400 ml, ONS300: 70 g Oral
Nutrition Supplement (ONS) dissolved in 250 ml water to a total volume of 300 ml.







































Fig. 4. Residual gastric volume at 60.120 and 180 min. All values are mean (95% CI) ml. P-values for all subjects: 60 min - CCD vs. ONS400 < 0.001, CCD vs. ONS300 = 0.006, ONS400
vs. ONS300 < 0.001; 120 min - CCD vs. ONS400 < 0.001, CCD vs. ONS300 < 0.001, ONS400 vs. ONS300 = 0.037; 180 min - CCD vs. ONS400 = 0.025, CCD vs. ONS300 = 0.25 (NS),
ONS400 vs. ONS300 = 0.55 (NS). Differences between males and females for each time point were not significant. CCD - clear carbohydrate drink: 400 ml Nutricia preOp®, ONS400:
70 g Oral Nutrition Supplement (ONS) dissolved in water to a total volume of 400 ml, ONS300: 70 g Oral Nutrition Supplement (ONS) dissolved in 250 ml water to a total volume of
300 ml.
by the two techniques are, in fact, slightly different. Scintigraphy
measures the residual isotope in the stomach and not the volume of
the contents. On the other hand, MRI measures the actual volume of
the gastric contents and this is usually a sum of the volume of the
drink administered and the volume of the gastric secretions. The
intragastric volume measured by MRI may, therefore, be increased
by feeds that increase gastric secretion significantly. Amino acids
stimulate gastrin release26 and, hence, gastric secretion27 and thus
may increase intragastric volumes and lead to a delay in decline in
gastric volumes postprandially.
The gastric residual volume had returned to the fasting baseline
within 120 min of ingesting CCD, once again confirming that it is
safe to administer such clear liquids up to 2 h prior to the induction
of anaesthesia. However, for ONS400 and ONS300 the mean
residual gastric volumes at 120 min were 3.4 and 2.4 times the
baseline, suggesting that a 2 h preoperative fast after ingesting
these drinks may not be adequate. However, at 180 min the residual
gastric volumes had returned to baseline for both ONS400 and
ONS300, indicating that this duration of preoperative fasting may
be safe when these drinks are administered. It has been argued that
patients have a certain degree of anxiety in the preoperative period
and that this may prolong gastric emptying time, thereby sug¬
gesting that data obtained from healthy volunteers on gastric
emptying time should be extrapolated to preoperative patients
with caution. However, it has been shown that preoperative
anxiety has no effect on gastric emptying time.5 Morbidly obese
patients have also been shown to have gastric emptying patterns
that are similar to those of lean patients.28,29 Diabetic patients with
autonomic neuropathy can have delayed gastric emptying, possibly
increasing the risk of regurgitation and aspiration,30 and results
obtained from healthy subjects are not applicable to this group of
patients. However, some patients with uncomplicated type-2 dia¬
betes can have normal gastric emptying and a study on preopera¬
tive carbohydrate loading did not find an increased aspiration rate
in type-2 diabetic patients.10 We can, therefore, recommend that
unless significant comorbidity is present, the period of preoperative
fasting after ingestion of 300-400 ml of a liquid suspension should
be between 3 and 4 h. This guidance is in addition to the standard
guidelines issued by several National Anaesthesia Societies rec¬
ommending intake of clear fluids up until 2 h before induction of
anaesthesia and a 6 h fast for solid food.2"4
It has been proposed that patients should be in a metabolically
fed state rather than fasted when they go to theatre. This can be
achieved by provision of a CCD before midnight and 2-3 h before
surgery. This treatment decreases preoperative thirst, hunger and
anxiety5"7 and reduces postoperative insulin resistance signifi¬
cantly.8 It also results in patients being in a more anabolic state with
less postoperative nitrogen and protein losses,31,32 and better
maintained lean body mass11 and muscle strength.33 Data from
a randomised trial suggests that preoperative carbohydrate loading
in patients undergoing colorectal surgery results in a shorter length
of hospital stay.9 Although ONS400 and ONS300 may have the
added advantage of improving gastrointestinal perfusion and
antioxidant defences, further studies looking at pharmacokinetic
profiles, effects on insulin sensitivity, clinical safety and clinical
efficacy have to be undertaken before general use can be
recommended.
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Randomized clinical trial
Randomized clinical trial of laxatives and oral nutritional
supplements within an enhanced recovery after surgery
protocol following liver resection
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Background: Routine laxatives may expedite gastrointestinal recovery and early tolerance of food within
an enhanced recovery after surgery (ERAS) programme. Combined with carbohydrate loading and oral
nutritional supplements (ONS), it may further enhance recovery ofgastrointestinal function and promote
earlier overall recovery.
Methods: Seventy-four patients undergoing liver resection were randomized in a two-by-two factorial
design to receive either postoperative magnesium hydroxide as a laxative, preoperative carbohydrate
loading and postoperative ONS, their combination or a control group. Patients were managed within an
ERAS programme of care. The primary outcome measure was time to first passage of stool. Secondary
outcome measures were gastric emptying, postoperative oral calorie intake, time to functional recovery
and length of hospital stay.
Results: Sixty-eight patients completed the trial. The laxative group had a significantly reduced time to
passage of stool: median (interquartile range) 4 (3-5) versus 5 (4-6) days (P = 0-034). The ONS group
showed a trend towards a shorter time to passage of stool (P = 0-076) but there was no evidence of
interaction in patients randomized to the combination regimen. Median length of hospital stay was 6
(4-7) days. There were no differences in secondary outcomes between groups.
Conclusion: Within an ERAS protocol for patients undergoing liver resection, routine postoperative
laxatives result in an earlier first passage ofstool but the overall rate of recovery is unaltered. Registration
number: NCT00538954 (http://www.clinicaltrials.gov).
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Introduction
If left unchecked, the metabolic response after abdominal
surgery can result in prolonged recovery, increased mor¬
bidity and a longer hospital stay1'2. Enhanced recovery
after surgery (ERAS) programmes combine interventions
that target the elements that delay recovery: pain, gastro¬
intestinal dysfunction and immobility3. Such protocols
are safe, effective, accelerate recovery and reduce hospital
stay following liver resection4, aortic aneurysm repair1,
oesophagectomy6 and colorectal resection7-11.
Copyright © 2010 British Journal of Surgery Society Ltd
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Evidence for the efficacy of individual protocol elements
within an ERAS programme is often extrapolated from
traditional care3. Morbidity and hospital stay are relatively
predictable after liver resection, which provides a suitable
model for testing the individual elements within the ERAS
protocol10-12.
Reduced gastrointestinal function is a major factor
that limits the success of enhanced recovery. Current
protocols employ a multimodal package including contin¬
uous thoracic epidural anaesthesia, enforced mobilization,
avoidance of excessive saline and early feeding which, in
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traditional perioperative care, can reduce postoperative
ileus13-15 or promote earlier passage of stool16. Adminis¬
tration of magnesium hydroxide has been described in an
unblinded, non-randomized study and employed in ERAS
programmes17; however, despite widespread use of laxa¬
tives there is limited evidence to justify their routine post¬
operative use717. Preoperative carbohydrate loading may
also promote earlier return of gastrointestinal function18.
Within an ERAS protocol, carbohydrate loading and early
oral nutritional supplements (ONS) may interact with lax¬
atives to enhance gastrointestinal recovery further.
Early gastrointestinal recovery allows early oral intake,
discontinuation of intravenous fluids and accelerated
recovery. Early food intake may attenuate postopera¬
tive catabolism. Oral carbohydrate loading before surgery
can also reduce this catabolic response and abate insulin
resistance19 20. By improving the response to anabolic stim¬
uli in the postoperative period, metabolic preconditioning
may promote greater benefit from early nutritional intake.
The perioperative administration ofONS has been shown
to improve nutritional status and reduce minor compli¬
cations within traditional perioperative care21'22. It is not
known whether the provision of combined metabolic con¬
ditioning/early oral nutritional support along with early
recovery of gastrointestinal function achieved with magne¬
sium hydroxide can promote more rapid overall recovery
within an ERAS protocol.
The aim of the Optimized Recovery with Accelerated
Nutrition and Gastrointestinal Enhancement (ORANGE)
study was to determine, within an ERAS protocol
designed for hepatic resection, whether postoperative
bowel stimulation with magnesium hydroxide and/or
metabolic conditioning/ONS are effective in promoting
early return of gastrointestinal function and overall
postoperative recovery.
Methods
This prospective randomized controlled trial with a two-
by-two factorial design was conducted with the approval of
Lothian Research Ethics Committee and the Ethics Com¬
mittee of Maastricht University Medical Centre. Patients
gave their written informed consent to participate. All
were between the ages of 18 and 80 years, and scheduled to
undergo hepatic resection for benign or malignant condi¬
tions at the LiverUnit, Royal Infirmary, Edinburgh, UK, or
Maastricht University Medical Centre, The Netherlands,
between July 2006 and June 2008. Patients with a body
mass index of less than 18 or greater than 30 kg/m2, pre¬
existing conditions limiting mobility, underlying cirrhotic
liver disease, a history of liver resection, and those in whom
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bile duct excision and central or extended hepatectomy was
planned before randomization, were excluded.
Recruitment took place during preoperative assess¬
ment at least 1 week before admission, allowing a period
of reflection before obtaining consent. Patients received
information packs and counselling related to the ERAS
programme, highlighting early mobilization and early
oral intake.
Trial protocol
Patients were randomized to one of four groups (con¬
trol, laxatives, ONS and laxatives + ONS). Randomization
was performed using sealed opaque envelopes created in
advance through block randomization with a random num¬
bers table. Owing to the nature of the study interventions
(nutritional supplements available in a variety of flavours to
encourage compliance and magnesium hydroxide suspen¬
sion produced by the hospital pharmacy), a suitable placebo
was not feasible and so the type of treatment could not be
masked. Patients randomized to laxatives received 1 g mag¬
nesium hydroxide orally twice daily from the day of surgery
until discharge. Patients randomized to ONS received
800 ml oral carbohydrate loading drink (Nutricia Prcop";
Nutricia Clinical Care, Trowbridge, UK.) at 22.00 hours
the night before surgery and 400 ml at 06.00 hours on the
morning of surgery. In addition, they received ONS (two
cartons per day comprising 400 ml, 600 kcal, 24 g protein,
Nutricia Fortisip®; Nutricia Clinical Care) from the day of
surgery until day 30. Patients randomized to the laxatives
4- ONS group received the combined regimen.
A standardized perioperative and anaesthetic regimen,
based on a previous ERAS protocol, was followed3. This
multimodal, enhanced recovery programme was modified
to cover all aspects of liver resection4. Notably, liver tissue
sealant (TachoSil®; Nycomed, Zurich, Switzerland) was
used to minimize bile leakage and haematoma formation,
routine perihepatic drainage was avoided and paraceta¬
mol was used at the discretion of the surgeon in cases
of extended resection. Patients were normally scheduled
for surgery in the morning and were nursed in a high-
dependency unit. Details of the ERAS liver protocol are
shown in Table 1.
Seven surgeons performed all resections between the two
centres. The extent of resection was classified according
to the Brisbane 2000 Terminology23. Subcostal incisions
were used and the transection plane determined by preop¬
erative imaging and use of intraoperative ultrasonography.
Resection was performed using a Cavitron Ultrasonic Sur¬
gical Aspirator (CUSA®; Valleylab, Boulder, Colorado,
USA) and argon beam coagulation. The raw surface of the
www.bjs.co.uk British Journal ofSurgery 2010; 97: 1198-1206
1200 P. 0. Hendry, R. M. van Dam, S. F. F. W. Bukkems, D. W. McKeown, R. W. Parks, T. Preston et al.
Table 1 Care plan for patients undergoing liver resection within
an enhanced recovery after surgery protocol
Day before surgery
Normal feeding until midnight
No preanaesthetic medication
Day of surgery
Mid-thoracic epidural analgesia (local anaesthetic and low-dose
opioid)
Short-acting anaesthetic agent
No nasogastric tube (removed immediately after surgery, if used)
Warm intravenous fluids and body warming device
Avoidance of excessive intravenous fluids
No routine drainage of peritoneal cavity
Free oral intake of water/nutrition started immediately
Patient out of bed for 2 h
Day 1 after surgery
Patient mobilized
Intravenous fluids discontinued
Patient to drink at least 1 litre of fluid
Normal diet
Continue mid-thoracic epidural analgesia
Paracetamol 1 g four times daily
Day 2 after surgery
Continue mid-thoracic epidural analgesia
Paracetamol 1 g four times daily
Normal diet
Patient mobilized
Day 3 after surgery
Stop epidural
Commence NSAIDs if appropriate
Remove urinary catheter
Encourage full oral intake and mobilization
Review discharge criteria
Day 4 after surgery
Encourage full oral intake and mobilization
Review discharge criteria
NSAID, non-steroidal anti-inflammatory drug.
liver remnant was subjected to argon beam coagulation and
sealed with TachoSiP. Abdominal drains were not placed
routinely and the abdomen was closed with a standard
running suture.
Study data were documented prospectively during the
hospital stay and 30 days after surgery at an outpatient
visit. Return of gastrointestinal function was determined
by the first passage of stool after surgery. Patients were
assessed for return of gastrointestinal function (passage of
flatus/stool) on a daily basis. Secondary outcomes were:
gastric emptying rate on day 3 after operation as deter¬
mined by stable isotope breath test, postoperative oral
nutritional intake on days 1-3 after surgery, functional
recovery and length of stay.
Stable isotope gastric emptying breath test
On the third day after surgery and following an overnight
fast, some patients in one centre underwent assessment
Copyright © 2010 British Journal of Surgery Society Ltd
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of gastric emptying rate by means of a non-invasive sta¬
ble isotope breath test. This employed a 200-ml liquid
test meal (Nutricia Fortisip" ) containing a stable isotope
tracer (75 mg sodium l-[13C]acetate)24. Breath samples
were collected before and at predetermined intervals fol¬
lowing consumption of the test meal. During the test
period, activity was restricted to allow control and estima¬
tion of the rate of elimination of carbon dioxide25. The
[13C]carbon dioxide enrichment of breath samples ('^C :
12C ratio) was measured by automated continuous-flow iso¬
tope ratio mass spectrometry26. Raw data were subjected to
curve fitting27 to derive the half-time (T1/2) of [bC]carbon
dioxide appearance in breath. The T1/7 for gastric emp¬
tying was estimated using a 'self-correcting' model28 that
accounts for the delayed expiration of [13C]carbon dioxide
owing to pooling within the body's bicarbonate system.
Oral nutritional intake
A senior dietician, in cooperation with the patient and ward
nursing staff, recorded daily postoperative oral intake on a
standard diet sheet. This was converted to energy intake
(in kilocalories) and the recommended nutritional intake
(RNI) was estimated using CompEat Pro'® for Windows'®
(Nutrition Systems, Banbury, UK). The percentage RNI
achieved on the first 3 days after surgery for each subject
was used in comparisons between study groups.
Functional recovery criteria
Functional recovery was defined as adequate pain control
requiring only oral analgesia, adequate oral intake with
no intravenous fluid requirement, independent mobility
sufficient to perform activities of daily living, and blood
results (liver function tests and inflammatory markers)
returning towards normal ranges4. Criteria were assessed
on a daily basis. An experienced clinician determined
readiness for hospital discharge. Time to achieve functional
recovery, initial length of stay (defined as number of nights
in hospital after surgery, excluding readmissions) and all
adverse events up to 30 days were recorded. Morbidity was
documented prospectively according to criteria described
previously29,30. Other data recorded for each patient
included mortality, readmissions and use of preoperative
chemotherapy.
Statistical analysis
Retrospective data (P. O. Hendry and K. C. H. Fearon,
unpublished results) indicated that the mean(s.d.) time to
passage of stool was 5-3(1-3) days. This study was powered
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(a = 0-05, P = 0-80) to detect a 20 per cent difference in
time to passage ofstool, the primary outcome. Based on this
calculation, 14 patients were required in each of the four
groups (56 patients overall). The secondary endpoints were
of an exploratory nature. Continuous data were expressed
as median (interquartile range). For comparison between
study groups, data were analysed usingMann-Whitney U
test, x2 test or Fisher's exact test, as appropriate. P < 0-050
was considered statistically significant. SPSS"" version 17.0
for Mac® (SPSS, Chicago, Illinois, USA) was used for
data analysis.
Results
Between July 2006 and June 2008, 74 patients were
recruited and randomized, 66 in Edinburgh and eight in
Maastricht. Six patients did not undergo hepatic resection
and were excluded. The remaining 68 patients were
managed within the ORANGE protocol (Fig. 1).
Demographic data for the four groups are shown in
Table 2. Overall the male to female ratio was 4: 3 and
median age was 62 (53-69) years. Sixty-two patients
(91 per cent) were treated for malignant disease, and
there were 53 major and 15 minor resections (Table 3).
There were no significant differences across the study
groups in sex, body mass index, American Society of
Anesthesiologists grade, pathology, malignancy, use of
neoadjuvant therapy or extent of liver resection.
Time to functional recovery and initial length of hospital
stay were 4 (3-5) and 6 (4-7) days respectively, and
were not significantly different between groups. The
postoperative morbidity rate was 25 percent overall, and
Fig. 1 CONSORT diagram for the trial. ONS, oral nutritional
supplements
did not differ significantly between the groups. Two
patients required reoperation owing to postoperative
haemorrhage. Five patients required readmission to
hospital (intra-abdominal collection, 2; severe constipation,
1; bile leak, 1; pneumonia, 1). There were two deaths from
myocardial infarction within 30 days of surgery (Table 4).
Discharge from hospital was delayed in some patients for
reasons outlined in Table 5.
Oral fluid intake was resumed on the day of surgery
in 94 per cent of patients. Reintroduction of diet was
achieved on day 1 in 3 7 per cent and by day 2 in
Table 2 Demographic and clinical data
Laxatives Oral nutritional supplements
Overall (n = 68) No (n = 34) Yes (n = 34) P No (n = 38) Yes (n = 30) P
Age (years)* 62 (53-69) 62 (51 -70) 61 -5 (55-69) 0-722* 65 (51 -70) 61 (52-63) 0-243+
Sex ratio (M: F) 38:30 21 :13 17:17 0-464* 20:18 18:12 0626*
ASA grade
1 15(22) 7(21) 8(24) 9(24) 6 (20)
II 43 (63) 20 (59) 23 (68) 23 (61) 20 (67)
III 10(15) 7(21) 3(9) 0-391* 6(16) 4(13) 0-973*
Body mass index (kg/m2)* 25 (23-28)1 25 (23-31) 25 (22-28) 0 394+ 25 (22-28) 25 (23-29) 0-882+
Pathology
Malignant disease 62 (91) 30 (88) 32 (94) 1-000* 35 (92) 27 (90) 1 -000*
Colorectal liver metastases 56 (82) 26 (76) 30 (88) 31 (82) 25 (83)
Other metastatic disease 6(9) 4(12) 2(6) 4(11) 2(7)
Benign disease 6(9) 4(12) 2(6) 0445* 3(8) 3(10) 0-829*
Neoadjuvant therapy 22 (32) 9 (26) 13(38) 0-127* 13(34) 9(30) 0-797*
Values in parentheses are percentages unless indicated otherwise; "values are median (interquartile range). ASA, American Society of Anesthesiologists,
tMann-Whitney U test; fx2 test. HCorrection added after online publication 26 May 2010: Body mass index 22 (23-28) was corrected to 25 (23-28).
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Table 3 Extent of liver resection
Laxatives Oral nutritional supplements
Overall (n = 68) No(n = 34) Yes (n = 34) P* No (n = 38) Yes (n = 30) P*
Major (trisectionectomy, central hepatectomy, hemihepatectomy) 53 25 28 31 22
Minor (sectionectomy, segmentectomy, metastasectomy) 15 9 6 0 560 7 8 0-557
Values in parentheses are percentages. 'Fisher's exact test.
Table 4 Outcome data
Laxatives Oral nutritional supplements
Overall (n = 68) No (n = 34) Yes (n = 34) P No (n = 38) Yes (n = 30) P
Time to first drink* 0 (0-0) 0 (0-0) 0 (0-0) 1 OOOf 0 (0-0) 0 (0-0) 0-8087
Time to first food* 1 (1-1) 1 (0-1) 1 (0-1) 0-2187 1 (0-1) 1 (0-1) 04997
Time to first flatus* 3 (2-4) 3 (2-4) 2-5 (2-3-5) 0 1087 3 (2-5) 3 (2-4) 0-2627
Time to first stool* 5 (4-6) 5 (4-6) 4 (3-5) 0 0341 5 (4-7) 4(3-5) 0-0767
Time to functional recovery* 4 (3-5) 4 (3-4-5) 4 (3-5) 0-2427 4 (3-5) 4 (3-4) 0-1107
Initial hospital stay* 6 (4-7) 5 (4-6) 6 (5-8) 0-0817 6(5-7) 5 (4-7) 03677
Readmission 5(7) 3(9) 2(6) 1 -000§ 3(8) 2(7) 1-0005
Reoperation 2(3) 1 (3) 1 (3) 1 0005 2(5) 0(0) 0-5045
30-day morbidity 17(25) 8(24) 9(26) 1 -OOOS 11 (29) 6(20) 0-5745
30-day mortality 2(3) 2(6) 0(0) 0-4945 2(5) 0(0) 0-5005
Values in parentheses are percentages unless indicated otherwise; 'values are median (interquartile range). IMann-Whitney U test; 5Fisher's exact test.
Table 5 Reasons for delayed discharge
No. of
patients
Caution owing to earlier complication or extensive surgery 5
Patient not confident to be discharged 4
Transport or social problems 2
Patient boarded to another ward before discharge 1
Patient drowsy owing to analgesia 1
91 percent. Intravenous fluids were discontinued on day
1 in 51 per cent of patients and by day 2 in 78 per cent.
Mid-thoracic epidural anaesthesia was commenced before
surgery in 99 per cent of patients and continued for at least
48 h after operation in 93 per cent; four epidurals failed
on day 1. Drains were used in nine patients (13 per cent).
Nineteen patients (28 percent) achieved mobilization on
the day of surgery. Sixteen patients (24 per cent) had
a urinary catheter in place beyond discontinuation of
epidural analgesia and 32 (47 per cent) received non-
protocol intravenous fluids in the perioperative period.
Overall, the median time to passage of stool was 5
(4-6) days. Patients randomized to ONS showed a trend
towards a shorter time to passage of stool: 4 (3-5) versus
5 (4-7) days (P = 0-076). Those randomized to laxatives
had a significantly reduced time to passage of stool: 4 (3-5)
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versus 5 (4-6) days (P = 0-034). Patients randomized to the
combination regimen also had a significantly reduced time
to passage of stool: 3 (3-4) versus 6 (4-7) days (P — 0-013).
There was no evidence of interaction between laxatives and
ONS (Fig. 2).
Thirty-two of 56 patients asked to participate in the gas¬
tric emptying protocol completed it (7 control, 10 laxative,
8 ONS, 7 laxative + ONS). Median postoperative gastric
emptying (T\/i) was 0-74 (0-46-1-41) h, with no significant
difference between study groups. Five patients had signif¬
icantly delayed gastric emptying (T1/2 more than the 90th
percentile of 1-69 h). In comparison with the remaining 27
patients who underwent measurement of gastric emptying
rate, this group had a significantly prolonged hospital stay:
10 (7-11) versus 6 (5-7) days (P = 0-019).
Oral intake of at least 50 per cent of recommended
nutritional requirement was achieved at a median of 1
(1-2) days after surgery for the whole group. This was not
significantly different between groups. Total calorie intake
(including ONS) on days 1-3 after surgery for those ran¬
domized to ONS was not significantly different from that
in patients who did not receive ONS (Fig. 3). The median
percentage change in bodyweight from preoperative level
for all subjects was 4-1-82 (-1-41 to 5-82) and -2-01
(-4-65 to -0-34) per cent on days 5 and 30 respectively
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Fig. 2 Interaction between laxatives and oral nutritional



























Fig. 3 Total calorie intake during the first 3 days after surgery.
Values are median with interquartile range. ONS, oral
nutritional supplements
after surgery; there were no significant differences between
groups (P = 0-166 and P = 0-200 respectively).
Discussion
In this study, laxatives significantly decreased the time to
passage of stool after liver surgery. Those randomized to
the combination regimen also had a significantly reduced
time to passage of stool, but with no evidence of interaction
between laxatives and ONS. There were no differences in
secondary outcomes between groups. These results are in
keeping with previous findings3132.
Previous studies suggested that early restoration of food
intake results in a more rapid return of gut function in
the postoperative period16. In the present study, calorie
intake (food plus ONS) of the group randomized to ONS
was no different from that of patients who did not receive
ONS, suggesting that ONS in the early postoperative
phase suppressed normal food intake to the point at
which there was no net benefit. The lack of interaction
between laxatives and ONS could therefore be explained
on the basis that ONS did not alter overall calorie intake.
This would also explain the lack of effect of ONS on the
secondary outcomes.
Patients following the ERAS protocol recommenced
oral fluid on the day of surgery, started eating the following
day, were mobile by the third day and achieved discharge
criteria on the fourth day. Median hospital stay was 6 days,
which is significantly shorter than the 8-14 days reported
in other centres following traditional perioperative
care11,12-33-34. This study provides further evidence to
support the use of an ERAS pathway following liver
resection to accelerate postoperative recovery and shorten
length of stay. It remains unclear which components of
reduced stay result from the introduction of a formal care
pathway rather than the enhanced recovery elements of
that pathway. In the present study, functional recovery
was achieved a median of 4 days after surgery, a median of
2 days before discharge from hospital. Itmay be possible to
achieve a shorter overall hospital stay by further tightening
the care pathway elements of the protocol35.
In this study, the overall morbidity rate was 25 per cent,
with a readmission rate of 7 per cent and mortality rate
of 3 per cent. Morbidity rates were lower and mortality
rates in keeping with those published from other countries
following traditional care (38-45 and 2-7-3-1 per cent
respectively)11 ■3 3 -36.
All patients received preoperative counselling and there
was a high level of compliance with most elements of
the protocol. Ninety-nine per cent of patients received
preoperative epidural anaesthesia. Intraoperative drainage
was used only in patients considered to have a higher
risk of bile leakage (13 per cent), in keeping with current
evidence3'38.
In the early postoperative period, adherence to the
protocol was lower than in the preoperative and intra¬
operative phases, as in previous studies35'39. Intravenous
fluids were discontinued on the day after surgery in
only half of the patients. Saline (0-9 per cent) was often
prescribed by out-of-hours medical staff, less familiar
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with the study protocol. Only 28 per cent of patients
were mobilized on the day of surgery; usual reasons
for failure to achieve this were epidural-related hypoten¬
sion or late return to the high-dependency unit. Future
ERAS protocols may overcome the issue of late return
to the ward by initiating mobilization in the recov¬
ery room. Postoperative variables are markers of both
protocol compliance and recovery; patients achieving
these protocol goals are those likely to achieve a faster
recovery.
There were no significant differences between study
groups in the rate of gastric emptying. The gastric
emptying protocol was available for 56 patients in the study,
but it was impractical for 15 and refused by nine patients.
The absence of significant differences between the groups
should be interpreted with caution. The use of a stable
isotope gastric emptying breath test as a postoperative
recovery marker is novel. Stable isotope gastric emptying
breath testing40'41 requires no specialist technical skills
and is well tolerated. This is an inexpensive method for
determining the gastric emptying rate and may be an
objective marker of recovery in the early postoperative
period. The limitations of the test may preclude it from
being suitable for comparing subjects with rapid gastric
emptying. It may be better suited to highlighting patients
who have delayed gastric emptying and are likely to have
a slower return to full diet, longer hospital stay and slower
postoperative recovery. In the present protocol, day 3 after
surgery was chosen for this test because the patients had
returned to the ward. It would be of interest to study this
variable at other time points.
Within the context of multimodal therapy it is difficult
to separate the effect of one protocol component from
another. A two-by-two factorial design is an efficient
way of assessing two different factors and evaluating their
potential interaction. The statistical design of the present
study meant that there was a potential confounder in
50 per cent of each group under description; this reflects
the exploratory nature of the evaluation of potential
interactions.
The present study has shown that laxatives can hasten
return of colonic function in patients undergoing hepatic
resection. However, there was no evident interaction with
ONS. More importantly, there seemed to be no benefit in
terms of enhanced oral intake or overall recovery. Thus
the benefit of routine laxatives or ONS is difficult to gauge.
Clearly the present findings cannot be extrapolated directly
to patients with an intestinal anastomosis. Future studies
might also evaluate the interaction between the present
variables and other measures designed to improve upper
gastrointestinal function and oral intake.
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